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Abstract
Over 50% of non-traumatic spinal cord injuries (NTSCI) are caused by mechanical
compression either due to osteophytes in degenerative disease, or tumours (New et al.,
2014). The pathophysiology of NTSCI is poorly understood, with no distinct injury
cascade (Karadimas et al., 2013). The aim of this project was to evaluate cellular
responses to mechanical insults in the context of NTSCI.
In-vitro, a model was developed to apply high and low velocity compression to
astrocyte-seeded collagen hydrogels. Outcomes included hydrogel contraction, GFAP
expression, cellular shape, and cytokine release. In-vivo a balloon lesion model was
modified to induce a non-traumatic ventral lesion, by developing an injection port and
inflating over 3 days. Functional deficits and histological outcomes were assessed.
In-vitro, 100 mm.s-1 compression elicited an astrogliotic and inflammatory response
from day 11, indicative of TSCI. This comprised a significant increase in GFAP area
per cell, astrocyte ramification, and IL-6 expression. Conversely, at <100 mm.s-1, no
differences were observed. The findings of this study suggest slow compression of
astrocytes alone does not induce NTSCI.
In-vivo, surgery was undertaken on 10 animals (including 3 shams). In injury groups,
functional deficits were observed , which increased with each inflation. Animals were
grouped into mild and severe based on their motor function (severe animals exhibited
paraplegia). Minimum motor function correlated with minimum cross-sectional area,
and greater parenchyma disruption. In the severe group only, there was a trend of mild
astrogliosis, demyelination and vasculature narrowing at the epicentre. This corresponds
with the wider literature, where demyelination and disruption to the vasculature are
hypothesised to be involved in NTSCI pathology.
Overall, in-vitro and in-vivo models of NTSCI have been successfully developed.
Physiological changes were observed in both models, with differences to TSCI. Further
investigations can be undertaken to understand the pathology of NTSCI.
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Chapter 1
Introduction
1.1 Preface
1.1.1 Spinal Cord Injury
The spinal cord connects the brain and peripheral nervous systems, processing and
transmitting motor and sensory information, and modulating reflex responses. Spinal
cord damage through compression or other mechanisms causes dysfunction in the form
of pain, limb weakness, numbness, bladder/bowel dysfunction, and irregular gait (NICE,
2016). Clinical outcomes vary with magnitude, type of injury, severity, location and
biomechanical origin. Spinal cord injuries can be classified by velocity. High velocity
insults, up to 4.5 m.s-1 (Wilcox et al., 2003), cause traumatic spinal cord injuries (TSCI).
Conversely, slow velocity insults where trauma is not involved, with development over a
timescale between months to years, can be classified as non-traumatic spinal cord injuries.
NTSCI are predominantly caused by chronic illness and disease, with 50% caused by
degenerative diseases and cancers (New et al., 2014). The key features which distinguish
NTSCI from TSCI, as determined by Karadimas et al. (2015) are:
1. No acute mechanical insult, slow velocity compression
2. Absence of gross haemorrhagic necrosis
1
Chapter 1. Introduction
3. Chronic and progressive nature (likely induces compensatory mechanisms)
There is a lack of data describing the epidemiology and aetiology of NTSCI. This is
likely to be due to the wide range of causes, the lack of national registries, and the
secondary nature of NTSCI leading to patients not always being admitted to specialist
spinal cord injury units (New et al., 2014). The prevalence of NTSCI has been estimated
to be 1120 per million and 2310 per million in the only two studies undertaken (Razdan
et al., 1994; Noonan et al., 2012). Annual incidence is estimated to be between 6 and 76
cases per million (New et al., 2014). Since the incidence of traumatic injury is estimated
to be between 10 and 40 cases per million per year, NTSCI affects the same number
or more people annually than traumatic injury (Lee et al., 2014). Demographic studies
have identified that NTSCI patients have median ages of 62 to 67 years old; with an even
gender divide (Gupta et al., 2009; Guilcher et al., 2010; New et al., 2011). In TSCI,
approximately 80% of patients are males and the mean age is between 38 and 52 years
old (Cosar et al., 2010; New et al., 2011; World Health Organisation, 2016).
Spinal cord injuries are a complex clinical problem, affecting quality of life and
lifespan. Alongside the damage caused by injury, complications and secondary illnesses
occur frequently in spinal cord injury, and vary based on type of injury. Urinary tract
infections, spasticity and pressure ulcers affect at least 20% of NTSCI patients (Gupta
et al., 2009). Mortality in all patients with spinal cord injury is up to three times greater
than the general population, with significantly higher levels of mortality in NTSCI patients
than TSCI patients (van den Berg et al., 2010). This difference in patients with NTSCI
may be due to the increased age of NTSCI patients, as well as increased rate of co-
morbidities in such populations.
New and Jackson (2010) carried out a study evaluating the costs associated with SCI
patients. In TSCI, the first admission to hospital is longer and more costly for traumatic
injury ($54,000, 51.3 days) than NTSCI ($18,000, 16.5 days). Patients with NTSCI had
an increased rate of subsequent readmission with disease progression, whereas this was
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not the case for TSCI patients. Therefore, comparing NTSCI and TSCI, case-by-case
costs are estimated to be similar overall (New and Jackson, 2010). However, NTSCI has
an increased prevalence than TSCI and therefore, may be a greater direct cost to society.
Indirect socio-economic losses to society also occur in spinal cord injuries. These are
linked to insufficient or inappropriate transport services and accessibility, chronic pain
and high rates of depression; all causing reduced societal participation (Goossens et al.,
2009; Ataoglu et al., 2013).
In patients with NTSCI, treatment is limited and predominantly involves surgical
decompression and fixation (NHS, 2010; NICE, 2015, 2016). These interventions may
arrest injury progression, but neurological deficits remain and one in twenty patients are
at risk of severe neurological complications (Alafifi et al., 2007).
With prevalence predicted to increase with the ageing population, a deeper
understanding and characterisation of NTSCI is needed to guide management and
improve outcomes of such injuries. Experimental models may be used to develop
understanding of the pathology of spinal cord injuries.
Both in-vitro and in-vivo models of spinal cord injury allow evaluation of cellular
and tissue morphology at various timepoints both before and after the injury. They also
allow greater control of the injury parameters themselves, minimising the variation seen
clinically. Together, this means greater understanding of how injury mechanics affect
injury outcomes can be established. In-vivo models allow assessment in a whole system
approach, and understanding of how systems interact in the injury cascade. However,
this can mean factors associated with other biological systems (e.g. an immune response,
damage to musculoskeletal tissues instead of the spinal cord) confound results and the
exact cause and response of a particular insult on a particular cell population cannot be
elucidated. Further, there are ethical implications of using animals for research. The 3R
principles (refinement, reduction and replacement) guide researchers towards alternatives
to in-vivo models. In the case of spinal cord injury and other neural injuries, there
have been studies using isolated primary cell populations in matrices to elucidate injury
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mechanisms. The advantages of in-vitro modelling are that the effects of a single input on
a single output can be studied in isolation, however the relevance to clinical physiology
must be validated. Once experimental models of injuries have been established, they
provide a platform for developing and testing new treatments.
1.1.2 Research Purpose
Non-traumatic spinal cord injury (NTSCI) has a poorly established pathophysiology in
spite of its increasing prevalence. Slow velocity lesions over an extended time frame are
rarely evaluated in spinal cord injury studies in-vitro and in-vivo. Therefore, neural cell
responses to such mechanical insults are not known. Other studies have shown that injury
mechanics directly affect outcomes in clinical circumstances, preclinical, and cellular
models. This research aims to establish how changing mechanical insults affect neural
cell responses in the context of NTSCI, through development of experimental models
(Figure 1.1). The first chapter will entail a literature review, describing the anatomy and
physiology of the spinal cord, pathology in spinal cord injuries, and methods to model
spinal cord injury experimentally.
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Figure 1.1: Overview of the core aims, research questions posed, and chapters in this thesis.
The document is split into seven chapters, incorporating literature review; general methods;
development and results from in-vitro and in-vivo studies; and a discussion.
5
Chapter 1. Introduction
1.2 Spinal Anatomy and Physiology
1.2.1 Gross Anatomical Structure
The spine provides skeletal stability and mobility from the skull to the pelvis (Harms and
Tabasso, 1999). In human adults, the spine is a column of 24 individual vertebrae plus the
fused sacrum and coccyx (comprising of and 4 vertebrae, respectively). Articulating (i.e.
non-fused) vertebrae are divided into anatomical regions, comprising 7 cervical (C1-7), 12
thoracic (T1-12), and 5 lumbar (L1-5) vertebrae. Vertebrae are connected with ligaments,
muscles and intervertebral discs (White and Panjabi, 1990). Each individual vertebra has
a central vertebral foramen which forms the vertebral canal running the length of the
spinal column (Figure 1.2). This encloses and protects the spinal cord; part of the central
nervous system. When the spinal cord is damaged, neurological deficits occur.
Figure 1.2: Anatomy of a single vertebra (left) and diagram of the gross structure and
meninges of the spinal cord (right). The vertebra shown is a superior view of L5. The spinal
cord sits within the central vertebral foramen, and runs from the base of the skull to the lumbar
region. The meninges protect the spinal cord. Image adapted from Gray (1918)
The spinal cord runs from the brain cranially to the cauda equina after approximately
the first lumbar vertebra (Martini et al., 2011). It is surrounded by meninges (the dura,
arachnoid and pia mater, Figure 1.2), which create a barrier to prevent entry of foreign
entities, and provide both form and physical protection for the cord (Russi and Brown,
2015). The spinal cord is 42 to 45 cm long, with a cylindrical shape 10 to 15 mm in
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diameter (Gray, 1918; Fratini et al., 2014). The diameter is largest at the cervical and
lumbar enlargements, where nerves from the limbs enter the spine (Panjabi et al., 1991,
1992). A total of 31 pairs of nerve roots split laterally from the spinal cord through the
interpedicular spaces, with one pair at each vertebral level (Martini et al., 2011). Each
nerve root innervates or is innervated by a distinct area of the body. These regions can be
roughly mapped on the skin as dermatomes (Greenberg, 2003; Lee et al., 2008).
1.2.2 Spinal Cord Cell Types
Neural tissue, including the spinal cord, comprises cellular components (80% of
total volume) in an extracellular matrix (20% of total volume) of proteoglycans and
glycosaminoglycans; which form basement membranes around vasculature, interstitial
matrix between cells, and organised perineuronal nets surrounding neurons (Nicholson
and Sykova, 1998; Sobel, 1998; Kwok et al., 2011; Burnside and Bradbury, 2014;
Haggerty et al., 2017). Cells interact with the matrix via trans-membrane integrins and
their receptors; which modulate behaviours such as plasticity, synapse formation, and
axon sprouting (Crapo et al., 2012). Neurons and glia are the two major cell types
in the spinal cord, and they have distinct roles (see Table 1.1). Neurons are oriented
cells which are responsible for the electrical signalling. They have a central cell body
and processes called neurites which either receive or transmit information (dendrites and
axons, respectively). Glial cells play a supporting role, and the two types of glia core to
spinal cord injury responses are astrocytes and microglia.
Astrocytes are the most abundant cell type in the CNS, constituting up to 30%
of all cells (Liddelow and Barres, 2017). They form connections with nodes of
Ranvier, modulating neuronal electrical transmission; synapses, regulating chemical
neurotransmission; vasculature and other astrocytes (Sofroniew, 2005). In the CNS, only
astrocytes express glial fibrillary acidic protein (GFAP). The amount of GFAP expressed
by astrocytes varies under physiological conditions in different brain regions (Schitine
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Table 1.1: Cell types in the central nervous system. The spinal cord contains neurons and glial
cells. The axons of cells in the white matter are coated with myelin, an insulating substance
increasing the speed of electrical propagation. The information in this table is simplified for the
scope of this project. (Gray, 1918; Sofroniew and Vinters, 2010; Burke et al., 2016)
Cell type Spinal cord location Function
Inter-
neurons
Within the grey matter. Their
axons are short and predominantly
unmyelinated.
Modulate (activate or inhibit) local
neurons in the grey matter
Motor-
neurons
(efferent
neurons)
Cell soma in the ventral grey
matter. Axons leave the spinal cord
via the ventral horn.
Receive electrochemical
information from interneurons and
descending tracts and transmit
information to effectors.
Sensory
neurons
(entering
cord)
Cell soma in dorsal root ganglia,
axons project onto neurons in grey
matter
Afferent myelinated neurons
transmit sensory information from
the peripheral to central nervous
systems.
Astrocytes The most common glial cell type,
found through the spinal cord.
They have a stellate shape.
Maintaining electrochemical
gradients, contributing to electrical
behaviour, controlling blood flow,
and metabolite storage/transport
Microglia Throughout the spinal cord Specialised macrophages with a
role in protection and repair of the
spinal cord
Oligo-
dendro-
cytes
Higher density within the white
matter
Myelinating cells, ensheathing
axons and creating the myelin
sheath.
et al., 2015). Morphological differences in astrocytes were identified even in Cajal’s early
drawings from the late 19th century (Garcia-Lopez et al., 2010). Two well established
populations from these drawings are fibrous and protoplasmic astrocytes (Garcia-Marin
et al., 2007). Fibrous astrocytes have longer but fewer processes, and are found in
the white matter; whereas protoplasmic astrocytes have a greater number of shorter
projections and are located in the grey matter (Khakh and Sofroniew, 2015). The latest
methods in molecular biology have shown that heterogeneity in astrocyte populations
extends to differences in gene expression, electrophysiological properties, and functional
differences. These have been reviewed extensively in the literature, yet clear consensus
on further sub-populations and their specific functions remains to be established (Zhang
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and Barres, 2010; Schitine et al., 2015; Yoon et al., 2017).
1.2.3 Spinal Cord Tissue Regions: Grey and White Matter
Further, the cord can be compartmentalised into grey and white matter (Gray, 1918; Silva
et al., 2014). The grey matter is central, and contains multipolar neurons. Neurons in
dorsal regions are innervated by sensory afferents, and those in ventral regions innervate
peripheral effectors. The white matter is made up of axons sheathed in myelin, an
insulating substance with a high fat content which improves conduction of electrical
impulses. These axons run along the length of the cord, and are grouped into tracts which
either ascend and transmit information to the brain, or descend and transmit information to
effectors (Figure 1.3). Ascending tracts have cell soma in the grey matter, with myelinated
axons which project into the white matter and transmit information up to the brain.
Conversely, descending tracts originate from cell soma in the brain, where myelinated
axons form tracts in the white matter that allow descending control of motor outputs by
modulating motorneurons. Damage to any of these tracts can cause functional deficits
that are apparent in spinal cord injury. The ventral spinal artery runs along the length of
the spinal cord within the ventral median fissure.
In man, the largest sensory tract is the dorsal column medical lemniscus pathway.
Found in the medio-dorsal area of the spinal cord white matter, this tract transmits
fine touch and conscious proprioception (Navarro-Orozco and Bollu, 2018). The
spinothalamic tract transmits nociception, thermoception and crude touch (Devlin, 2012).
The corticospinal tract is the major motor pathway, controlling voluntary distal
movements, including skilled movements such as walking (Welniarz et al., 2017).
Damage to the tract has profound effects on walking (Nathan, 1994; Petersen et al., 2012).
The corticospinal tract has has two components, dorsal and ventral. The lateral fibres
are lateral to the grey matter dorsal horn, whereas the ventral fibres are in the ventral
white matter, adjacent to the ventral median fissure. The ventral bundle innervates trunk
muscles, and as such ends at the mid-thoracic level (Lingford-Hughes and Kalk, 2012).
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In the dorsal column medial lemniscus tract and lateral corticospinal tract, the lateral
most axons transmit information from and to the legs. Medial to these axons are areas
associated with the trunk, and medial to the trunk axons are areas associated with the
arms (Raiszadeh and Spivak, 1999).
Figure 1.3: Human spinal cord cross-section showing grey and white matter, with position of
ascending and descending tracts Grey matter forms a central butterfly-like shape; white matter
surrounds this and contains tracts. Ascending tracts (on the left of the diagram) transmit sensory
information from effectors to other parts of the central nervous system. Motor tracts (right of the
diagram) transmit motor information from the brain to caudal parts of the nervous system. Image
adapted from (Watson et al., 2009)
1.2.4 Mechanical Properties of the Spinal Cord
Understanding the mechanical properties of the spinal cord can help predict responses to
loading, deformation, and injury (Clarke, 2011). There is no consensus on the properties
of the spinal cord; with elastic modulus ex-vivo being reported between 40.12 kPa to
1.37 MPa for post-mortem human tissue (Bilston and Thibault, 1996; Mazuchowski and
Thibault, 2003; Karimi et al., 2017), and 6.63 to 40 kPa for other mammals (Chang
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et al., 1981, 1988; Ichihara et al., 2001; Fiford and Bilston, 2005). It is worth noting
that these studies all use post-mortem tissue, and not tissue in-situ, which could affect
results. Variations in values are likely to be due to differing experimental procedures and
apparatus. A recent review describes the advantages, disadvantages and confounding
potential of several methods for testing the mechanical properties of the spinal cord
(Bartlett et al., 2016a). For instance, the tissue source (species, age) and preparation can
affect reported material properties of the spinal cord. This was demonstrated in a study
which conducted tensile mechanical testing of porcine spinal cords in-vivo and ex-vivo
showed significantly greater peak stress and relaxation in ex-vivo specimens (Ramo et al.,
2018).
Further, the spinal cord is anisotropic and viscoelastic, which may also lead to
differences in measured mechanical properties (Feng et al., 2013). The stiffness of
viscoelastic materials therefore depends on the strain rate (Dogliotti and Yelland, 1964;
Hussein, 2018). These properties are seen widely across organised soft tissues (Fung,
1993; Taylor et al., 2009). They also add complexity to mechanical testing where factors
such as pre-conditioning, strain rate, and amount of strain must be controlled during
each test (Bilston and Thibault, 1996; Ichihara et al., 2003). As an example, increasing
the strain rate from 0.5 s-1 to 50 s-1 in transverse compression increased the compound
elastic modulus of the porcine spinal cord by 170% (Fradet et al., 2016). In-vivo the
cord is subject to perfusion pressure of between 60 and 90 mmHg (Werndle et al., 2014),
temperature of 36.6oC ± 1oC (Khan et al., 2007), and a pH of 7.32 (Langer et al., 2016).
These environmental factors are often unreported, yet inadequate replication of these
conditions during mechanical testing could contribute to variation.
Overall, the spinal cord is a complex anisotropic structure with non-linear
viscoelastic properties and a low elastic modulus (Clarke, 2011). The reproducibility of
previous data, its relevance to human tissue in-vivo and how these mechanical properties
influence injury are not fully understood. The low elastic modulus of the spinal cord
means that it is easily deformed which has the potential to damage cells. It is important
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to understand the extent physiological deformation of the spinal cord before the impact of
spinal cord injury can be established.
1.2.5 Physiological Deformations on the Spinal Cord
The greatest physiological deformation of the spinal cord occurs during flexion-extension
movements, and at rest due to rhythmic movements associated with breathing and
circulation. Flexion causes an increase in cervical cord length of 7% for the ventral region,
and 11% for the dorsal region (Koschorek et al., 1986; Yuan et al., 1998; Kuwazawa
et al., 2006). The thoracic spinal cord has less mobility due to attachment of the ribcage
(Harrison et al., 1999a; Lee, 2015). By contrast, there is substantial elongation (3.6%) of
the lumbosacral cord (Tani et al., 1991; Harrison et al., 1999b). At the conus medullaris,
which is tethered to the coccyx, movement is minimal in flexion (Fettes et al., 2006). This
reduced vertebral canal diameter means impingement onto the spinal cord is increasingly
likely; in particular during extension where in healthy populations the vertebral canal
decreases in diameter by 3 to 5% (0.5 mm) (Sayıt et al., 2015). Spinal cord deformation
from 0.60 to 1.32 mm has been identified during the cardiac cycle and forced breathing
(Cai et al., 2007; Figley and Stroman, 2007; Winklhofer et al., 2014). Although these
values are minimal and not an issue for the healthy population, in patients with spinal
canal stenosis and vasculature remodelling they may be different and become problematic,
resulting in spinal cord impingement.
The spinal cord is deformable, and deformations during physiological movement do
not lead to functional deficits. When a mechanical insult results in supra-physiological
loading or displacement of the cord, cells in the spinal cord either directly become
damaged, respond to the change through direct connections to the extracellular matrix,
or respond indirectly through signalling mechanisms or ischaemia. The close interactions
between neural cells and the spinal cord extracellular matrix mean mechanical insults to
the cord have the capacity to cause changes in cellular phenotype and function.
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1.3 Spinal Cord Injury Pathophysiology and
Biomechanics
International standards have been developed to categorise injury (International Standards
for Neurological Classification of Spinal Cord Injury, published by the American Spinal
Injury Association (ASIA)). (Kirshblum et al., 2011). Injury level describes where along
the length of the spinal cord it has been damaged. Absence of sensation or motor output in
one dermatome means the injury is above that associated vertebra. The lowest dermatome
where function is normal is defined as the level of injury. Further, injury severity is based
on which tracts or cells are damaged. ‘Complete’ injuries occur when the entire cord
is damaged, and no motor or sensory function is maintained. If there is any motor or
sensory function below the injured level, the injury is ‘incomplete’. Across all global
regions, 71% of patients with NTSCI experience paraplegia, the remaining 29% are
tetraplegic (New et al., 2014). Further, incomplete injuries are 20 to 40% more common
than complete injuries (McKinley et al., 1999; Cosar et al., 2010; Marinho et al., 2012).
This indicates that NTSCI predominantly affect areas below the lower cervical region
and do not damage all tracts i.e. are incomplete and cause paraplegia. These facts are
important considerations in experimental modelling of NTSCI.
1.3.1 Pathological Cascade in Spinal Cord Injury
Categorisation of NTSCI based on aetiology has only recently been attempted; and
divides injuries into congenital-genetic or acquired disorders (New and Marshall, 2014).
Acquired disorders such as degeneration and neoplasms are biomechanical in origin
(i.e. caused by direct compression of the spinal cord) and will be the focus of this
study. The biological consequences of chronic compression-induced spinal cord injury
have similarities and differences to that of traumatic injury (Table 1.2). Many of the
pathological features found in NTSCI have not been extensively assessed or reliably
established, and further study is required. Conversely, in traumatic spinal cord injury,
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a primary and secondary injury cascade have been identified and well-established (Anwar
et al., 2016; Morin, 2018). Primary injury comprises the discrete mechanical insult itself
and associated cell death, whereas secondary injury entails ischaemia, necrosis, Wallerian
degeneration, and glial scar formation (Table 1.2). The glial scar and astrogliosis are
major parts of the secondary injury cascade in traumatic spinal cord injury, and are
initiated by glial cells in the spinal cord. This separation of injury into primary and
secondary events is clear in traumatic injuries since the injury itself is a one-off, singular
event. In NTSCI, there is no clear pathological distinction between primary and secondary
events due to the continuous nature of the insult. In NTSCI with a biomechanical
sequence, the canal is slowly and progressively occluded.
There have been several attempts to identify the change in cross-sectional area
required to elicit symptomatic spinal cord compression at the cervical level. Differences
in cross-sectional area reduction observed in symptomatic and asymptomatic populations
have ranged from 15 to 30% (Penning et al., 1986; Kadanka et al., 2017). One study using
a cut off of 60%, found that after 5 years, 100% of subjects with over 60% reduction in
spinal cord cross-sectional area developed myelopathy (Matsunaga et al., 2008). This
study did not define how they determined if myelopathy was present. Other studies have
tried to identify asymptomatic cervical cord compression in healthy subjects, but findings
have indicated a change in shape (i.e. one dimension of the cord such as anterio-posterior
diameter due to disc protrusion), and no reported significantly different changes in cross-
sectional area (Boden et al., 1990b; Matsumoto et al., 1998, 2013; Nakashima et al., 2016;
Martin et al., 2018). A discordance exists between imaging outcomes and spinal cord
compression (Witiw et al., 2018).
Similar trends have been identified in lumbar stenosis. Asymptomatic patients often
have degenerative changes and disc herniation (Boden et al., 1990a). A multi-centre
analysis found radiological severity was not associated with clinical outcomes before
or after decompressive surgery in lumbar stenosis (Weber et al., 2016). Another study
found that a 25% reduction in spinal cord (dural sac) cross-sectional area was associated
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with low back pain, but only used participants from one area of Japan (Iwahashi et al.,
2016). A retrospective study identified a reduction in vertebral canal cross-sectional area
of 41% and a reduction in dural sac cross-sectional area of 47% between control and
symptomatic patients (Lim et al., 2017). These studies do not indicate the minimum
value of compression at which symptoms occur, but this must be below the range of 25
to 50%. Overall, the picture for lumbar stenosis is no more clear than that of cervical
myelopathy, and the radiological criteria currently are not well established (Steurer et al.,
2011).
Overall, the effect of compression extent and reduction of cross-sectional area on
symptoms is not clear. Studies are contradictory, but suggest that a reduction in area of
15 to 50% is apparent in symptomatic populations. Compression of the spinal cord above
the threshold level damages nerve fibres (Table 1.2). Increasing compression corresponds
with onset of symptoms, which then progressively deteriorate as occlusion continues to
increase (Kim et al., 2004; Kubota et al., 2011). The latent period, followed by insidious
onset of symptoms and progressive deterioration are key features of NTSCI.
The picture is further complicated since stenosis identified on MRI or CT scans does
not correlate with functional deficits, due to viscoelasticity, remodelling and plasticity of
neural circuits in the spinal cord. Instead, NTSCI is associated with a 33% reduction in the
number of local blood vessels (Karadimas et al., 2013; Long et al., 2014). Microvascular
remodelling has traditionally been measured with ex-vivo extraction and preparation of
the tissue for antibody-labelling. This has disadvantages and results in poor understanding
of disease progression due to the limited availability of samples over time. However,
future improvement in microCT scanning may provide a method for assessing vascular
changes in-vivo. This may give a more accurate representation of changes associated
with injury (Long et al., 2014). Improved understanding of the mechanisms of NTSCI is
required, particularly how the extended time frame and slow velocity of the primary insult
influences the pathological cascade.
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Table 1.2: Pathophysiology of spinal cord injuries. Symptoms are similar between traumatic
and non-traumatic injury, but pathophysiologies are distinct. Abbreviations: CNS = central
nervous system; IHC = immunohistochemistry; NTSCI = non-traumatic spinal cord injury; TSCI
= traumatic spinal cord injury.
Feature Traumatic spinal cord
injury
Non-traumatic spinal
cord injury
References
Timescale/
velocity
High velocity acute
injuries – dynamic
loading at 4.5 m/s
No quantitative detail of
velocity
NTSCI: no studies
available. TSCI
(Wilcox et al.,
2003)
Immediate
(primary)
changes
Gross damage causing
non-specific cell death,
haematoma, microglial
activation and ischaemia
No changes occur
immediately due to the
long term nature of this
type of injury
TSCI: (Donnelly
and Popovich,
2008; Rowland
et al., 2008)
Vascular
changes
Gross immediate
ischaemia due to damage
to vasculature from insult
itself.
Gradual compression of
the cord in confined
environment reduces local
vascular supply
(ischaemia). Endothelium
is disrupted, unknown
mechanisms.
NTSCI:
(Karadimas et al.,
2013; Long et al.,
2014).TSCI:
(Anwar et al.,
2016)
Vascular
remodelling
No opportunity for
remodelling during the
injury process as insult is
immediate.
Vascular remodelling seen
in humans and animal
studies. Chronic
compression leads to local
hypoxia, and
compensatory changes.
NTSCI: (Doppman,
1990; Kurokawa
et al., 2011;
Karadimas et al.,
2012)
Blood-spinal
cord barrier
Dramatically disrupted in
injury event and
subsequent cytokine
release, but permeability
recovers after several
weeks
Increased permeability
due to endothelial cell
damage – allow white
blood cells to enter. This
is maintained to chronic
stages
NTSCI:
(Karadimas et al.,
2013). TSCI:
(Strbian et al.,
2008; Cohen et al.,
2009)
Cell death Necrosis. Cell contents
are released from neurons
and endothelial cells
which are damaged during
the insult. This causes
necrosis.
Apoptosis, as determined
in several human tissue
and animal experiments.
Predominantly
oligodendrocyte apoptosis
with some neuronal cell
loss (see ’Myelin’)
NTSCI:
(Newcombe et al.,
2015).
TSCI:(Macaya and
Spector, 2012)
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Pathophysiology of spinal cord injuries continued
Feature Traumatic spinal cord
injury
Non-traumatic spinal
cord injury
References
Neuronal
(Wallerian)
degeneration
Expansive number of
secondary consequences
causes injury site to
expand, and nearby axons
to further degenerate,
forming neuronal end
bulbs
Wallerian degeneration
has been seen in mouse
models, proportional to
compression. This occurs
mainly in ventral horn
neurons (motor neurons in
grey matter)
NTSCI: (Uchida
et al., 2002).
TSCI:(Dong et al.,
2003; Bradke et al.,
2012)
Immune cell
invasion
Injury immediately
activates microglia.
Neutrophils invade after 3
hrs, but M1 macrophages
infiltrate at day 7 and 60
Microglia activate, recruit
peripheral immune cells
(predominantly
macrophages, less
lymphocytes and
neutrophils)
NTSCI: (Yu et al.,
2011). TSCI:
(Anwar et al.,
2016; Kjell and
Olson, 2016)
Effect of
immune
response
Inflammatory response up
to day 7 (M1
macrophages), followed
by anti-inflammatory M2
macrophages stabilisation
of scar
M1 macrophage
activation, leading to
synapse degeneration
proportional to
compression
NTSCI: (Takano
et al., 2014). TSCI:
(Zhou et al., 2014)
Myelin Oligodendrocyte necrosis
within an hour of injury
due to enzyme release
from nearby cells, chronic
apoptosis due to Wallerian
degeneration.
Demyelination occurs due
to oligodendrocyte
apoptosis. Some evidence
myelin is susceptible to
mechanical pressure.
NTSCI:
(Karadimas et al.,
2013). TSCI:
(Dong et al., 2003;
Almad et al., 2011)
Glial scar
formation
Astrocytes at periphery of
lesion are activated, and
express glial fibrillary
acidic protein. Forming a
scar
No reports of in-vivo glial
scar formation in the
literature. Human MRI
studies show lightened
areas which may be
gliosis
NTSCI: (Coronado
et al., 2009). TSCI:
(Wanner et al.,
2013)
Lesion
expansion
Oligodendrocyte
apoptosis away from
initial site causes
expansion
Not established TSCI: (Almad
et al., 2011; Aarabi
et al., 2012)
Plasticity Short timescale of acute
injury – no plasticity
Long timescale permits
CNS plasticity
NTSCI: (Zhou
et al., 2015)
17
Chapter 1. Introduction
1.3.2 Biomechanical Events in Spinal Cord Injury
The mechanics of traumatic spinal cord injuries vary with injury type. Dislocation,
flexion-distraction and burst fracture account for 75% of all traumatic injuries; these
are associated with lateral translation, tension and compression respectively (Sekhon and
Fehlings, 2001; LaPlaca et al., 2007). In burst fractures, vertebral bone fragments are
displaced into the vertebral canal at velocities of between 1 and 4.5 m.s-1 (Wilcox et al.,
2003). Clinically, the severity of traumatic injuries, in particular car crashes, depends on
the velocity and energy transferred to the spinal cord (Smith et al., 2005). For instance,
people in vehicles colliding with fixed objects had a greater risk of severe spinal cord
injury (Bilston et al., 2011); as did those not wearing a seatbelt (Funk et al., 2012).
This highlights the importance of and interaction between velocity, force and energy in
outcomes of spinal cord injury.
NTSCI involves increasing compression of the spinal cord over an extended period
of time. The two major causes, degenerative disease and neoplasms, will be discussed
further. It is worth noting that neoplasms also have the potential to cause a burst tissue
fracture (Whyne et al., 2003; Tschirhart et al., 2004). Degenerative disease, known as
spondylosis, stenosis or myelopathy, can occur at any level but cervical spondylotic
myelopathy and lumbar stenosis are major causes of NTSCI (Kalsi-Ryan et al., 2013).
The diseases begin in the spinal discs, with the central gel-like nucleus pulposus losing its
water drawing capacity and becoming increasingly stiff (Roughley et al., 2006; Ferrara,
2012). This means intradiscal pressure and disc height are reduced, and the disc begins
to herniate dorsally into the vertebral canal. Further, the reduced load-bearing capacity of
the disc causes impairment of the dorsal ligamentous complex which, in turn, increases
load on vertebral endplates (Baptiste and Fehlings, 2006; Ferrara, 2012; Tetreault et al.,
2015). In response to this, osteophytes can grow from the ventral vertebral body into the
vertebral canal which further impinge the cord. These changes are exacerbated over time
and compression of the cord continues. As an example, one study found that cervical
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spondylotic myelopathy can cause a reduction in cervical canal diameter of 3.03 ± 0.99
mm (Jiang et al., 2016). It is worth noting that these causes of injury (osteophytes and
disc degeneration) compress the cord from the ventral aspect, and predominantly cause
flattening and indentation; both direct compression without shear components (Martin
et al., 2018). The time frame or velocity, and pressure or load, exerted onto the spinal
cord in these injuries had not been quantified in the literature. If the timeframe were to be
estimated, this would be between weeks for an infection, up to months for a cancer, and
years for bone spurs.
A total of 70% of neoplasms in the spine affect the thoracic region, with metastases
arising from the ventral vertebral body (Klimo and Schmidt, 2004). In these tumours,
cancer cells multiply and form a tumour which can grow into the foramen and thus
compress the spinal cord. Similarly to spondylosis or myelopathy, these tumours
compress the cord from the ventral aspect. Alternatively, metastases can cause fractures
to the vertebral body, resulting in TSCI, although the frequency of this is not fully
understood (Hamimi et al., 2015). Biomechanical-induced NTSCI causes increasing
displacement of the spinal cord, which in turn causes symptomatic onset. Further research
is required to establish the importance of factors such as velocity and displacement in
non-traumatic spinal cord injury; and the response of neuronal or glial cells in isolation
compared with a whole-system.
1.4 Experimental Modelling of Spinal Cord Injury
Experimental models can be used to investigate spinal cord injury; including improving
understanding of pathophysiology. Spinal cord injury models have been developed using
both in-vivo and in-vitro methods; the utilities and drawbacks of each of these will be
further discussed.
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1.4.1 Modelling Spinal Cord Injury in-vivo
In-vivo models recapitulate the complex architecture of the spinal cord and allow it to be
evaluated in the context of other biological tissues and systems, and with greater detail
than would be possible in human studies. Animal experiments allow recordings before,
during and after the injury process by terminating animal at various timepoints. This
detail of baseline, injury pathology, and recovery is not feasible clinically. Further, the
injury process can be controlled and measured in order to minimise variation.
Rats are widely used in spinal cord injury studies. They have reduced ethical
constraints, are well understood, easy to handle, relatively low cost, small enough to house
in substantial numbers, and of sufficient size to undertake spinal cord surgery without
specialist equipment (Talac et al., 2004; Zhang et al., 2014). Rat models of traumatic
spinal cord injury have shown a pathological cascade involving initial haemorrhage and
subsequent scar formation, similar to that of humans (Kjell and Olson, 2016). All animal
models come with limitations and restrictions. Across animal research, adherence to the
‘3R’ principles motivates researchers to use fewer animals wherever possible (Russell
and Burch, 1992). Nevertheless, in-vivo rat models remain essential in studying complex
pathologies using a whole system approach.
There are anatomical differences between humans and rats which have the capacity
to alter outcomes of spinal cord injury. The rat spinal cord is approximately 3.5 mm
in diameter; compared with 12.5 mm for a human spinal cord (Watson et al., 2009).
This means functional recovery following injury is more likely in rats since axons have a
reduced distance to grow and therefore neural networks can be more easily re-established
(Kjell and Olson, 2016). Furthermore, the locations, size, and relative importance of
ascending and descending tracts are different in humans and rats (Figure 1.4 compared
with Figure 1.3 in section 1.2). In humans, the major corticospinal bundle is in the
lateral column while in rodents it is in the ventral part of the dorsal funiculus. The
corticospinal tract is responsible for voluntary skilled movements (Silva et al., 2014).
20
Chapter 1. Introduction
In man, the corticospinal tract has evolved for extensive fine control of distal muscles;
and some fibres synapse directly onto motor neurons. Rats do not have such sensitive
digital control, and the corticospinal tract projects onto interneurons in the grey matter
(Watson et al., 2009). In rats the reticulospinal tract and spinothalamic tract are closest to
the ventral median fissure. The reticulospinal tract has large numbers of connections to
interneurons and propriospinal neurons in rats (Mitchell et al., 2016). The tract initiates
motion and is responsible for postural control and left right motor activity in rats. In
rats, the spinothalamic tract, in the ventral funiculus, transmits crude touch and pressure
(Sengul and Watson, 2015).
Figure 1.4: Rat spinal cord cross-section showing grey and white matter, with position of
ascending and descending tracts Grey matter forms a central butterfly-like shape; white matter
surrounds this and contains tracts. Ascending tracts (on the left of the diagram) transmit sensory
information from effectors to other parts of the central nervous system. Motor tracts (right of the
diagram) transmit motor information from the brain to caudal parts of the nervous system. Image
adapted from (Watson et al., 2009)
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1.4.1.1 Inducing Non-Traumatic Spinal Cord Injury In-vivo
To accurately recapitulate the types of injuries experienced by humans in animal models
is challenging for several reasons; summarised in Table 1.3. Clinical injuries are caused
by a series of internal pathological events; whereas the injury in animal models is induced
by external mediators. Furthermore, the clinical time frame of NTSCI is in the range of
months to years, and extended beyond the lifespan of a rat. Therefore, time frames must
be scaled down to suit the model. Across models of NTSCI, the temporal profile is a
key factor which should be represented. The three stages of injury progression are initial
stenosis of the canal with no symptoms (a latent period), followed by increased stenosis
and symptom onset, followed an increase in symptom severity (functional degeneration)
(Kim et al., 2004). The parameters most pertinent to this study are the biomechanics to
induce injury, and methods to measure outcomes.
Factors which must be considered in developing an in-vivo model of NTSCI include:
• Capacity to control the insult i.e. control the degree of stenosis during the study
• Capacity to measure the insult i.e. measure the degree of stenosis either during or
after the study
• As minimally invasive as possible to prevent disruption to spinal stability
• In keeping with time scale of the project
• From the ventral aspect to mimic clinical NTSCI injuries
• Allow decompression
• Replicate temporal profile (i.e. not in the range of milliseconds).
This last factor of timescale is core to modelling NTSCI as opposed to TSCI. All the
other factors would be relevant for both NTSCI and TSCI.
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Table 1.3: The ideal animal model of non-traumatic spinal cord injury. In-vivo modelling of spinal cord injury of traumatic origin is
well established. However to accurately model non-traumatic injuries, and their subsequent stabilisation, further considerations must be
taken into account and measured.
Factor Details Confounding potential Control or measurement Reference(s)
Injury level Clinically, most NTSCI occurs
at thoracic or lumbar levels.
Surgically, consider
surrounding tissues
Injury level in-vivo directly
affects outcome measures.
High risk at cervical and
lumbar levels due to increased
vascular density
Injure at the lower thoracic
level on all animals to be
clinically relevant, aid
outcome measure and
preclude risk
(Tveten, 1976;
McKinley
et al., 1999)
Surgical
approach for
inducing
pathology
Clinically, surgery does not
cause NTSCI and most lesions
are from ventral vertebral
body. Surgically, minimise
surrounding tissue damage.
Different approach will cause
different symptoms due to
anatomical asymmetry of the
spinal cord. A dorsal approach
and laminectomy is
technically easier in surgery
and minimises tissue damage.
Ideally injure using a ventral
method, but accessing the
injury site dorsally. Use sham
procedure and healthy control
groups to ensure the surgery
itself is not confounding
results.
See text in this
section for
further details.
Extent of
injury
Clinically, injuries are
incomplete, and symptoms
occur with stenosis greater
than 22 to 25% vertebral canal
cross-sectional area.
Differing extent of injury will
directly affect symptoms and
outcomes of animal model
Vertebral canal stenosis should
be the same extent in all
animals. Maximum canal
stenosis should be less than
100%. Measure where
possible (MRI/CT imaging)
(Teresi et al.,
1987; Dimar
et al., 1999;
Nakashima
et al., 2016;
Sun et al.,
2016)
Injury
timescale
Clinically, NTSCI take place
over months to years.
Surgically, must consider the
time/cost requirements in
relation to the research project.
A fast injury would induce
traumatic spinal cord injury;
which has a different
pathological cascade to
non-traumatic injuries.
10 years in a human is
approximately equivalent to 2
weeks, 1 year in a human is
equivalent to 1.5 days.
Therefore, the timescale of the
injury should be greater than
1.5 days in a rat.
(Quinn, 2005;
?)
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The ideal animal model of non-traumatic spinal cord injury continued.
Factor Details Confounding potential Control or measurement Reference(s)
Method for
inducing
injury
Should recapitulate clinical
temporal profile of injury, and
symptoms. Surgically, lesion
should be closed (i.e. no
laminectomy at lesion site
itself)
Non clinically-relevant
paradigm will not cause a
relevant NTSCI; so subsequent
investigations will not be valid
Develop a method using a
closed lesion site. Ex-vivo
characterisation of method
prior to use in animals. Then,
able to correlate compression
with functional deficits.
See text in this
section and
Table 1.4
Decomp-
ression
Clinically, decompression is
the main treatment for NTSCI.
Surgically, must be able to
remove the cause of
compression without causing
further damage
Must be able to remove cause
of compression easily and
prevent further damage to
surrounding tissues
Develop a method where
decompression is facilitated.
Compare injured and sham
operated/control groups
None found.
No studies
have
undertaken
decompression.
Physiological
outcomes
Outcomes must be relevant to
clinical non-traumatic injury
Poor measurement of
outcomes will prevent valid
conclusions being drawn about
effects of injury/intervention
Behavioural methods
(BBB/locomotor analysis),
electrophysiology, imaging,
ex-vivo outcomes
(Kwon et al.,
2002; Sharif-
Alhoseini and
Rahimi-
Movaghar,
2014)
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Several methods have been developed for inducing NTSCI in-vivo. The most basic
involves implanting a material into the vertebral canal; however this does not replicate
the unique temporal profile of NTSCI (Sekiguchi et al., 2004; Ito et al., 2007; Karadimas
et al., 2013). One method which replicates the temporal profile is a screw-tightening
model, wherein a device is implanted that can manually compress the cord with each
screw turn; but this method is highly invasive (Xu et al., 2008; Lee et al., 2012; Sun et al.,
2016). A further, less invasive model involves using a wire to surround the spinal cord of
a juvenile rat. As the rat grows, the cord compresses (Iwamoto et al., 1995; Kubota et al.,
2011). The cord is compressed in all directions, whereas clinically in NTSCI compression
is from the ventral aspect alone. Further, this method has a time frame of 9 months for
each rat, so is not suitable for use in the present study. Finally, the model of injury
must allow decompression for future research into interventions. Injection of cancer cells
to form metastatic lesions has been used to induce NTSCI in previous in-vivo models;
but this method has a lack of control of stenosis, and the process of decompression is
highly complex (Hojjat et al., 2012; Zibly et al., 2012). The remaining two methods in
the literature have the potential to be minimally invasive, with increasing compression, a
relevant temporal timescale, and allow decompression. These are an expanding material;
or an implanted balloon catheter (Table 1.4).
It is worth noting that the balloon catheter method has only been used to induce
traumatic injuries (i.e. expand fully immediately upon insertion, followed by removal
before suturing). This method could be adapted by implanting the balloon catheter in the
vertebral canal, and inflating it slowly over an extended time period relevant to NTSCI.
Clinically, NTSCI occurs ventrally (see section 1.3.2), whereas all models used for NTSCI
have introduced the injury from the dorsal aspect or by compression the entire cord.
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Table 1.4: Previous balloon catheter or expanding material in-vivo models of spinal cord
injury. Expanding material models induced NTSCI (increase in area over an extended duration);
whereas balloon catheter models caused TSCI (increase in area during surgery, and immediately
decompress). All of these models used a dorsal approach. CSA: cross-sectional area.
Reference Method Model Size/volume
changes
Timeframe
(Kim et al.,
2004) Aquaprene
material
Rat C5-6 Initially 3 x 5 x 0.7
mm.
Volume increased
by 24% in 24 hours
(Kurokawa
et al., 2011)
Rat, C5-6 Initially 3 x 5 x 0.7
mm.
Not described
(Hu et al.,
2011)
Agarose gel
polymer, dried
and coated with
polyurethane
membrane with
laser-cut
microholes
Rat,
Cervical
Size described as
‘thin’.
Maximum
expansion in 24 hrs
(Long et al.,
2013)
Rat, C5-6 1 x 3 x 1 mm; max.
expansion (7x)
volume in 2 or 24
hr
Changes not
reported
(Xu et al.,
2017)
Rat, C5-6 Not described Not described
(Yang et al.,
2015)
Polymer network
1:1 polyvinyl
alcohol and
polyacrylamide
Rat T8-9 Initially 2.5 x 2.0 x
0.8mm to 3.5 x 3.0
x 2.4mm
Not described
(Fonseca
et al., 2016)
Expanding balloon
(4F fogarty
catheter)
Rabbit Inflated with 1000
µL air
Inflated rapidly, left
for ten minutes,
then removed
(Vanicky
et al., 2001)
Expanding
balloon (2F
fogarty
catheter)
Rat, T8-9 Inflated with 10 to
20 µL of saline
Inflated rapidly, left
for five minutes,
then removed
(Lonjon
et al., 2010)
Rat, T8-9 Inflated with 10 or
15 µL of water
Inflated rapidly,
then removed
(Pedram
et al., 2010)
Rat, T8-9 Inflated with 20 µL
of water
Inflated rapidly, left
for five minutes,
then removed
(Chung et al.,
2013)
Rat, T9 Inflated with 20 to
50 µL of saline
Inflated rapidly, left
for ten minutes,
then removed
(Su et al.,
2015)
Rat, T7 Inflated with 200
µL air
Inflated rapidly, left
for ten minutes,
then removed
The direction of injury (ventral or dorsal) is important, since the spatial distribution
and relative importance of white matter tracts varies in humans and rats (Figure 1.4 in
section 1.4.1 compared with Figure 1.3 in section 1.2). In humans, bilateral corticospinal
tract lesions greatly impact walking, and cortical activity via the corticospinal tract is
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vital for walking in humans. This has been determined by studying patients undergoing
cordotomies for pain relief in cancer, and using electroencephalogy in healthy humans
(Nathan, 1994; Petersen et al., 2012). In rats, the dorso-lateral rubrospinal tract and
corticospinal tract are both important for gait, spinal cord function, and injury modelling
(Morris and Whishaw, 2016) (Figure 1.5). Grill et al. (1997) compared the effects
of damaging the dorsal corticospinal tract in rats versus dorsal hemisection (damaging
corticospinal and rubrospinal tracts). Animals with a dorsal hemisection had persistent
deficits in sensorimotor skills, whereas those with corticospinal tract damage alone did
not.
Figure 1.5: Tracts injured in various rat spinal cord injury models.
Control of gait and locomotion in rats is further complicated since dorsal hemisection
injuries (which would damage both dorsal corticospinal and rubrospinal tracts) produce
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different outcomes to injuries where ventral tracts are also damaged (Agrawal et al.,
2010). A study by Metz et al. (2000) compared a dorsal hemisection to a contusion
model using the New York University impactor in rats. Animals with a contusion
had histological damage to the ventral and dorsal tracts, and had a reduced open field
locomotor score for two weeks post-injury compared with dorsal hemisection alone.
Where lesions to the lateral and ventral spinal tract were performed and compared in rats,
the strongest correlations to locomotor score were in lesion depth and spared white tissue
matter in the ventral reticulospinal tract (Schucht et al., 2002). Further, reticulospinal
tract neurons showed an increased propensity to sprout fibres in a cervical hemisection
injury, and are involved in propriospinal plasticity following injury (Filli et al., 2014). In
another study, at T10, lesions to the ventral funiculus were produced in isolation and in
combination with dorsal funiculus lesions, both at T10 (Loy et al., 2002). At 4 weeks
post-lesion, animals with lesions to both dorsal and ventral components had significantly
reduced open field locomotor scores compared with either dorsal or ventral lesions. This
indicates locomotion in rats has dorsal and ventral white matter components. The role of
white matter tracts in locomotion are complex, and tracts in both the dorsal and ventral
spinal cord have a role. All of the studies described evaluating tract contribution to
locomotion in spinal cord injury have used TSCI methods (transection or contusion), none
have used NTSCI models.
The expanding materials used in NTSCI studies are either not commercially available
in the UK (Aquaprene) or have a complex manufacturing process which are not suitable
for this study. However, other commercially available materials which absorb water may
be used (Figure 1.6).
Cellulose sponges absorb up to 50% of their volume in water at equilibrium, but
absorb water rapidly (Goodfellow, 2017). Conversely, nylon 6 absorbs 2.7% water
isotropically over 24 hours; with equilibrium being reached at 8 to 10% (Baschek et al.,
1999; Gerbig, 2014; Goodfellow, 2017). Nylon 6 is sold in membranes; so one approach
may be to encase a cellulose sponge in nylon film. The outer membrane will allow slow
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Figure 1.6: Potential methods for inducing non-traumatic spinal cord injury in-vivo. These
include water-absorbing materials which swell in volume over time, or using a balloon catheter
with osmotic mini-pump. All three methods can be easily sterilised, or are supplied sterile. All
will require characterisation ex-vivo prior to the use in animal experiments. Research
collaborations exist between the research group at the University of Leeds where the model of
NTSCI was being developed, and the relevant research group who have developed the balloon
catheter model for TSCI.
water penetration; and the cellulose sponge will increase in volume. Collagen hydrogels
also absorb water. This occurs upon their initial creation (Ahmed, 2015). They can also be
freeze dried to form sponges which can then be implanted and absorb water in-vivo. This
sponge can be made of rat type I collagen, meaning it would be biocompatible in-vivo;
this is important to prevent a host immune response. However, its absorption mechanics
require further evaluation.
A third method is to use a 2F balloon catheter which expands slowly over time.
This could be achieved through attachment to an osmotic mini pump or port for repeat
injections (Figure 1.6). Balloon catheters have been used to induce traumatic spinal cord
injuries (Vanicky et al., 2001; Lonjon et al., 2010; Pedram et al., 2010; Chung et al., 2013;
Su et al., 2015); and osmotic mini pumps have been used to apply drugs within the spinal
cord (Maier et al., 2009); the two components have not been used for filling a balloon
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catheter to induce spinal cord injury. Using either the osmotic pump or injection port has
advantages since the volume filling the balloon can be controlled, and balloon expansion
can be characterised ex-vivo initially. When implanted in-vivo, the measurements of the
balloon would be understood, and functional deficits could be measured. This would
facilitate correlation between balloon expansion (i.e. cord compression) and functional
deficits. Balloon catheter insertion into the vertebral canal can be undertaken using
a laminotomy or partial laminectomy at just one spinal level (Vanicky et al., 2001).
One research group have developed a method to insert the balloon catheter to form a
ventral lesion, although this is yet to be published (Urdzikova and Kwok, 2019). This is
noteworthy since all previous studies have only used dorsal lesions.
1.4.1.2 The Effects of Injury Mechanics in Spinal Cord Injury in-vivo
Various in-vivo spinal cord injury studies have been carried out with control of either
displacement, force or speed. In rats, two studies have carried out compression at T10
(Scheff et al., 2003; Sparrey et al., 2008). In the study undertaken by Sparrey et al.
(2008), the speed of the injury was either 3 or 3000 mm.s-1; with a displacement of 1mm
in both cases. At two minutes after injury, the fast lesion model had a greater haemorrhage
volume in the white matter, and greater axonal damage (p<0.05). It is worth noting that
the recorded force also varied between groups; with 0.54N being applied at 3 mm.s-1, and
2.37 N at 3000 mm.s-1. Another study applied force-controlled injuries at 1, 1.5 and 2 N
with a controlled speed of 130 mm.s -1 (Scheff et al., 2003). Increasing force correlated
with reduced locomotor activity and loss of grey and white matter at 7 and 42 days post-
injury. However, the displacement extent also varied with force; from between 0.8 mm to
1.2 mm.
A further rat contusion study, with injury at C6, evaluated the effects of both speeds
and displacement (Lam et al., 2014). Comparing impact speeds of 8, 80 and 800 mm.s-1
and displacements of 0.9 and 1.5 mm; the greater displacement caused greater functional
deficits and nerve fibre damage across all speeds. This could indicate that displacement
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extent is more important than speed in determining injury outcome; however force also
differed across groups.
In a non-human primate contusion model using a speed of 1000 mm.s-1 and two
displacement parameters, displacement and force correlated with paralysis and lesion
volume (Salegio et al., 2016).
Some studies describe displacement extent as the predominant factor determining
injury severity (Anderson, 1982; Bresnahan et al., 1991; Behrmann et al., 1992; Pearse
et al., 2005; Maikos et al., 2008), and report no effect of changing velocity (Kearney
et al., 1988; Kwo et al., 1989; Kim et al., 2009). Whereas others state velocity is the
most important (Anderson, 1985). It is likely that a combination of these factors is
important (Dohrmann and Panjabi, 1976; Noyes, 1987; Black et al., 1988; Basso et al.,
1996; Jakeman et al., 2000; Seki et al., 2002; Lam, 2013; Lam et al., 2014). Work done
is not frequently reported in these studies; but should be considered as it incorporates
both displacement and load, and reflects the energy imparted onto the system. There is
a need to characterise the effect of mechanical parameters in isolation, which is nigh on
impossible in-vivo. Further, all of these studies have used traumatic spinal cord injuries
and no studies have carried out experiments at speeds under 1 mm.s-1.
1.4.2 Modelling Spinal Cord Injury in-vitro
In-vitro models allow evaluation of cellular responses in a controlled environment. Using
these models also helps implement the 3Rs (replacement, reduction, refinement), by
reducing animal numbers (Fenwick et al., 2009). In-vitro models allow greater control of
isolated parameters and assessment of their individual effects which would not be possible
in-vivo. For example, the effects of varying strain rate on individual cell populations
can be established. In-vitro cell culture systems can either be 2D or 3D, and comprise
varying matrices (Table 1.5). Systems which are 3D are more physiologically relevant;
since the presence of a 3D matrix influences cellular behaviour, cell-cell and cell-matrix
interactions in keeping with physiological conditions (Abu-Rub et al., 2010).
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Table 1.5: In-vitro models of the spinal cord using 2D and 3D methods. Cells previously used
in such models include astrocytes, dorsal root ganglion cells, neural crest stem cells and
mesenchymal stem cells (East et al., 2010, 2012, 2013)
2D cellular
model
3D organotypic
slice culture
3D hydrogel
model
3D synthetic
model
Diagram
Type of
model • Monolayer of
cells on a
functionalised
surface
• Approx. 350
µm thick slices
of animal
spinal cord
• Natural peptide
hydrogel (e.g.
collagen)
seeded with
cells
• Synthetic
material (e.g.
polycapro-
lactone) seeded
with cells
Pros
• Simple
• Low cost
• Cells within 3D
environment
• Have been used
to mimic lesion
injury
• Cell adhesion
motifs retained
• Cells within 3D
environment
• Have been used
to mimic injury
and gliosis
• Modification of
chemical/
physical
properties
Cons
• No mechanical
cues from
matrix, or
cell-matrix
interactions
• Cannot induce
mechanical
insult
• Must be <500
µm thick
• No control of
cells or matrix
• Needs animals
• Inherent
damage during
preparation
• Cannot easily
tailor
mechanical
properties
• Does not
replicate all
areas of the
cord
(grey/white
matter)
• Increased
complexity/cost
• Cell adhesion
motifs not
inherent
• Does not
replicate all
areas of the
cord
Ref-
erences
(Hopkins et al.,
2015)
(Abu-Rub et al.,
2010)
(East et al., 2010;
Phillips, 2014b;
Caliari and
Burdick, 2016)
(Schaub et al.,
2016)
A 3D organotypic slice model is the most physiologically relevant 3D milieu,
since it contains adhesion motifs and represents the tissue-level architecture of the
spinal cord. Rat and mouse spinal cord slices 350 µm in thickness have been used
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to study spinal cord injury responses, by transecting the slices directly using a scalpel
(Bonnici and Kapfhammer, 2008; Weightman et al., 2014). In these studies, astrocytes
became increasingly reactive at lesion margins, microglia infiltrated the lesion site, and
neuronal axon regeneration across the lesion site could be measured. A further study
using transection of rat spinal cord slices used electrophysiology readings to investigate
functional regeneration (Heidemann et al., 2015). Similarly, weight drop devices have
been used in rat spinal cord slices to simulate spinal cord injury, resulting in cell death
and TNF-alpha expression (Pandamooz et al., 2019). Lesioned slices have been used
to evaluate the efficacy and regenerative capacity of synthetic scaffold bridges, valproic
acid, and a novel peroxisome proliferator-activated receptor agonist (Esposito et al., 2012;
Weightman et al., 2014; Pandamooz et al., 2019).
There are difficulties in preparation and maintenance of organotypic spinal cord slice
cultures, such as damage induced during slicing and death of slices after a week in culture
(Sypecka et al., 2015). It is difficult to evaluate the effects of spinal cord injury on a
single cell population in isolation using spinal cord slices. For instance, slices contain a
heterogenous distribution of neurones and glia. Further, the matrix is also heterogenous,
containing white and grey matter, the proportions of which differ based on spinal level.
To fully understand the impact of an injury on one cell type, all cell types and matrix
components should be controlled, and the same for every test undertaken.
In terms of materials, a 3D collagen hydrogel model has been shown to be compatible
with various cell types, with primary neural cells able to retain their phenotype through
the inherent presence of adhesion motifs (East et al., 2010, 2012, 2013). Such motifs
are not present in synthetic materials. Mechanical compression has been applied to
simple geometry, disc shaped collagen hydrogels in-vitro with neural cells to model
traumatic brain injury (Bar-Kochba et al., 2016). Tethered collagen hydrogels models
have also previously been used in spinal cord injury studies (East et al., 2010; Phillips,
2014a; Smith, 2016). Collagen hydrogels have further advantages in evaluating matrix
remodelling; their composition of a single material means deposition of new matrix and
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other proteins can be easily studied.
1.4.2.1 Inducing Spinal Cord Injury in-vitro
Methods used to induce cellular phenotypic changes observed in spinal cord injury in-
vitro include changing the chemical environment; such as hypoxic conditions and adding
moieties, or through causing a mechanical insult (Table 1.6). The biochemical pathways
and cytokines involved in NTSCI are not established in the literature. As such, chemical
induction of NTSCI is not possible based on current knowledge and understanding.
Of the methods used for inducing a mechanical injury to the spinal cord in-vitro,
only three are appropriate for applying a controlled mechanical insult to a 3D hydrogel
model to simulate spinal cord injury: using increasing pressure in pulsatile flow system,
using a microfluidic platform, and using a mechanical device such as the Infinite Horizon
impactor or BOSE 5110 Electroforce bioreactor. There are three factors which further
determine the suitability of each of these methods for the study of NTSCI. The first is
availability of the apparatus, materials testing machines have the capacity to be adapted
for applying mechanical insults in-vitro, BOSE manufactured devices have been used
in spinal cord injury studies (Busby et al., 2013; Koivisto et al., 2017; Kirk, 2018).
The second factor is the mechanics and relevance to clinical injuries: one key feature
distinguishing TSCI and NTSCI are velocity, with TSCI being in the range of metres per
second (Wilcox et al., 2003), whereas NTSCI taking between months to years. So, any
device needs to apply both high and low velocities. In-vivo impactors have a maximum
velocity of 0.333 mm.s-1, whereas materials testing machines use a range of velocities
(Stokes, 1992; Scheff et al., 2003; TAInstruments, 2016). The third factor is the capacity
to perform long-term studies simulating NTSCI under sterile conditions. The BOSE
5110 Electroforce fits this purpose as it has a bioreactor system, which can be sterilised
(TAInstruments, 2016; Kirk, 2018).
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Table 1.6: Methods used to induce spinal cord injury in-vitro. Several methods have been used
to simulate spinal cord injury in-vitro. Each of those detailed in the table have associated
advantages and disadvantages. It is worth noting that none have specifically used a
biomechanical insult to induce non-traumatic spinal cord injury (NTSCI)
Injury induction Advantages Disadvantages Reference(s)
Chemical moieties
(kainite,
transforming growth
factor β)
• Induce
glutamatergic
excitotoxicity
• Scar-like cascade
in astrocytes
• Does not
recapitulate
mechanics
• Excitotoxicity not
established in
NTSCI
(East et al., 2009;
Shabbir et al.,
2015a,b; Vogelaar
et al., 2015; Kaur
et al., 2016; Samano
et al., 2016)
Ischaemia: reducing
amount of O2 in
media or
environment
• Better replicates
ischaemia of
NTSCI
• Does not
recapitulate
mechanics
• Ischaemia in
NTSCI not fully
understood
(Oliveira et al., 2014;
Samano et al., 2016)
Ex-vivo injury
induction (via scalpel
blades or weight
drop device) on
healthy spinal cord
slices
• Use mechanical
insult
• Not used in
NTSCI
• Requires use of
whole animals
• Disadvantages of
slice model
method
(Bonnici and
Kapfhammer, 2008;
Esposito et al., 2012;
Weightman et al.,
2014; Sypecka et al.,
2015; Pandamooz
et al., 2019)
Polymer (mimicking
spinal cord) in a fluid
under pulsatile flow
and increasing
pressure
• Does not require
animals
• Increasing fluid
pressure could
mimic stenosis
• Complex systems.
• Have not been
used in long-term
experiments
(Frieboes and Gupta,
2009)
Dual layer system:
microfliuidic
channels atop
cell-seeded platform
• Single axon
studies (20µm
diameter) can be
carried out
• Complex set up
• Have not been
used in NTSCI
(Hosmane et al.,
2011; Fournier et al.,
2015)
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Methods used to induce spinal cord injury in-vitro continued.
Injury induction Advantages Disadvantages Reference(s)
Compression of
model using
impaction system
• Long term
compression
• Control conditions
(mechanics and
environment)
• Require
characterisation of
force and loads
• Not established in
current literature
(Butler et al., 2009;
TAInstruments,
2016)
1.4.2.2 The Effects of Injury Mechanics in Spinal Cord Injury in-vitro
In-vitro studies evaluating neural cell responses to varying mechanical parameters focus
on traumatic brain injuries. These have key differences to NTSCI in terms of the type of
strain (shear strain as opposed to compression in NTSCI); and strain rates (up to 30.s-1
compared with quasi-static in NTSCI). However, the 3D environments and types of cells
are similar in both conditions.
Through applying varying strain rates to neurones and astrocytes in culture, several
observations and potential mechanisms for cellular damage have been established. Cullen
et al. (2007) evaluated the effect of shear strain on primary neurons and astrocytes in 3D
gel environments. Strain rates of 1 s-1, 10 s-1 and 30 s-1, with a maximum strain of 0.5,
were applied. The strain rate of 30 s-1 caused significantly more cell death than lower
rates (p<0.05), and induced GFAP expression at 2 days post-injury. In the lower strain
rate groups, cell density was increased. The lowest strain rate of 1 s-1 caused expression
of chondroitin-sulphate proteoglycan; a molecule associated with glial scar formation.
A similar study evaluating isolated neuronal populations found increased cell death
at 30 s-1 compared with 20 s-1; with a controlled maximum strain of 0.5 (Cullen and
LaPlaca, 2006). Across various studies, shear strain rate has been shown to induce
changes in cellular permability (Cullen et al., 2011) and intracellular calcium release via
NMDA receptors (Cargill and Thibault, 1996; LaPlaca et al., 1997; LaPlaca and Thibault,
1998; Maneshi et al., 2015, 2017, 2018). Applying tension to neural cells caused rate-
dependent neuronal matrix re-organisation (Zhang et al., 2016) and astrocyte swelling due
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to aquaporin 4 over-expression (Sturdivant et al., 2016). One study assessed the effects
of compression, applying strain rates of 10 s-1 and 75 s-1 up to a strain of 0.30 (Bar-
Kochba et al., 2016) to neurons. After 10 hours, neurons under both strain rates showed
pathophysiological features including dendrite thinning at 10 s-1 and bleb formation at 75
s-1; associating with membrane permeability and cell death.
Although the pathological context and strain rates are different to NTSCI, in-vitro
brain injury models have identified that neural cell responses vary with strain rate, and
have elucidated potential pathological mechanisms. This research provides the hypothesis
that in NTSCI, varying the magnitude and rate of compressive strain will cause different
responses in neural cell populations. The effects of changing displacement extent, force,
and overall energy applied to an NTSCI model system are unknown, and need to be
established.
1.5 Summary and Research Objectives
1.5.1 Summary
Clinical NTSCI has a variety of causes, most of which are associated with an ageing
population. As such, these injuries are increasing in prevalence due to the changing
demographics of society. In spite of this, the pathophysiological origins of NTSCI are not
fully understood. This means developing or evaluating new treatments or management
techniques is challenging. Furthermore, mechanics vary in both traumatic and non-
traumatic injuries; but the effect of this is unknown. Due to the heterogeneity of NTSCI,
and the relatively low patient numbers, clinical studies are difficult.
Experimental studies can be undertaken to evaluate the pathology of spinal cord
injuries under various injury mechanics protocols. To achieve this, models must first
be developed, characterised and evaluated. Previous rat models of NTSCI in-vivo
have limitations, including timescales of over 6 months and an invasive nature. A
balloon catheter model, with gradual inflation, can mimic NTSCI clinically whilst being
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minimally invasive. Furthermore, simplified in-vitro models of the spinal cord have been
established and will be used to evaluate cellular responses to injury-like scenarios. The
use of a collagen hydrogel system seeded with primary neural cells ensure a mechanically
relevant 3D environment initially. Subsequently, mechanical insults will be applied
to the system using the BOSE 5110 bioreactor system. This allows control of force,
displacement, and speed. Hence, energy can be calculated. Cellular outcomes will be
established in injury scenarios with varying energy transfer.
1.5.2 Aims
The aim of this project is to evaluate biological responses to loading scenarios
representative of NTSCI both in-vitro and in-vivo.
1. In-vitro model
A - To develop methodology to apply displacements and forces (of varying
extent and speed) relevant to non-traumatic spinal cord injury in-vitro.
B - Develop and characterise a reproducible type I collagen hydrogel seeded
with primary rat astrocytes, a relevant neural cell type.
C - To evaluate the effects of clinically relevant displacement and speeds on
neural cell outcomes; with a focus on astrocytes (including GFAP expression
and cytokine release).
2. In-vivo model
D - To develop a clinically-relevant model of non-traumatic spinal cord injury
in-vivo; with increasing canal stenosis over an extended time frame (i.e. days)
and using a ventral lesion.
E - To assess the histological and functional outcomes which occur after long
term spinal cord compression in-vivo.
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Materials and Methods
2.1 General Materials and Equipment
Details of consumable materials, equipment and reagents/chemicals used are in
appendices A, B and C, respectively.
The use of the materials and methods described herein can be split into those
associated with the in-vitro models, and those for the in-vivo models. In-vitro models
will comprise astrocyte-seeded collagen hydrogels compressed by the BOSE Electroforce
5110 Biodynamic. Both the cell system and mechanical device require characterisation.
Then, astrocyte outcomes will be established in control and pathological conditions,
as well as after compression at various velocities. In-vivo a model will be developed
using a modified balloon catheter, which can be implanted into rats, in order to induce
a slow, graded spinal cord compression. Histological and functional outcomes will be
determined.
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2.2 General Methods
2.2.1 Sterilisation and Disinfection of Equipment
2.2.1.1 Class II Biological Safety Cabinet Disinfection
Cell culture was carried out using aseptic technique in a class II biological safety cabinet.
Before use, fans were engaged to ensure HEPA filtered air flow. The interior of the cabinet
was sprayed with 1% (w/v) Virkon, followed by 70% (v/v) ethanol. Any materials placed
into the cabinet were also sprayed liberally with 70% (v/v) ethanol. While undertaking
work, gloves were worn and samples were covered wherever possible. Furthermore,
solutions opened within the cabinet were sterilised before use.
2.2.1.2 Sterilisation and Disinfection Methods
Autoclave (moist heat) sterilisation was used to sterilise solutions and materials wherever
appropriate. This incorporated heating at 15 psi, 121oC for twenty minutes.
Filtration was used to sterilise solutions in a class II biological safety cabinet.
The solution was added to a 10 mL syringe and dispensed through a 0.22 µm filter.
Materials not suitable for autoclave or filtration (such as tubing, reservoir bottles, plastic
components of the BOSE 5110 Electroforce apparatus) were sterilised by soaking in 1%
(v/v) Trigene solution for at least 30 minutes. Before use, they were washed in sterile
water.
Surgical tools used in-vivo were sterilised prior to surgery using dry heat sterilisation
at 190oC in an oven for 4 hours. Between animals, tools were washed using soap and hot
water, rinsed and left to dry. Then, tools were further sterilised using a hot glass bead
steriliser. Instruments were placed in the steriliser at 300oC for 1 minute. Tools were then
placed into 100% (v/v) ethanol before being allowed to air dry.
Coverslips and dissection equipment used in-vitro were sterilised prior to use by
soaking in 70% (v/v) ethanol for at least 3 minutes, before air drying at room temperature
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in a sterile biological safety cabinet.
2.2.2 pH Measurement
Measurement of pH was undertaken using a Jenway 3510 pH meter. Before changing the
pH of any solutions, the pH meter was calibrated using stock solutions with pH values of
4.0, 7.0 and 11.0. Where required, the pH of solutions was altered using NaOH at 1M or
0.1M, and HCl at 1M or 0.1M. All pH measurements were taken at room temperature.
2.2.3 Stock Solutions
Ethanol: A volume of 7L of 100% ethanol was diluted with 3L of distilled water to
produce 70% (v/v) ethanol. The solution was stored at room temperature for up to three
months.
Virkon: A solution of 1% (w/v) Virkon was made by combining 50g Virkon powder into
5L distilled water. The solution was stored at room temperature for up to three months,
or until the solution changed colour from bright pink to colourless.
2.2.4 Antibody Reagents
The antibodies used in immunocytochemistry experiments herein are described below
(Table 2.1).
2.2.5 Microscopy
Bright Field Microscopy
During cell culture, an Olympus CK-40-SLP microscope was used. This optical
microscope was set up for Ko¨hler illumination to check cells visually and for total cell
counts.
Widefield Microscopy
For imaging of coverslips or quick evaluation of staining, widefield microscopy was
undertaken on a Zeiss Axio Imager.M2. Filters used were 49 DAPI (excitation 365, beam
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splitter 395, emission 445/50 nm); 38 GFP (excitation 470/40, beam splitter 495, emission
525/50 nm); and 20 Rhodamine (excitation 546/12, beam splitter 560, emission 575-640
nm). These were used for imaging blue, green and red fluorescence respectively.
Confocal Microscopy
A Zeiss LSM880 Axio Imager.Z2 (upright) was used for confocal imaging of cellular
hydrogels and slides following immunochemistry. The lasers used were Diode 405; Argon
458, 488, 514; DPSS 561; and HeNe 633. Associated colours to the wavelengths were
blue, green, red and far red/violet, respectively.
Confocal imaging had benefits over widefield imaging; since confocal imaging
illuminates only one single spot of light in one focal plane. Conversely, widefield
microscopy illuminates the entire thickness of the specimen. Therefore, widefield
Table 2.1: Details of antibodies used in-vitro and in-vivo. Including both primary and secondary
antibodies.
Antigen Host Isotype Conjugate Dilution Details
Glial Fibrillary
Acidic Protein
(primary)
Rabbit
IgG (anti-
mouse)
Poly-
clonal
N/A 1:300 Z03334, Dako,
UK
Myelin Basic
Protein
(primary)
Rabbit
(anti-
mouse)
Mono-
clonal
N/A 1:300 ab40390
Abcam, UK
Rabbit IgG
(secondary)
Goat
(anti-
rabbit)
N/A Alexa
Fluor 488
1:500 Abcam, UK
CS-56
(primary)
Mouse
IgM
(anti-rat)
Mono-
clonal
N/A 1:300 C8035 Sigma
Aldrich, UK
Mouse IgM
(secondary)
Goat
(anti-
mouse)
N/A Alexa
Fluor 568
1:500 A21043
Abcam, UK
RECA-1
Endothelial
Cells (primary)
Mouse
(anti-rat)
Mono-
clonal
N/A 1:100 MA140240
Thermo Fisher
Scientific, UK
Mouse IgG
(secondary)
Goat
(anti-
mouse)
N/A Alexa
Fluor 647
1:500 A21236
Thermo Fisher
Scientific, UK
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imaging resulted in out of focus light and noise from above and below the in-plane cells
in the 3D collagen hydrogel. This was not present in confocal imaging.
2.3 General in-vitro Materials and Equipment
2.3.1 BOSE 5110 Electroforce Biodynamic
The BOSE 5110 Electroforce Biodynamic instrument allows single-axis compression
and tension of materials (Barthelat et al., 2014; BOSE, 2014). The apparatus includes
a biodynamic chamber which can be sealed and flooded with media to simulate a relevant
environment (Figure 2.1) (Donnay et al., 2013; Koivisto et al., 2017).
Figure 2.1: BOSE 5110 Electroforce Biodynamic.Entire apparatus (left), platen fixture motor
shaft with disc platen (right). Both disc platens provided with the instrument had a central
depressed portion (BOSE, 2014)
Furthermore, mechanical parameters in the form of displacement, load and
axial command can be controlled using WinTest R© software and proportional-integral-
derivative control loops; and recorded over time. The Electroforce 5110 consists of two
platens. The lower motor platen moves up to a maximum of 13 mm displacement; the
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upper is connected to a load cell of either 22N or 200N.
2.3.2 Primary Cells
Primary neural cells were extracted from Wistar rat pups two to three days post-natal
(section 2.4.2.4) Cell culture techniques were undertaken in a class II biological safety
cabinet under aseptic conditions (see sections 2.2.1 and 2.4.2).
2.4 General in-vitro Methods
This section describes the general methods used in in-vitro modelling. These methods are
used in chapters 3 and 4; to develop and evaluate an in-vitro model of mechanical insults in
NTSCI (Figure 2.2). This includes characterisation and validation of both the mechanical
device (BOSE 5110 Electroforce) and 3D cellular model (primary rat astrocyte seeded
collagen hydrogel). Subsequently, the 3D model will be compressed using the apparatus,
and cellular outcomes established based on input velocity.
2.4.1 Cell Culture
2.4.1.1 General Cell Culture Solutions
Cell media: Primary astrocytes and mixed glia were cultured in DMEM with 4.5g.L-1
glucose, supplemented with 10% (v/v) FBS, 2mM L-glutamine, penicillin (100 U.mL-1)
and streptomycin (100 µg.mL-1) (Smith, 2016). L-glutamine, penicillin, streptomycin,
and serums were stored at -20oC and defrosted prior to use. The media was stored for no
longer than two weeks at 4oC.
Trypsin/EDTA: For cell passage, trypsin (0.05% (v/v)) and EDTA (1mM) were
combined. The solution was stored in 5 mL aliquots at -20oC and defrosted before use.
Poly-D-lysine: For coating with poly-d-lysine (PDL), 50 µg.mL-1 solution was used.
This was prepared by dissolving 50 µg of PDL powder per 1 mL distilled water. The
solution was filter sterilised, stored at -20oC, and defrosted as required.
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Figure 2.2: Aims, objectives, and methods used in in-vitro studies. Chapters are split into model development, and evaluation of neural
cells in response to the model.
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Transforming growth factor beta: A stock solution of transforming growth factor
beta (TGF-beta) was made up at 0.1 mg.mL-1 in sterile water. Aliquots were frozen and
stored at -20oC for up to 3 months. When required, these were defrosted and diluted as
appropriate.
2.4.1.2 Reagent Preparation for Primary Cell Isolation
Trypsin solution: A solution of 1mg.mL-1 (0.1% (w/v)) trypsin with activity of 13,000 to
20,000 units.mg-1 was prepared in sterile PBS. This was subsequently stored at -20oC in
2mL aliquots for up to one year.
DNase solution: A solution of 100 µg.mL-1 of DNase (0.01% (w/v), activity of 2000
units.mg-1) was made up in Hanks’ buffered salt solution with calcium and magnesium.
It was subsequently stored at -20oC in 2mL aliquots for up to one year.
Triturating solution: A solution containing 10 mg.mL-1 (1% (w/v)) bovine serum
albumin; 500 µg.mL-1 trypsin inhibitor (activity of 10,000 units.mg-1); and 20 µg.mL-1
DNase (activity of 2000 units.mg-1) was made up in Hank’s buffered salt solution without
calcium and magnesium. Aliquots (2mL in volume) were stored at -20oC for up to one
year
2.4.1.3 Cellular Assay Solutions
Immunocytochemistry
Antibody diluent: A volume of 60 mL of antibody diluent was made up using 6 mL of 1%
(v/v) sodium azide, 300 µL of 5% (w/v) bovine serum albumin (see below) in 40 mL of
1x TBS. The pH was adjusted to 7.6 before being made up to 60 mL using 1x TBS. The
solution was stored at 4oC for up to three months.
Bovine serum albumin (BSA): A solution of 5% (w/v) BSA was made by adding
0.5g of BSA to 10 mL PBS, and stirred using a magnetic stirrer. The solution was sterile-
filtered using a 0.2 µm filter, and stored at -20oC for up to six months.
Hoechst counterstain: Hoechst 33258 2 µg.mL-1 was made up of 1000 µg of Hoechst
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powder in 500 µL sterile water, stored at -20oC and defrosted when required. Used at
1:1000 dilution (i.e. 2 µg.mL-1).
Tris buffered saline (TBS): A total of 24g of Trizma base and 8.8g of NaCl were
dissolved in 700mL distilled water. The pH of this solution was changed to 7.6 using
6M HCl dropwise. The solution was topped up to 1L using distilled water, before being
autoclaved. This produced 10x concentrated TBS. Upon use, it was diluted using 100 mL
10x TBS in 900 mL distilled water for a 1x solution. The solution was kept for up to three
months at room temperature.
Tris buffered saline with Tween (TBS-T): A volume of 1.5 mL of Tween 20 was
added to 500 mL of 1x TBS. The solution was mixed using a magnetic stirrer, and the pH
adjusted to 7.6 using 6M HCl and 6M NaOH dropwise. This solution was stored for up
to three months at room temperature.
Tris no saline (TNS): A total of 3 g of Trizma base was added to 500 mL of distilled
water. The pH of the solution was changed to 7.6 using 6M HCl dropwise. The solution
was stored at room temperature for up to three months.
Marvel blocking solution: The blocking solution used was 0.5% (w/v) Marvel
powdered milk in 50 mL 1x TBS, which was made up on the day of use and not stored. It
was made up using 1 scoop of Marvel in 50 mL 1x TBS.
TritonTM X-100: A volume of 1 mL TritonTM X-100 was made up to 1L using sterile
water. The solution was mixed and stored for up to one year at room temperature.
Dead stain from the Live/dead R© assay
Ethidium homodimer (dead stain) from the live/dead R© fluorescence assay was prepared
as per the manufacturers instructions. This comprised 4 mL of appropriate cell culture
media, 2 µL ethidium homodimer-1 were added and mixed. Where used, 4 µL of Hoechst
33258 was also added. The solution was used immediately, and the assay carried out in
the dark. The method for the assay is described in 2.4.4.
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Enzyme-Linked Immunosorbent Assay (ELISA)
Antibody standards: A total of 8 antibody standards were made up using serial solutions
in accordance to manufacturers instructions, using standard/sample diluent provided.
Diluted standard was used on the same day, and surplus standard was discarded.
Biotin-conjugate Detection Antibody: The detection antibody was diluted at 1:100 in
diluent provided. The solution was used on the same day and surplus was discarded.
Streptavidin-horseradish peroxidase B: The streptavidin solution was diluted at
1:100 in the diluent provided. The solution was used on the same day and surplus was
discarded.
Wash Buffer: The wash buffer provided was diluted twenty-fold, as per
manufacturers instructions.
2.4.2 Cell Culture Methods
2.4.2.1 Aseptic Technique
Cell methods were carried out using aseptic technique in a class II biological safety
cabinet.
2.4.2.2 Primary Rat Glial Cells Culture Requirement
Primary rat glial cells were adherent to poly-D-lysine coated tissue culture plastic, and
grew in a monolayer. They required 8% (v/v) CO2 in air.
2.4.2.3 Poly-D-Lysine Coating
Coating flasks or coverslips with poly-D-lysine facilitated adhesion of primary glial cells.
One 20 mL aliquot of PDL was defrosted at room temperature. Then, a sufficient volume
of PDL to cover the surface was added. For a T75 flask, this was 5 mL; for a 22 x 22 mm
coverslip, this was 400 µL. The flask or coverslips were then placed into a 37oC incubator
for at least one hour. PDL was removed and returned to the -20oC freezer, to be re-used
up to three times. Then, two 10 mL PBS washes were undertaken, followed by a final
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wash with media. This media was discarded. Flasks or coverslips were left to dry for at
least four hours at 37oC, 8% CO2 (v/v) in air. Following this, PDL-coated flasks or plates
were stored at 4oC for up to two weeks, sealed using parafilm.
2.4.2.4 Primary Glial Cell Isolation
Dissection of Cerebral Cortex
Details of the solutions used in this section can be found in section 2.4.1.2. Primary glia
were isolated from female Wistar rat pups, between post-natal days two and three. Each
rat was sacrificed using cervical dislocation. Death was confirmed before subsequent
procedures were carried out; according to the UK Animals Scientific Procedures Act
1986, under Home Office Project License PPL 70/8085.
Each head was cut away from the body using scissors, and placed in a falcon tube
in ice. Once all heads were removed, further dissection was carried out. Each head was
sprayed with 70% (v/v) ethanol. Dissection of the brain was carried out using springbow
scissors and forceps (Figure 2.3). First, bissecting the skin, then the skull, to reveal the
brain (steps A to D). When the cortex was removed from the skull (step E), it was placed
into a sterile petri dish containing 4oC HBSS without calcium or magnesium. Removal of
the midbrain was then carried out (step F). Following this, meninges were removed from
the outer layer of the cortex using a dissection microscope. The process was carried out
for each hemisphere; and dissected cortices were placed into another petri dish containing
HBSS without calcium or magnesium at 4oC.
Isolation of Cells from Cortex
Once dissected, the cortices were pooled to minimise intra-animal variation. Then, a
straight-edged razor blade was used to chop the cortices into small pieces. Following this,
the suspension was transferred to a 15 mL Eppendorf tube and centrifuged at 150g for
five minutes. Then, the supernatant was removed and trypsin solution was added. This
was incubated at 37oC, 8% (v/v) CO2 for 20 minutes. Following this DNase solution
was added, and the suspension was incubated for a further five minutes at 37oC, 8%
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Figure 2.3: Steps in methodology to isolate cerebral cortex from pre-weaner rats.
A: Wistar rats (2 to 3 days postnatal) were sacrificed using cervical distraction. The head was
decapitated, and sprayed liberally with 70% (v/v) ethanol.
B: The skin was bisected sagittally using springbow scissors from the caudal surface to in line
with the eyes. The skin was then pulled back to reveal the skull.
C: The skull was cut as shown (using springbow scissors) to create flaps overlying the cortex.
Care was taken to only cut through the skull at this stage and not damage underlying cortex.
D: The skull was pulled back to expose the underlying cortical lobes.
E: The cortex was removed using a spatula, and placed into a petri dish containing cold medium.
Here, it was cut down the mid-sagittal line; separating cerebral hemispheres.
F: View of the brain in cross-section. Using fine forceps, the midbrain and caudal parts of the
cortex which fold back upon the cortex proper were removed. The cortex was retained. Image
adapted from gensat.org (Heintz, 2017)
(v/v) CO2; or longer until the suspension was no longer viscous. This indicated all the
released DNA contents were degraded. The suspension was centrifuged at 150g for five
minutes. The supernatant was discarded, and the pellet resuspended in triturating solution.
Then, the cells were added to PDL coated T75 flasks (6 cortices into 3 flasks) containing
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supplemented DMEM (section 2.4.1.1) at 37oC. Flasks were incubated at 37oC, 8%
(v/v) CO2. Media was changed the following day, and then every three to four days
subsequently.
Separation of Mixed Glial Cells into Enriched Populations
Approximately ten days following isolation, or when the cells reached 80% confluency,
mixed glial cells were separated into enriched populations of astrocytes and microglia.
The lids of flasks were sealed, either using closed caps or parafilm. Flasks were then
placed on a plate shaker at 150 rpm for 4 hours at 37oC, 8% (v/v) CO2 in air. The
media, containing a higher proportion of microglia, was added to PDL coated T75 flasks
with 5mL of fresh pre-warmed (37oC) supplemented DMEM. A total of 12 mL fresh
supplemented DMEM (pre-warmed to 37oC) was added to the flasks from the plate
shaker, containing a higher proportion of astrocytes.
2.4.2.5 Cell Maintenance and Passage
In flasks or gels containing cells, media was removed and replaced fresh media pre-
warmed to 37oC. This was undertaken using a pipette and taking care not to disrupt the
cellular monolayer or the gel surface. In flasks, once the cellular monolayer reached up
to 80% viability, passage was undertaken. Media was removed and two 10 mL PBS
washes were undertaken to remove any traces of media. Following removal of PBS, cells
were incubated with 3 mL of trypsin/EDTA at 37oC (with the appropriate percentage
(v/v) CO2 in air) for between five and ten minutes. A volume of 10 mL of pre-heated
media (37oC) before a light microscope was used to check if cells had detached from the
monolayer. If, after ten minutes of incubation, cells remained adherent, a cell scraper was
used to manually detach the cells. Once cells were detached, the contents of the flask was
transferred to a universal tube, and centrifuged at 150g for ten minutes. The supernatant
was discarded and the cell pellet resuspended in 2 to 4 mL of pre-heated media. A cell
count was carried out before cells were redistributed at appropriate concentrations.
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2.4.2.6 Cell Count and Seeding
Cell counts were carried out using the trypan blue exclusion assay. Trypan blue is
excluded from live cells by their plasma membrane, but not dead cells since their
membrane is no longer intact. Upon addition of trypan blue and evaluation under light
microscopy, live cells appear colourless and dead cells appear blue. For this study, a
dilution factor of 2 was used i.e. 20 µL of media with cells and 20 µL of trypan blue. A
volume of 20 µL of the suspension was dispensed onto the haemocytometer, below the
coverslip. Corner squares were counted under phase contrast light microscopy (Figure
2.4). The number of cells in each corner square should have been between 100 and 300;
otherwise the cells were resuspended in a more appropriate volume. Knowing that each
corner square has a volume of 0.1 mm3 (height 1 mm, width 1 mm, depth 0.1 mm), i.e.
0.0001 mL; the total number of live cells per mL of the original cell suspension were
established according the the equation:
Total number of live cells per mL = Counted live cells
No. of squares counted
×Dilution factor × 104
Once total number of cells was established, the volume of media required to obtain
an appropriate cell concentration was added to the cell suspension. This resuspended
volume was seeded into the relevant container or other material (e.g. T75 flask, coverslip
or collagen gels).
For T75 flasks, cells were added to pre-warmed 37oC media to a total volume of 12
mL per flask. For coverslips, a volume of 200 µL of cells were added to each coverslip
(previously PDL-coated, if required) in a 6 well plate. These were left to settle for ten
minutes before the well was filled with 5 mL pre-warmed 37oC L media. For distributing
cells in collagen hydrogels, see methods below.
2.4.3 Collagen Gel Production
Simple geometry collagen gels of various volumes were created in multi-well plates. The
desired end volume of each gel or batch of gels was multiplied by 1.1 to account for
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Figure 2.4: Haemocytometer Layout. Only live cells (colourless with a blue ‘halo’ were
counted). Those on the top and left edges were counted; and the bottom and right were discarded
to prevent counting cells more than once. At least three corner squares were assessed
swelling. For both cellular and acellular gels, collagen was dispensed using wide bore
pipettes to facilitate smooth dispersion. Steps were taken to prevent bubble formation,
such as mixing gently and dispensing reagents slowly.
For cellular gels, 80% of the total volume was rat tail collagen (type I, 2 mg.mL-1
in 0.6% (v/v) acetic acid), 10% was 10x minimum essential medium (MEM), 4.2% was
media containing cells, and the remaining volume (approximately 5.8%) was 1M NaOH.
Prior to creating cellular gels, well plates were placed on ice blocks. The cold temperature
slowed the time before gelation.
Collagen and MEM were mixed in a bijou and stored on ice. Cells were then
prepared to an appropriate concentration in media using the trypan blue cell count assay.
This prevented cells being at a high concentration in a low volume for extended durations,
minimising cell death. Collagen/MEM solutions were neutralised by adding NaOH
dropwise until colour change was observed (Figure 2.5). The cellular suspension was
triturated to resuspend any cells which had settled, and the appropriate volume was
added to the neutralised collagen. This was then mixed gently, before being dispensed
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as appropriate into a multi-well plate. Gels were left to set for up to fifteen minutes at
room temperature. Then, a volume of pre-warmed 37oC media equal to the volume of gel
was added to prevent the gels drying out and add nutrients. If gels contained cells, media
was replaced every 3 to 4 days.
For acellular gels used in evaluating the mechanical capacity of the BOSE 5110
Electroforce system, Purecol was used. This bovine collagen I was supplied at 5 mg.mL-1.
As such, it was easily diluted and tested at different collagen densities. Collagen was
diluted with PBS to the desired concentration. Then mixed gently and dispensed into well
plates on ice blocks. Gels were left to set for 30 minutes at 37oC, as per manufacturers
guidelines, before a volume of PBS equal to the gel volume was added on top to prevent
dehydration.
Figure 2.5: Creation of collagen gels. Neutralisation of collagen and MEM using NaOH. A:
collagen and MEM without NaOH. B: Incomplete neutralisation reaction, further NaOH
required C: complete neutralisation. D: Excess NaOH added, discard solution
2.4.4 Methods for Assessing Cellular Response
2.4.4.1 Ethidium Homodimer Stain from the Live/dead R© Viability Assay
Ethidium homodimer is the dead stain in the Live/Dead R© viability assay. It was used to
visually identify dead cells. The intact plasma membrane of live cells excluded ethidium
homodimer-1. Conversely, dead cells readily took up ethidium homodimer-1 due to poor
membrane integrity. In dead cells, ethidium homodimer-1 could bind to nucleic acids to
create red fluorescence (absorbance 528 nm, emission 617 nm) (Carpanese et al., 2014).
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The solutions used in this assay are described in section 2.2.3.
2.4.4.2 Counterstain
Both Hoechst and DAPI counterstains bind to the minor groove of DNA (Estandarte,
2012). The two dyes have similar excitation and emission profiles; of 346/460 nm
(Hoechst) and 354/454 nm (DAPI). Hoechst is positively charged, and as such crossed
the cell membrane of viable cells. Therefore, it has been preferred for staining live cells
(Demchenko, 2008). Conversely, DAPI is not charged. So, to stain living cells, incubation
times had to be increased, or cells had to be fixed and permeabilised. Due to its ability
to stain both living and fixed cells more easily, Hoechst was used as the counterstain
throughout this research.
2.4.4.3 Immunocytochemistry in Gels
Techniques such as immunocytochemistry were used to assess cellular phenotype and
spatial distribution. For each of the stages detailed below, the volume of reagent
added was equal to gel volume. Wash steps were carried out for five minutes at room
temperature.
First, media was removed from cells through washing with TBS three times. The
fixative used was 4% (w/v) paraformaldehyde (PFA). This was defrosted from -20oC to
room temperature. PFA fixed proteins through cross-linking, preventing autolysis and
degradation of cellular components (Howat and Wilson, 2014). Cellular hydrogels were
fixed using 4% (w/v) paraformaldehyde (PFA) for at least three hours at 4oC.
Subsequently, PFA was removed and gels were washed with TBS three times. At this
point, gels could be stored for up to two weeks at 4oC. Permeabilisation was then carried
out using a thirty minute incubation at room temperature with 0.1% (v/v) TritonTMX-
100. This allowed antibodies and stains to penetrate the cellular membrane in subsequent
steps. After three further TBS washes, 0.5% (w/v) Marvel powdered milk suspension
was added. The proteins in the milk powder block non-specific binding of antibodies,
reducing background staining. The incubation in Marvel was carried out for thirty minutes
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at room temperature. A further three TBS wash steps were carried out before primary
antibody incubation. Antibodies were diluted in antibody diluent, at the appropriate
concentrations. Antibody incubation was carried out in a humidified chamber at room
temperature overnight. Following primary antibody incubation, two TBS-T and two TBS
washes were undertaken to thoroughly remove residual antibody.
Finally, secondary antibody and counter stain were made up. Again, these were
diluted in antibody diluent at appropriate concentrations; and incubated for one hour in
a humidified chamber at room temperature. During this incubation, the chamber and its
contents were protected from light wherever possible by covering the chamber in foil.
Following incubation, two TBS-T and two TBS washes were carried out. The final,
stained samples were stored at 4oC until imaged (ideally the same day, or the next day
to prevent fluorophore fading). Where gels were imaged, they were placed beneath a
coverslip for at least five minutes prior to imaging. Imaging was undertaken on widefield
or confocal microscopes.
2.4.4.4 Immunocytochemistry of Cells on Coverslips
Immunocytochemistry of cells on coverslips was also undertaken in this research. The
protocol for preparing coverslips was similar to that of gels, but with shorter incubation
steps since reagents did not have to penetrate into a 3D environment. In this protocol, the
volume of TBS or TBS-T used for wash steps was consistently 2 mL; whereas the volume
of other reagents was 300 µL (sufficient to cover the entire 22 x 22 mm coverslip). The
duration of each wash step was thirty seconds.
Initially, media was removed and three TBS washes were undertaken to remove
all traces. Then, fixation using 4% (w/v) PFA was carried out for 30 minutes at room
temperature. PFA was then removed with three TBS washes. Permeabilisation took
place by adding 0.1% (v/v) TritonTMX-100 to each coverslip, with incubation at room
temperature for fifteen minutes. This was removed, and washed off with three TBS wash
steps. Then, 0.5% (w/v) Marvel powdered milk suspension was added to each slide for
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fifteen minutes at room temperature. This was similarly removed and washed off with
three TBS washes. Primary antibodies were diluted in antibody diluent, added to each
slide, and incubated for one hour at room temperature. Antibodies were washed off
with two TBS-T and two TBS washes. Then, coverslips were incubated in secondary
antibodies (in antibody diluent) for 1 hour at room temperature. Primary and secondary
antibody incubations were carried out in a humidified chamber, covered in foil. Secondary
antibody was removed with two TBS-T and two TBS washes. Coverslips were mounted
on to slides using mounting medium containing Hoechst. Slides were then stored in the
dark at 4oC for up to three days before imaging.
2.4.4.5 Image Analysis Following the Live/Dead R© Viability Assay
Following imaging, image analysis was undertaken the software FIJI. FIJI includes
ImageJ software with plugins specifically for image analysis techniques. A basic protocol
(Labno, NA) was amended to incorporate FIJI plugins. In brief, the protocol comprised
converting single fluorescent channel images into 8-bit images; using a local threshold
to distinguish cells based on their brightness and size, whilst accounting for differences
in brightness across images; splitting up multi-cellular entities and finally counting
objects based on size and circularity. Several iterations of image analysis algorithm were
attempted, including changing threshold techniques, incorporating watershed features,
and altering size range and circularity of particles analysed. Manual cell counting was
compared with automated methodology to ratify the methodology.
Manual cell counting was undertaken on cells in focus and distinguishable on each
image. The RGB image was split into separate individual channel images. Using the point
tool, all the stained cells on the red image (ethidium homodimer stained dead cells) were
selected. The counter was reset and the cells on the blue image (Hoechst stained cells)
were counted. Overall, the proportion of living cells could be calculated by knowing the
total number cells (cells stained with Hoechst); and the number of dead cells (cells stained
with ethidium homodimer).
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2.4.4.6 Analysis of Astrocyte Reactivity using GFAP
Glial fibrillary acidic protein (GFAP) is a component of the astrocyte intermediate
filament network (Hol and Pekny, 2015). As such, it is involved in cytoskeletal structure
and function; with associated roles in cell motility and vesicle trafficking (Middeldorp
and Hol, 2011). For this study, its role in neural injury pathogenesis was most important.
When exposed to chemical or mechanical stress, such as injuries or ischaemia,
phenotypic changes occur in astrocytes, going from physiological to a reactive astrogliosis
phenotype. Astrogliosis is hallmarked by upregulation of GFAP, increase number of
astrocyte processes, and hypertrophy of these processes (Hol and Pekny, 2015). The
degree of astrogliosis varies with injury severity, with the most severe form contributing
to the glial scar in traumatic spinal cord injury (Sofroniew, 2005). The role of GFAP
in astrogliosis in response to neural injury has been confirmed in knockout mice. These
GFAP-null animals showed an increased susceptibility to traumatic spinal cord injuries
and ischaemia (Nawashiro et al., 1998, 2000). However, the role of GFAP in non-
traumatic spinal cord injury specifically has not been established. In this study, reactive
astrogliosis was measured using immunocytochemistry GFAP-labelling of astrocyte
populations. The number of cells expressing GFAP, area of GFAP per cell, and number
of astrocytic processes were calculated using image analysis.
2.4.4.7 Image Analysis of GFAP Staining
Analysis of astrocyte reactivity, using fluorescent images of GFAP immuno-staining, was
carried out in a similar manner to Smith, to facilitate comparison between studies Smith
(2016). Automated image analysis minimises user bias, allows for variation in staining
intensity, and increases the speed of the analysis process. Each fluorescently-labelled
object could be evaluated for size and shape parameters.
First, multi-channel fluorescence images were separated by channel to show one
fluorophore per image. The channel incorporating GFAP staining was selected. On this
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channel, areas which were labelled for GFAP (objects of interest) were distinguished
from background using an automatic threshold technique. This produced a binary image
of objects of interest based on intensity. Similarly to previous studies, the ’Phansalkar
Auto Local Threshold’ tool was chosen to account for background noise between images
(as described and rationalised in Smith (2016)). The scale was set on this binary image
to conform to the original image (Figure 2.6). From the binary image, objects of interest
were analysed. Objects less than 10 µm2 were discarded as per the previous study (Smith,
2016). No maximum area was defined since the maximum area of GFAP expression per
object was unknown. Outcomes measured were total area, area per object of interest, and
circularity. Circularity is a measure of the shape of the object, using the equation below.
A circularity of 1.0 was a perfect circle, and as the value reduced it indicates an elliptical,
elongated, or irregular shape (ImageJ, 2012).
Circularity = 4pi × Area
Perimeter2
A macro of this method was developed to facilitate analysis. This macro is in
Appendix D.1. The binary image of objects was exported, and compared with the
original images for quality. If the binary image did not represent the original images,
for example in images with high background staining the objects of interest could not be
fully distinguished, the result for that image was discarded.
2.4.4.8 Contraction Assay
At various timepoints, images were taken of the gels in each well. Gel contraction was
measured using FIJI, tracing the circumference of the base of the well, followed by the
perimeter of the gel. The measure tool in FIJI then provided the area of each of these, and
thus percentage contraction of the gel could be calculated.
2.4.4.9 Enzyme-linked Immunosorbent Assay (ELISA)
The ELISA tests used were sandwich ELISAs with pre-coated plates. Standards and
solutions were made up according to section 2.4.1.3. For IL-6 ELISA, incubations were
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Figure 2.6: Example of binary GFAP fluorescence image using in image analysis. The single
channel GFAP fluorescence image (left) was separated from the multi-channel microscopy image
using FIJI. The ’Auto Local Threshold’ tool and ’Phansalkar’ settings were used to create the
binary image (right). From this image, objects with an area >10 µm2 were analysed.
carried out at 37oC. For IL-10 ELISA, incubations were carried out at room temperature,
as per the manufacturers instructions.
A volume of 100 µL of standard, control or sample was added to each well. The
plate was sealed with an adhesive plate sealer, and incubated for 90 minutes with gentle
shaking at 50 rpm.
Solutions were then aspirated and wells washed three times with 400 µL wash buffer
per well using an automatic plate washer at room temperature. The plate was blotted on
paper towel to remove any residual solution.
A volume of 100 µL of biotin-conjugate detection antibody was added to each well.
The plate was sealed and then incubated for 60 minutes with gentle shaking at 50 rpm.
The same wash steps as above were repeated (3 x 400 µL washes and blotting).
Streptavidin solution (100 µL) was added to each well, and the re-sealed plate
incubated for 30 minutes with gentle shaking at 50 rpm. The same wash steps as above
were repeated (3 x 400 µL washes and blotting).
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A volume of 100 µL substrate solution was added to each well. This produced a
colour change at high concentrations of the cytokine being detected. The plate was sealed
and covered in foil to protect from the light. The substrate solution was incubated for 15
minutes with gentle shaking at 50 rpm.
Finally, 100 µL of stop solution was added to each well, and the plate was tapped
gently to ensure thorough mixing. The optical density of each well was determined using
a plate reader at 450 nm.
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2.5 General in-vivo Materials and Methods
Details of general methods, materials, equipment and reagents used can be found in 2.3.
The details of each method described in this section are used in the following chapters
5 and 6, describing in-vivo model development and outcomes, respectively (Figure 2.7).
In brief, a balloon catheter system was developed for implantation ventrally within a rat
vertebral canal, which could be inflated over days to induce a NTSCI. The ventral balloon
catheter system was characeterised for TSCI, and then adapted for NTSCI. Histological
and functional outcomes were established in NTSCI study groups, compared to control.
2.5.1 Solution Preparation
Surgical Solutions and Perfusion
Iodine ethanol solution: A total of 1 L of iodine ethanol solution was made up using
500 mL of 100% (v/v) ethanol, and 500 mL tincture of iodine. The solution was stored
for up to one year at room temperature.
Buprenorphine (Vetergesic): The analgesic solution (Vetergesic) was diluted in
sterile saline to an end concentration of 0.03 mg.mL-1. It was administered at 0.015
mg.kg-1.
Enrofloxacin (Baytril): The antibiotic solution (Baytril) was diluted in sterile saline
to an end concentration of 0.25 mg.mL-1. It was administered at 0.25 mg.kg-1.
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Figure 2.7: Aims, objectives, and methods used in in-vivo studies. Chapters are split into model development, and evaluation of neural
cells in response to the model.
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Phosphate buffer: For one litre of phosphate buffer, 33.75 g of sodium phosphate
monobasic and 7.72 g of sodium hydroxide (final concentrations 0.24 M and 0.2 M,
respectively) were added to distilled water to make 2X concentrated phosphate buffer.
The pH of the solution was changed to 7.4. Where 1X phosphate buffer was required,
this was diluted 1:1 with distilled water. Both solutions were filtered and stored at room
temperature.
8% (w/v) Paraformaldehyde: A total of 900 mL of distilled water was heated to
60oC. Then, 80 g of paraformaldehyde powder was added. Subsequently, the solution
was cleared by addition of 1 M NaOH dropwise. Once the solution cooled, the pH was
adjusted to 7.4 by the addition of 1 M HCl dropwise. The volume was topped up to 1 L
using distilled water. The solution was stored at 4oC for up to one day.
4% (w/v) Paraformaldehyde in phosphate buffer: Paraformaldehyde solution 8%
(w/v) was diluted 1:1 with 2X phosphate buffer. The solution was filtered and then
immediately used.
30% (w/v) Sucrose and 0.1 % (v/v) sodium azide: A total of 30 g sucrose and 0.1
mL sodium azide were added to 99.9 mL filtered 1X phosphate buffer (0.12 M sodium
phosphate monobasic, 0.1 M NaOH, pH 7.4). The solution was stored at 4oC.
Histology and Immunohistochemistry
1x TBS, 1x TNS and 0.3% (v/v) TBS-T were made up according to details in section
2.4.1.3
Blocking buffer: A solution of 10% (v/v) horse serum was made up in 0.3% (v/v)
TBS-T. The solution was mixed and stored at 4oC for up to two weeks.
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2.5.2 Surgical Techniques and Care
2.5.2.1 Animal Housing and Care
Animal experiments either took place in Prague, Czech Republic (Institute of
Experimental Medicine); or Leeds, UK (University of Leeds). In either case, female adult
(3 month old) Wistar rats were used in each experiment. In studies carried out in Prague,
experiments were performed in accordance with the European Communities Council
Directive of 22nd September 2010 (2010/63/EU) regarding the use of animals in research,
and were approved by the Ethics Committee at the Institute of Experimental Medicine,
Academy of Sciences of the Czech Republic, Prague, Czech Republic (experimental
project number 53/2014). Animals were obtained from the in-house breeding facility
at the Academy of Sciences of the Czech Republic, Prague. For studies carried
out at the University of Leeds, animals were sourced from the University of Leeds
Central Biomedical Services. Methods used complied with the UK Animals (Scientific
Procedures) Act 1986, under project license PPL 70/8085, with approval from the internal
University of Leeds ethics committee.
All animals were kept in a temperature controlled environment (19 to 21oC) with
a 12 hour day/night cycle (lights on at 7 AM). Each had ad libitum access to food and
water. Animals were housed individually after surgery, with manual bladder expression
twice a day if required. Any minor skin wounds or irritation were treated with a topical
application of Isathal (10 mg/g fusidic acid) to prevent infections.
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2.5.2.2 Spinal Cord Lesion Surgical Preparation
Anaesthesia was induced using 5% (v/v) isoflurane in oxygen at 2 L.min-1. Anaesthesia
was confirmed by a lack of righting reflex, toe pinch withdrawal reflex, and corneal
blinking reflex. At this point, the animal was transferred to a face mask and isoflurane
was reduced to 2.5% to maintain the anaesthetised state. During all subsequent surgical
proceedings, the animal was on a heat mat warmed to 37oC.
The back of each animal was shaved from the base of the skull to caudal of the
ribcage. Iodine solution was applied to the area using gauze. A two to three centimetre
long incision was made using a scalpel, from approximately T6 to T12.
The T10 vertebra was identified by working upwards from the caudal floating rib
(T13). Musculature was disrupted at this level using blunt dissection, allowing access to
the vertebral bone. Once the posterior spinous process and lamina could be identified,
rongeurs were used to create a partial (right-hand side only) laminectomy at T10 and
expose the spinal cord (Figure 2.8A). The right hand side of the lamina were fully
removed, from the midline vessel to the lateral most aspect.
Any minor bleeds during surgery were quelled using sterile cotton buds, application
of saline, or use of bonewax on a sterile cotton bud. For moderate bleeds, small pieces of
wet Spongostan were applied to the bleeding area to promote clotting.
At this point, isoflurane was reduced further to 2%. The patency of each balloon
catheter system was tested prior to use in-vivo. Sterile water was used to inflate the
balloon, and provided there were no leaks in the system the water was removed until the
curved edges of the inflated balloon became straight again. The balloon catheter was then
introduced at the laminectomy site (T10), on the right-hand lateral edge of the spinal cord
within the vertebral canal. The catheter was pushed both rostro-ventrally until resistance
was met. This signified the ventral surface of the vertebral body had been reached. The
catheter was further advanced rostrally until a length 1 cm below the bottom of the balloon
was inserted into the canal (Figure 2.8B and Figure 2.9). Based on understanding of rat
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anatomy, the tip of the balloon was positioned at spinal cord level T7/8 (aligning with
vertebral level T7) with the balloon itself being at T8/9 (vertebral level T7/8) (Hebel and
Stromberg, 1976). The balloon was either inflated immediately and then removed, or
implanted depending on the study. Subsequently, the spinal cord muscle layer was closed
using resorbable Vicryl sutures. The skin was closed using Prolene sutures.
Figure 2.8: Schematic diagram of key stages in balloon catheter surgery for inducing spinal
cord injury. Surgery was undertaken in female adult Wistar rats. A: the native tissue in the
surgical region. B: Laminectomy was performed at T10, and balloon catheter inserted
ventro-laterally in the vertebral canal caudally up to 1 cm below the caudal end of the balloon
(previously marked on the catheter).
Figure 2.9: Dimensions (mm) of portion of 2F Fogarty balloon catheter inserted into vertebral
canal. A total length of 18 mm of the balloon catheter was inserted into the vertebral canal of
rats to induce spinal cord injury. Not to scale, dimensions in mm.
67
Chapter 2. Materials and Methods
Each animal received subcutaneous injections of analgesia (Vetergesic, 0.015
mg.kg-1), antibiotic (Baytril, 0.25 mg.kg-1), and 5 mL pre-warmed (37oC) saline during
suturing to prevent pain or infection, and facilitate animal recovery.
After suturing, isoflurane was reduced to 0%, and the animal was left breathing
oxygen at 2 L.min-1 until they came around from anaesthesia. Then, the animal was
placed in a 32oC housing chamber until they were fully recovered from the anaesthesia.
Analgesia and antibiotics were given for three days post-surgery at the same
concentrations as previously stated.
2.5.3 Behavioural Testing
2.5.3.1 Open Field and BBB scale testing
Motor function was assessed according to the BBB scale (Basso et al., 1995). The scoring
system is a scale of 21 (Appendix E), from 0 (complete paralysis, no movement) to 21
(normal gait, co-ordination, toe clearance, paw position, stable). This scoring took place
over 4 minutes per timepoint, with the animal on an open field, radius 0.9 m. Animals
were assessed in a random order.
2.5.4 Histological Preparation
To perform histology on organs and tissues, the animal had to first be perfused with
fixative. It was important to remove all blood from the system prior to fixation since
blood has auto-fluorescent properties and thus could have interfered with imaging and
analysis.
2.5.4.1 Perfusion and Tissue Dissection
Animals were prepared for perfusion using an intraperitoneal injection of sodium
pentobarbital at 200 mg.kg-1. For a 300 g animal this was approximately equivalent to a
400 µL injection of 20% (w/v) Pentoject. Once toe pinch withdrawal and corneal reflexes
were lost, the animal was prepared for perfusion. If these reflexes were not lost within
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five minutes of the initial injection, a further volume of 200 µL was injected.
Forelimbs were spread and held in place using needles. Then, a midline incision was
made just below the ribcage. The skin was detached from underlying musculature using
blunt dissection. A laparotomy was performed across the entire width of the abdominal
wall at this level. Then, the diaphragm was released from the thoracic wall. Subsequently,
the ribs were cut on each side (lateral to the lungs) in order to lift the ribcage and sternum
up over the head for access to the heart. Any remaining connective tissue was removed.
The heart was positioned straight down along the midline. Iris scissors were used to make
an incision just lateral of the apex of the heart, in the left ventricle. A 15 gauge blunt-
tipped needle catheter was introduced to this incision, which was then pushed until it just
reached the aorta. A further incision was made in the right atrium using iris scissors.
Phosphate buffer was perfused trans-cardially through the needle catheter at 8 to
12 mL.min-1. This could be confirmed by movement of the animals limbs and tail,
discolouration of the liver and feet. This perfusion continued until the fluid running out of
the right atrium was clear. This confirmed all blood was removed from the body. Next, the
catheter was transferred to 4% (w/v) PFA in phosphate buffer. The animal was perfused
with fixative until the limbs and organs were stiff.
Following perfusion, the spinal cord and brain were harvested from every animal
and placed in 4% (w/v) PFA in phosphate buffer for a further 24 hours to ensure complete
fixation. Tissues were stored in 30% sucrose at 4oC for up to one week before histology
was carried out.
If tissues were stored for a longer duration, tissues were transferred to containers
with 30% (w/v) sucrose and 0.1% (v/v) sodium azide, and again stored at 4oC.
2.5.4.2 Tissue Preparation
Embedding Cryo-blocks
Spinal cords were placed into a petri dish containing fresh 30% (w/v) sucrose solution,
handling gently to prevent damage. The cord was cut into approximately 2 mm slices.
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Each of these was tried gently using blue roll, and subsequently placed into a cryo-mold
containing a thin layer of optimum cutting temperature compound (OCT). Four spinal
cord slices were placed into each cryo-mold, ensuring they all had the rostral surface
facing downwards and flat. The molds were subsequently filled with further OCT. Then,
they were placed into a metal tray containing a slurry of dry ice and absolute (100%
(v/v)) ethanol. Again, ensuring the cryo-molds were flat. The OCT changed colour from
colourless to opaque white, and changed consistency from gel-like to solid. Once the
whole block had frozen, it was removed from the slurry and placed on dry ice whilst the
rest of the cord was frozen. After this, cryo-blocks were stored in a zip-lock bag with air
removed, at -80oC.
Cryo-sectioning
Cryo-sectioning was undertaken at -20oC. Each cryo-block was serially sectioned at 40
µm thickness. Torn or damaged sections were noted. Four sections were placed onto one
Superfrost plus slide. Slides were left at room temperature for at least 30 minutes before
being stored at -20oC for up to one week or -80oC for longer storage.
2.5.4.3 Histological Staining
Prior to any of the following staining procedures, slides with frozen sections were left
to air dry for at least one hour at room temperature. This ensured sections were fully
adherent to the slides and thus less likely to fall off during staining.
Haematoxylin and Eosin
Slides to be stained were left to thaw at room temperature for at least one hour. The
slides were then placed in a slide rack and washed in running tap water for three minutes
to remove excess OCT. After this, slides were immersed in Mayer’s Haematoxylin for
one minute, and subsequently rinsed in tap water until the water ran clear. Slides were
checked under a light microscope at this point. If the haematoxylin staining was too
weak, the slides were immersed again for 1 minute, followed by rinsing in tap water. This
was repeated until staining was sufficient. The haematoxylin stain underwent blueing
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by immersion in 1X Scott’s tap water substitute for three minutes, and then a further
three minute rinse in tap water. Sections were stained with eosin by immersion for thirty
seconds. Eosin was washed off using tap water until the water ran clear. Then, sections
were placed into 70% (v/v) ethanol for twenty seconds, followed by three immersions
into fresh 100% (v/v) ethanol for one minute, two minutes and three minutes respectively.
Slides were immersed into clean 100% (v/v) xylene for ten minutes, twice. Then,
coverslips were mounted onto slides using DPX mountant. The xylene and DPX stages
were undertaken within a fume hood. Slides were then left to dry overnight until the DPX
had fully dried. Imaging was undertaken using brightfield microscopy. Subsequently,
images were imported into FIJI and the area of each section was evaluated (Appendix
D.2). Stained tissue was discriminated from the background using the Phansalkar auto
thresholding method (Figure 2.10). The area of this tissue was then calculated.
Figure 2.10: Example of image analysis for H&E stained spinal cord sections. Sections 40 µm
thick were stained with H&E at 1 mm intervals throughout the spinal cord. Image analysis was
undertaken in ImageJ, creating a binary image using the Phansalkar image thresholding method.
The stained area was then evaluated from the binary image. Scale bar = 1 mm
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Immunohistochemistry
Once the injury site was determined using haematoxylin and eosin staining, relevant
sections in this region were stained using immuno-fluorescence. Three regions were
imaged: central to the injury, caudal, and rostral to the injury site. Three sections were
imaged in each region. Wash steps were carried out for ten minutes at room temperature,
using an excess of reagent. Slides were removed from the freezer and left to thaw for at
least one hour prior to staining. This ensured that all the sections were stuck to the slide.
Subsequently, three washes in TBS were undertaken to remove excess OCT. Then, 400
µL of blocking buffer (8% (v/v) goat serum in 0.3% (v/v) TBS-T was added to each slide
for two hours at room temperature. A piece of parafilm was placed on top of each slide to
cover the sections. This ensured solutions were retained on the sections, and the solutions
did not evaporate. After this, the blocking buffer was removed and 400 µL of primary
antibody diluted to the appropriate concentration in the same blocking buffer was added
to each slide. Again, parafilm was placed on top of each slide. Slides were incubated in
primary antibody overnight at 4 oC.
The following day, primary antibody solution was removed and slides were washed
three times with TBS. Secondary antibody was diluted to the appropriate concentration in
blocking buffer containing Hoechst at 2 µg.mL-1. A volume of 400 µL was added to each
slide. Parafilm was placed on top of each slide and slides were incubated for two hours at
room temperature. Subsequently, three washes were undertaken in TBS, and a final wash
in TNS. Slides were mounted using Fluorsave. The slides were covered in foil and stored
at 4oC until imaging was undertaken (at most three days).
Imaging was undertaken using an upright confocal microscope. For each animal,
three slides were imaged (one per region): caudal to the injury region, epicentre of
the injury, and rostral to the injury region. On each slide, three sections were imaged.
Subsequently, images were analysed using FIJI, using a similar method to previously
described for cells in hydrogels (section 2.4.4.7). Images were evaluated using an
automated macro similar to that used for H&E staining (appendix D.3).
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Figure 2.11: Example of image analysis for fluorescent labelled spinal cord sections. Sections
40 µm thick were stained for various immuno-fluorescent markers. Imaging was undertaken on a
confocal microscope. Subsequent image analysis was undertaken in ImageJ, creating a binary
image using the Phansalkar image thresholding method. The stained area was then evaluated
using this binary image. Scale bar = 1 mm
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In brief, for each fluorescent channel, stained regions were distinguished based on
the Phansalkar local threshold method to produce a binary image (Figure 2.11). From
this, the area of all the stained regions was analysed. For GFAP, CS-56 and MBP staining
the area of immuno-staining was determined for each image using an automated macro,
and then normalised as a percentage of the tissue present on the nearest H&E section.
For RECA-1 labelling, only spinal cord parenchyma was evaluated (i.e. meninges and
surrounding tissue were excluded). The average size of each stained object and the count
of number of stained objects per image were assessed.
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In-vitro model development
3.1 Introduction
The aim of this project was to evaluate cellular responses to loading scenarios in NTSCI
both in-vitro and in-vivo. The aim of this chapter in particular is to develop in-
vitro methods to evaluate astrocyte responses to NTSCI. The introduction will outline
the background, followed by methods used to develop the model, and the results of
experiments using those methods. The discussion will critically appraise the wider
scientific literature, describe the context of the results, and draw conclusions.
Three-dimensional environments are more physiologically relevant than two-
dimensional environments for in-vitro models due to the presence of 3D matrix-cell
interactions (Abu-Rub et al., 2010). Collagen hydrogels have been previously used to
model a 3D environment to evaluate neural cell responses (East et al., 2010, 2012; Phillips,
2014a; Bar-Kochba et al., 2016; Smith, 2016; Kirk, 2018). In these studies, the collagen
hydrogels supported neural cell survival, and allowed application of mechanical insults.
In previous research at the University of Leeds, both the Infinite Horizon and BOSE 5110
Electroforce apparatus have been used to apply traumatic spinal cord injury insults to
neural cell seeded collagen hydrogels (Smith, 2016; Kirk, 2018).
The Infinite Horizon impactor was used to model traumatic spinal cord injury in
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astrocyte-seeded collagen hydrogels (Smith, 2016). However, this apparatus does not
allow control of displacement and velocity parameters which are crucial in differentiating
TSCI and NTSCI (Presysin, 2019). Subsequent research used the BOSE 5110
Electroforce apparatus to compress astrocyte-seeded collagen hydrogels at 3000 mm.s-1
(Kirk, 2018). However, no mechanical data such as load, output velocity or maximum
displacement were reported from impaction experiments. Nor were mechanical outputs
of the apparatus compared with input parameters, i.e. neither verification (checking the
device compared to specification) nor validation (checking the device and specification
captures the user’s needs). Kirk (2018) described recoil of the system at impaction,
leading to a secondary ramp at 3 mm.s-1 being required to impact the final 0.1 mm of
the hydrogel. The cause of this was hypothesised to be recoil due to the elastic properties
of the gel, but the system was not tested in air, which would have determined if the recoil
was indeed due to the gel properties, or inherent to the apparatus. Questions remain
regarding the mechanical outputs of the apparatus at high velocity parameters, and no
testing or characterisation has been carried out at low velocity parameters. Accurate and
precise application of velocity is core to differentiating TSCI and NTSCI.
This chapter aimed to estbalish a reliable method for using the BOSE 5110
Electroforce to apply controlled and reproducible uniaxial compression to hydrogels to
mimic relevant loading scenarios in spinal cord injury (both TSCI and NTSCI). If this
was the case, the displacement and velocity profiles input into the apparatus would closely
match the output mechanical data. This would be apparent at every velocity tested, and
both with and without gels present in the system.
Astrocytes are core to the pathology of TSCI, forming the glial scar (section 1.3.1).
The effects of injury mechanics on astrocyte morphology have been studied in-vitro in a
TSCI context (Section 1.4.2.2). The aim of this chapter was to establish a 3D astrocyte
culture model.
To assess the cells in 3D culture, they were seeded into collagen hydrogels. In
previous studies, collagen hydrogels have been seeded with primary astrocytes, with
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cells remaining viable for up to 14 days (East et al., 2009; Smith, 2016; Kirk, 2018).
Transforming growth factor beta (TGF-beta) has been used in several studies to induce
spinal cord injury phenotypes in astrocytes (Table 1.6 in section 1.4.2). Treatment with
TGF-beta induced reactive astrogliosis and glial scar formation (Logan et al., 1994;
Vogelaar et al., 2015). Astrocytes in a 3D hydrogel environment treated with TGF-
beta have previously shown increased GFAP expression (area per cell) and hydrogel
contraction (Cullen et al., 2007; East et al., 2009). In this study, as in the previous
research, the astrocyte-seeded hydrogels were treated with TGF-beta as a positive control
for astrogliosis. By reproducing previous research, this can further validate the phenotype
of the cell population; specifically in the context of spinal cord injury.
3.2 Aims
The aims of this chapter specifically were to develop methods of evaluating biological
responses to loading scenarios representative of NTSCI in-vitro. This links to the aim
of this whole project, which is to evaluate biological responses to loading scenarios
representative of NTSCI both in-vitro and in-vivo (Figure 3.1). Specific objectives for
this chapter:
1. To develop methodology to apply displacements and forces (of varying extent and
speed) relevant to non-traumatic spinal cord injury in-vitro:
A Determine the maximum velocity of the BOSE 5110 Electroforce apparatus.
B Determine the effects of newly designed novel platens on mechanical outputs
(displacement and maximum velocity) of the system.
C Identify the optimal gel volume for use within the BOSE 5110 Electroforce
apparatus.
D Determine the effect of incorporating acellular collagen hydrogels at 2
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mg.mL-1 and 5 mg.mL-1 into the system on displacement and velocity at
various velocities (1000, 100, 10, 1 and 0.1 mm.s-1).
E Determine the effect of working distance on displacement and velocity when
hydrogels are incorporated into the system.
2. Develop and characterise a reproducible type I collagen hydrogel seeded with
primary rat astrocytes, a relevant neural cell type:
A Evaluate the percentage of cells isolated from rat primary mixed glial
cell preparations which are positive for GFAP expression (using immuno-
labelling), and cell death using ethidium homodimer and Hoechst staining on
coverslip culture after three days in culture.
B Evaluate cell viability using ethidium homodimer and Hoechst staining of
primary astrocytes at days 1, 4, 7, 11 and 14 after seeding in rat collagen I
hydrogels.
C Evaluate the effects of 10 ng.mL-1 TGF-beta treatment on primary rat
astrocyte viability in 3D rat collagen I hydrogels using ethidium homodimer
and Hoechst staining, and area using GFAP immuno-labelling at days 1, 4, 7,
11 and 14 post-seeding.
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Figure 3.1: Hypothesis and research questions asked in Chapter 3, relating to the whole study.
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3.3 Experimental Setup
An overview of the methods used in relation to the aims and objectives provides further
detail and context for this chapter, developing models of spinal cord injury in-vitro. This
chapter has two parts: verification and characterisation of the BOSE 5110 Electroforce
system, and evaluation of the astrocyte cell population. Each will be discussed in turn.
(Figure 3.2).
3.3.1 Characterisation of the BOSE 5110 Electroforce System
Methods used in this section, and relation to objectives, are detailed in Figure 3.2.
The BOSE 5110 Electroforce system (described in section 2.3.1) allows uni-axial
compression or tension of a material, with control using a P.I.D tuning system. A
schematic representation of the apparatus depicts the setup with connection to a reservoir
bottle with media (Figure 3.3). Upon initial setup of the apparatus, the zero position was
noted as the displacement when the motor and load platens touched (as determined by a
change in load of over 0.1N). These were subsequently moved apart using the WinTest
software, the sample loaded in, and chamber closed. The platens were subsequently
moved slowly together using the WinTest software in increments of 1 to 10 µm until
surface tension caused the sample to adhere to the load platen. This meant gel height
could be recorded relative to the zero position.
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Figure 3.2: Aims, objectives, and methodologies used in Chapter 3: Verification of the BOSE 5110 Electroforce and evaluation of
astrocyte populations.
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Figure 3.3: Photograph and schematic diagram of the BOSE 5110 Electroforce apparatus
loaded with hydrogel sample. Photograph from suppliers website (TAInstruments, 2016)
3.3.1.1 Evaluation of BOSE 5110 Electroforce Mechanical Parameters with New
Platen Fixtures
The original platen fixtures for the BOSE 5110 Electroforce were not flat, and the outer
portion of the platen surface was raised compared with the internal disc portion (Figure
2.1 in section 2.3). This could have lead to discrepancies in measuring gel height. Further,
during compression experiments the outer edges of the gel would have been compressed
more than the central portion i.e. compression would not be uniform across the sample.
New platens were designed and manufactured to overcome these issues (Figure 3.4).
Platens A and B were provided with the apparatus. Platen C was a new platen for the
upper load fixture to apply the compression uniformly. Platen D and E were two new
platens for the motor fixture where the sample was loaded. Platen E was completely flat.
Platen D had a central indented portion, to prevent sideways slippage of the sample.
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Figure 3.4: Platens designed for the BOSE 5110 Electroforce. The ‘disc’ (B) and ‘empty’ (A) platens were provided with the instrument
itself, and the others were designed and manufactured in house at the University of Leeds. Platens were made of 316L stainless steel. All
measurements are in millimetres
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The proportional, integral, and derivative (P.I.D.) control system of the apparatus
was calibrated from the supplier, with tuning undertaken in air at 1000 mm.s-1 over 12
mm. P.I.D. values were 0.536222, 0.008357 and -2.26814 respectively. Using these P.I.D.
values, the inertia of novel platen fixtures were tested. They were first weighed three times
each; and then affixed to the motor plate in turn. A trapezoid displacement profile was
used; comprising a 0.1 second dwell, ramp to a displacement of 10 mm at 3000 mm.s-1,
a 10 second dwell, then ramp back by -10 mm at 3000 mm.s-1. This was repeated four
times for each platen fixture. Displacement over time was recorded, and from this velocity
was calculated. Statistical analysis was undertaken using two-way ANOVA with Tukey’s
post-hoc test. Mass and displacement correlation was determined using linear regression
in Microsoft Excel. The standard error of the correlation coefficient was determined using
the following equation, where y was the true value of y (velocity), yˆ was the predicted
value of y, and n was the number of data points.:
Standard error of the correlation coefficient =
√∑
(yˆ−y)2
n−2
3.3.1.2 Use of Hydrogels in the BOSE 5110 Electroforce System
Evaluating Gel Height: Varying Well Plate Size and Gel Volume
This preliminary experiment created individual acellular collagen gels of various
volumes, using the methods described in section 2.4.3. The gels were made of neutralised
rat collagen I, and were acellular; substituting media alone for media containing cells.
Gels were created with the end volumes of 250 µL, 500 µL and 750 µL in a 48 well plate,
and 300 µL, 600 µL and 1000 µL in a 24 well plate (n = 1 per condition). Gels were placed
in to the BOSE 5110 Electroforce, and their heights measured using methods described in
section 3.3.1. Linear regression between volume and gel thickness was determined using
Microsoft Excel. The standard error of the correlation coefficient was determined using
the equation described in the previous section.
Reproducibility of Gel Height
In all subsequent studies where hydrogels seeded with rat primary astrocytes at 1x106
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cells.mL-1, gel volume and corresponding gel heights were measured. This allowed
evaluation of variation of the gel heights based on gel volume. All of the gels were made
in a 48 well plate, and either comprised a volume of 300 or 400 µL.
3.3.1.3 Mechanical Outputs of the BOSE 5110 Electroforce System Incorporating
Hydrogels
Mechanical outputs of the BOSE 5110 Electroforce system were determined with
hydrogels present compared with air alone. The gels used were acellular bovine collagen
hydrogels with a volume of 400 µL and a collagen density of either 2 mg.mL-1 or 5
mg.mL-1. Four gels were seeded for each data point. The motor platen used was
entirely flat (platen E, figure 3.4), and the load platen had a 10 mm diameter (platen C in
figure 3.4). The experimental profile was a symmetric trapezoid; comprising movement
to the desired displacement at the desired velocity, a 0.1 s dwell, and return to initial
displacement at the same velocity. Displacement and time were recorded throughout
each test. During the initial displacement ramp, maximum velocity was noted and mean
velocity was calculated. Statistical analysis was undertaken using two-way ANOVA with
Tukey’s post-hoc test.
Gels were set in a 48 well plate, thus had a diameter of 11 mm (Corning, 2008). The
load platen with a diameter of 10 mm compressed over 80% of the gel cross-sectional
area. Theoretical velocities of 0.1, 1, 10, 100 and 1000 mm.s-1 were used. Preliminary
testing (data not shown) identified that a working distance of 1.5 mm was sufficient to
reach all maximum velocities except 1000 mm.s-1; where a working distance of at least
8 mm was required. Therefore, hydrogel compression was carried out at two working
distances; from 6.5 mm above the upper gel surface (i.e. total working distance 8 mm)
and from 0 mm above the gel surface (i.e. touching the gel, total working distance 1.5
mm). The same working distances of 8 mm and 1.5 mm were used in air.
85
Chapter 3. In-vitro model development
3.3.2 Methods for Evaluating Astrocyte Cell Populations
Before experiments could be undertaken which evaluated astrocyte responses to varying
mechanical inputs, the cell population itself required evaluation (Figure 3.2). This
included assessing the proportion of astrocytes in the cell population, cellular viability
and growth within hydrogels, and response to TGF-beta (a compound previously shown
to induce spinal cord injury-like phenotypes in astrocytes (East et al., 2009), Table 1.6
in section 1.4.2). Further, these studies allowed characterisation of the assays to monitor
cellular responses.
3.3.2.1 Determination of the Proportion of Astrocytes in Enriched Mixed Glial
Populations
Astrocytes were the neural cell used in this study, since they have a role in sensing
mechanical changes in the local environment (section 1.2.2). The primary cell isolation
method used the entire cortex of a rat to extract mixed glial cell populations (described
in section 2.4.2.4). Even after enriching astrocyte populations, there was a possibility
that the primary cells isolated could include microglia from brain tissue, fibroblasts from
the meninges, or other cellular contaminants. Therefore, the proportion of astrocytes in
enriched mixed glial populations had to be established.
Mixed glial cells were isolated from four P3 pre-weaner rats (Section 2.4.2.4). These
were seeded into two PDL-coated T75 flasks, and after 14 days astrocytes were enriched
using methods described in section 2.4.2.4. The remaining cell population was further
cultured for two days before being dispensed on to six PDL-coated 22 mm2 coverslips
at 3.6x104 cells per mL (as per previous study (Smith, 2016), methods described in
section 2.4.2.6). After a further three days in culture, coverslips were stained with a
combination of the live/dead assay and immunocytochemistry. This comprised ethidium
homodimer (the dead component of the live/dead assay) incubation for one hour (methods
in section 2.4.4), followed by immunocytochemistry for GFAP expression with Hoechst
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counterstain (methods in section 2.4.4.3). The experiment was repeated in triplicate.
Controls included a positive cell death control, where staining was preceded by a 30
minutes 70% (v/v) ethanol incubation; and negative antibody controls including using
TBS instead of the primary antibody, and using an IgG isotype control.
Coverslips were imaged on the widefield microscope (Zeiss, Axio Imager M2),
identifying all cells with Hoechst staining; dead cells with ethidium homodimer staining,
and cells expressing GFAP using antibody-labelling. Image analysis took place using
automatic tools (counting Hoechst and ethidium stained cells) and manual counting
(number of cells stained with GFAP).
3.3.2.2 Astrocyte Viability and GFAP Expression in 3D Collagen Hydrogels
After evaluation in 2D, the cells isolated using the same methods were evaluated in a 3D
collagen hydrogel environment. Positive control samples were treated with TGF-beta; a
chemical known to stimulate astrocyte reactivity. Over two weeks, the astrocyte response
(GFAP expression and viability) were recorded with and without TGF-beta treatment.
The total number of cells were also recorded. This was carried out using Hoechst staining
(total number of cells), ethidium homodimer staining (number of dead cells) and GFAP
immuno-labelling.
Primary mixed glial cells were isolated from six P3 pre-weaner rats. After 14
days, microglia were removed using shaking at 250 rpm for four hours (as described
in section 2.4.2.4) to obtain astrocyte-enriched cultures. These cells were seeded into 300
µL collagen hydrogels in a 48 well plate at 1x106 cells.mL-1. This cell concentration has
been used previously in the literature for astrocytes in 3D hydrogel matrices. For instance
(Smith, 2016) used an astrocyte density of 1x106cells.mL-1 in a collagen hydrogel model,
and (Cullen et al., 2007) used an astrocyte density of 1.25x106 cells.mL-1 in Matrigel.
Time points used were days 1, 4, 7, 11 and 14 post-seeding. Six gels were seeded per
timepoint, three untreated and three treated with 10 ng.mL-1 TGF-beta within the media.
Staining was visualised using the confocal microscope (10x objective), 5 random fields of
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view were evaluated per gel, with each comprising a 7 x 10 µm Z stack (total depth 60 µm).
Additionally, images were taken of one treated and one untreated gel at 20x magnification
per time point. These images comprised a 9µm Z stack (10 x 1 µm slices) and allowed
evaluation of GFAP expression phenotype at higher resolution. Image analysis was
carried out on images taken with the 10x objective, identifying dead cells (ethidium-
stained), all cells (Hoechst-stained) and GFAP expression. Image analysis was undertaken
using automatic cell count tools in FIJI to determine the number of nuclei (Hoechst
staining) and number of dead cells (ethidium staining). To quantify area of GFAP per
image, the green channel image (due to the secondary antibody used) was used. Areas
with staining were distinguished from the background using the Phansalkar method (as
described by Smith (2016)). Further details are described in Section 2.4.4.7. Total area of
staining per image was evaluated. Statistical analysis used two-way ANOVA comparing
untreated and treated gels over time. A p value of <0.05 was deemed significant, and
Tukey’s post-hoc test was used to subsequently identify significant differences.
A contraction assay was used to characterise the gel contraction over time (methods
described in section 2.4.4.8). Gel contraction by astrocytes is indicative of reactivity. To
achieve this, photographs were taken of the treated and untreated gels at day 11 and day
14. These were the longest timepoints for the experiment, and other studies have shown
that TGF-beta response is greatest at longer timepoints (up to 15 days after cell seeding)
(Cullen et al., 2007). Percentage gel contraction was measured by measuring the area
of the well itself, and the gels contained within. This was achieved using FIJI software,
manually drawing around each feature, and using the ’measure’ tool to quantify area.
Mean percentage differences in area between the well and gel were then calculated.
Statistical analysis was carried out in Microsoft Excel, using the Real Statistics add-
in. Two factor regression ANOVA was used for image analysis data, with Tukey’s post-
hoc test (significance level of p <0.05). Comparisons were made between the total area
of GFAP expression; and proportion of viable cells. For contraction assay results, an
unpaired t-test was carried out with a significance level of p <0.05.
88
Chapter 3. In-vitro model development
3.4 Results
3.4.1 The BOSE 5110 Electroforce was accurate at low velocities, but
less accurate at over 100 mm.s-1
The BOSE 5110 Electroforce apparatus was able to compress collagen hydrogels with
control of either load or displacement parameters. However, the system had not been
validated in the literature to have been used for this purpose. Input and output parameters
had not been compared to evaluate the accuracy of the apparatus. Nor had the optimal
gel height for working with the apparatus been established. The initial aims of this study
were to characterise the mechanical output of the BOSE 5110 Electroforce system, test
new fixtures, and optimise the use of collagen hydrogels in terms of gel volume and
height.
3.4.1.1 Maximum velocity of the BOSE 5110 Electroforce did not match the input
velocity, but did not change with introduction of new platens
The experiment described in this section aimed to determine the mechanical outputs of
the BOSE 5110 Electroforce apparatus using previously supplied and newly manufactured
platens. This included maximum velocity, displacement and inertia correlated this with
mass (see chapter 2, methods section 3.3.1.1; Figures 2.1 and 3.4). Platens were weighed
and then affixed to the motor shaft. Outputs were determined by recording displacement
and time using input parameters of 10 mm displacement at 3000 mm.s-1. Displacement
and velocity were correlated with mass.
The velocity profile output did not reach the theoretical velocity input parameters
The maximum input velocity was 3000 mm.s-1, whereas the output velocity was 1440
mm.s-1 (across all platen fixtures). Further, a positive velocity (i.e. movement of the
platen upwards) was observed in the output velocity. Comparing the different platens to
each other, there was no significant difference in maximum output velocity (p >0.05).
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The theoretical input and experimental output displacement profiles matched more
closely than the velocity profiles (Figure 3.5). The maximum displacement of -10 mm
was achieved in all tests, although there was a time delay of approximately 0.08 seconds
in all cases. There was an effect of displacement recoil with all platens.
Figure 3.5: Experimental displacement profiles of various platen fixtures in the BOSE 5110
Electroforce. Data series for platens overlap and are not distinguishable on the graph. The
theoretical experimental profile was upward displacement of 10 mm at 3000 mm.s-1; dwell for 10
seconds, downward displacement of 10 mm at 3000 mm.s-1.
At the timepoint when theoretical displacement first reached 10 mm (0.107 seconds),
experimental displacement for each platen was noted. An increase in mass was associated
with a reduction in displacement, with a linear correlation coefficient of 0.76 and (Figure
3.6). The largest difference in displacements at this timepoint was just 49 µm, and
differences were not statistically significant (p >0.05). These values were recorded at
a velocity of 1440 mm.s-1.
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Figure 3.6: The effects of mass on the displacement of various platen fixtures in the BOSE
5110 Electroforce at a single time point. Time point selected was 0.107 seconds; when
theoretical displacement first reached 10 mm. Data shown with the y-axis from zero (left) and, for
clarity, with a modified y-axis scale (right). n = 4 each data point. Data shown is mean ± S.E.M.
(S.E.M. is in the order of 0.0001 to 0.001 mm)
3.4.1.2 Hydrogels were easily incorporated and optimised for use within the BOSE
5110 Electroforce system
To characterise the BOSE 5110 Electroforce system mechanical outputs using collagen
hydrogels, gels had to be of sufficient height to account for the precision of the apparatus;
as well as to allow handling (loading and unloading from the apparatus itself). The first
subsection herein describes a preliminary experiment for assessing collagen hydrogel
height; and the second describes the apparatus mechanical outputs of the apparatus when
hydrogels were in place.
To evaluate reproducibility in gel thickness, along with how gel volume equated to
gel height, acellular gels of varying heights were produced as previously described (for
methods, see section 3.3.1.2). Photographs of the gels in the BOSE 5110 Electroforce
apparatus can be observed in Figure 3.7. The heights of gels fabricated in the 48 well
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plate followed a linear regression with a correlation coefficient (R2) of 0.9987, and a
standard error of the estimate of 0.069. The correlation was lower for 24 well plate gels
(R2 = 0.8963, standard error of the estimate 0.64) (Figure 3.8). Based on the equations
describing gel height, a volume of 400 µL in a 48 well plate, or 470 µL in 24 well plate
was required for a gel height of 2 mm.
Figure 3.7: Images of collagen hydrogels of varying volumes made in 24 or 48 well plates.
Various gel sizes were created with the aim of creating a hydrogel between 2 and 3 mm in
thickness. Gel height was assessed in the BOSE 5110 Electroforce
The smallest gel volumes in each plate (250 µL in a 48 well plate, and 300 µL in a
24 well plate) were difficult to handle and remove from the plate. All other gel volumes
were successfully handled; placed into and removed from the BOSE 5110 Electroforce
without damage.
92
Chapter 3. In-vitro model development
Figure 3.8: Thickness of collagen hydrogels of varying volumes fabricatee in either 24 or 48
well plates. As measured using the BOSE 5110 Electroforce, by moving the motor platen upwards
until the gel was touching the load platen (n=1 for each data point).
Gel heights were reproducible
Gel height reproducibility was established by measuring gel heights in all subsequent
studies where hydrogels were seeded with primary astrocytes at 1x106 cells.mL-1. Gel
height was measured using the method described in section 3.3.1, and box plots of the
data were established (Figure 3.9). The first six tests used gels 400 µL in volume in a 48
well plate, and had a mean gel height of 2.79 ± 0.047 mm. Subsequently, two following
tests used gels of 300 µL in volume in a 48 well plate. These gels had a mean gel height of
2.05 mm ± 0.055 mm (73% of 2.79 mm). In both volumes, gel heights were consistently
within 30% of the mean.
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Figure 3.9: Box plot of gel heights of 300 and 400 µL collagen hydrogels. The height of rat type
I collagen hydrogels, seeded with primary astrocytes at 1x106 cells.mL-1 were measured using the
BOSE 5110 Electroforce apparatus. Experiments 1 to 6 (inclusive) used 400 µL gels, and
experiments 7 and 8 (inclusive) used 300 µL gels. n = at least 10 gels per experiment
3.4.1.3 The mechanical outputs of the BOSE 5110 Electroforce system did not
differ when 2 mg.mL-1 collagen hydrogels were introduced
A study was undertaken to characterise the BOSE 5110 Electroforce system, specifically
comparing theoretical input and experimental output velocities over a variety of working
distances.
The mechanical outputs of the BOSE 5110 Electroforce were tested using acellular
collagen hydrogels (method described in section 3.3.1.3). Two densities of collagen I
hydrogels were tested, 2 mg.mL-1 and 5 mg.mL-1. Five theoretical velocities were tested
1000, 100, 10, 1 and 0.1 mm.s-1 at two working distances: 1.5 mm (from the top of the
gel surface) and 8 mm (from 6.5 mm above the gel surface). Tests with gels were run four
times, and tests in air (no gels) were run three times. In some gel tests, the gels slipped
off the platens during compression and as such their results could not be included. The
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number of samples per test were as follows:
• 5 mg.mL-1 collagen gels (all velocities and working distances) n=4
• Air (all velocities and working distances) n=3
• 2 mg.mL-1 collagen gels: 1000 and 100 mm.s-1 n=4
• 2 mg.mL-1 collagen gels: 10 and 1 mm.s-1 n=2
• 2 mg.mL-1 collagen gels: 0.1 mm.s-1 n=3
The target displacements (from 1.5 to 8 mm) were reached under every condition,
velocity and working distance (Figure 3.10). Recoil of apparatus was observed at both
working distances at 1000 mm.s-1, and to a lesser extent at 1.5 mm at 100 mm.s-1 (A, B,
C in Figure 3.10).
Maximum theoretical input velocity was reached in all but six tests (Table 3.1). Five
of these were at 1000 mm.s-1. The sixth was at 100 mm.s-1, at a working distance of
1.5 mm with 5 mg.mL-1 collagen hydrogel present. At high velocities (>10 mm.s-1),
exceeding the theoretical velocity was due to overshoot on the compression ramp. At low
velocities (≤ 10 mm.s-1), theoretical velocity was exceeded due to noise in the system.
In all tests, standard error of the mean compression velocity was small (errors bar in
A to E, Figure 3.11). At 0.1 and 1 mm.s-1, there were no significant differences in mean
and theoretical velocities, nor based on working distance or condition. At 10 mm.s-1,
velocity was reached at both working distances for air and 2 mg.mL-1 collagen hydrogel.
For the 5 mg.mL-1 collagen hydrogel, velocity was not reached at 1.5 mm, but was reached
at 8 mm. At 100 mm.s-1, increasing the working distance significantly increased mean
velocity outputs from 92.5 to 96.5 mm.s-1 (p <0.05). With the working distance of 8 mm,
theoretical velocity was reached in all conditions. At 1000 mm.s-1, increasing working
distance increased mean velocity output by 738 mm.s-1 (p <0.05). With a collagen
hydrogel at 5 mg.mL-1, this was still insufficient to reach the theoretical input value. In
spite of the overshoot observed at the higher velocities, overall the displacement over time
was maintained and stable for the duration of the experiment.
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Table 3.1: Maximum velocity output of the BOSE 5110 Electroforce apparatus, at various theoretical velocities, with and without
hydrogels. Velocities were recorded with and without bovine type I collagen hydrogels present (collagen at 2 mg.mL-1 and 5 mg.mL-1), at
various combinations of theoretical velocity and working distance. Data shown are mean ± S.E.M. for between n = 2 and n = 4 tests. All
data are significantly greater than the input velocity apart from those denoted by *: these are significantly lower than the input velocity (p
<0.05)
Distance Condition
Theoretical input velocity (mm.s-1)
0.1 mm.s-1 1 mm.s-1 10 mm.s-1 100 mm.s-1 1000 mm.s-1
1.5 mm
Air 0.18 ± 0.02 1.83 ± 0.17 15.00 ± 0.01 118.33 ± 1.67 241.67 ± 1.67*
2 mg.mL-1
hydrogel
0.32 ± 3.4 x10-3 2.00 ± 0.02 15.00 ± 0.02 105.00 ± 2.04 215.00 ± 0.01*
5 mg.mL-1
hydrogel
0.34 ± 0.02 2.00 ± 0.01 15.00 ± 1.6 x10-3 96.25 ± 1.25* 228.75 ± 1.25*
8 mm
Air 0.16 ± 0.01 1.98 ± 0.14 12.00 ± 1.9 x10-3 114.17 ± 0.83 963.33 ± 1.67*
2 mg.mL-1
hydrogel
0.17 ± 0.01 1.79 ± 0.12 12.00 ± 0.01 116.25 ± 1.25 1022.50 ± 1.44
5 mg.mL-1
hydrogel
0.17 ± 0.008 1.93 ± 0.09 12.00 ± 0.03 111.25 ± 1.25 992.50 ± 6.61*
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Figure 3.10: Displacement profiles from the BOSE 5110 Electroforce, at various theoretical velocities, with and without hydrogels
present. Displacement was recorded with and without collagen hydrogels present (collagen at 2 and 5 mg.mL-1), at various combinations
of theoretical velocity and working distance.
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Figure 3.11: Velocities produced by the BOSE 5110 Electroforce apparatus, with and without
collagen hydrogels present. Theoretical velocities of 1000 (A), 100 (B), 10 (C), 1 (D), and 0.1
(E) mm.s-1 were tested in the BOSE 5110 Electroforce system, without gels present and with
collagen hydrogels at 2 and 5 mg.mL-1. Two working distances were used: 1.5 mm (from gel
surface) and 8 mm (from 6.5 mm above gel surface). Data shown are mean values for the
displacement ramp ± S.E.M.
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3.4.2 Establishment of 3D astrocyte culture model
The aim of this study was to evaluate neural cell responses to varying mechanical
inputs. The cell type of interest was primary rat astrocytes. Before use in experimental
studies applying mechanical insults, the cells themselves had to be evaluated in both 2D
and 3D scenarios. For instance, identifying whether the extracted primary cells were
predominantly astrocytes; evaluating cellular density in collagen hydrogels; and assessing
physiological and pathological changes in GFAP expression.
3.4.2.1 Astrocytes in hydrogels were activated by TGF-beta.
The proportion of astrocytes was determined in a population of cell isolated from mixed
glial cells which had been subjected to shaking for 4 hours at 250 rpm to remove
microglia. Cells were seeded onto coverslips, and immuno-stained for GFAP. Cells which
stained positively for both Hoechst and GFAP were considered to be astrocytes, whereas
cells stained with Hoechst only were other cell types. Methods are described in section
3.3.2.1.
A total of 89.7 ± 3.5% of all cells were stained with GFAP. In the 70% (v/v) ethanol
control, 100% of cells were stained with both ethidium-homodimer and Hoechst (i.e. were
dead). Across the remaining samples, an average of 11.7 ± 2.9% of all cells were dead.
In order to characterise the 3D hydrogel astrocyte-seeded model used in this study, an
experiment was undertaken evaluating cellular responses to TGF-beta treatment. Methods
described in section 3.3.2.2. In brief, at 5 timepoints over 14 days, GFAP expression (a
marker of astrocyte reactivity) was evaluated alongside ethidium homodimer staining (a
marker of dead cells) in astrocyte seeded collagen gels treated with TGF-beta or untreated
(n = 3 per timepoint for each condition).
In test gels incorporating cells treated with TGF-beta, the morphology of astrocytes
changed from rounded (day 1) to increasingly ramified (day 14) (Figure 3.12). The area
of GFAP expression per field of view was quantified using FIJI software. With TGF-beta
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treatment, total area stained with GFAP increased by 227% over the 14 day experiment;
conversely GFAP expression in untreated gels remained relatively constant (Figure 3.13).
There was significantly more GFAP expression in TGF-beta treated cells versus untreated
cells at day 14 (p <0.05).
In untreated and TGF-beta treated gels, 13.5 ± 3.3% and 13.6 ± 3.5% (mean ±
S.E.M) of cells were dead, respectively. Between days 1 and 14, the proportion of dead
cells decreased by 90.8% for untreated cells, and 82.5% for TGF-beta treated cells (Figure
3.14). In both conditions, there was a significantly greater proportion of viable cells on
day 14 than days 1 and 7 (p <0.05). In TGF-beta treated cells, there were significantly
more viable cells on day 14 vs day 4; and in untreated gels there were significantly more
viable cells on day 11 vs day 7 (p <0.05). There was no significant difference in viability
between untreated and TGF-beta treated cells at any time point.
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Figure 3.12: Confocal microscope images, taken using 20x objective, of primary astrocytes in collagen gels, treated with TGF-beta
Collagen hydrogels were seeded with primary astrocytes at 1x106 cells.mL-1; and immunostaining carried out at 5 timepoints over 14
days. GFAP expression is a marker of astrocyte reactivity
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Figure 3.13: Proportion of image stained positively for GFAP, in astrocyte seeded hydrogels
Collagen hydrogels were seeded with primary astrocytes at 1x106 cells.mL-1; half of which were
treated with 10 ng.mL-1 TGF-beta. Immunostaining was carried out at 5 timepoints over the 14
day experiment for GFAP; a marker of astrocyte reactivity. Area stained with GFAP was
calculated using FIJI software. For each data point, n=3. Data shown is mean ± S.E.M.
Figure 3.14: Proportion of dead cells per image, in astrocyte seeded hydrogels Collagen
hydrogels were seeded with primary astrocytes at 1x106 cells.mL-1; half of which were treated
with 10 ng.mL-1 TGF-beta. Staining was carried out at 5 timepoints over the 14 day experiment
for ethidium homodimer and Hoechst; markers of dead cells, and all cells, respectively. Dead
cells were identified by both ethidium homodimer and Hoechst staining; whereas living cells
stained with Hoechst only. Proportion of dead cells was calculated using FIJI image analysis
software. For each data point, n=3. Data shown is mean ± S.E.M.
102
Chapter 3. In-vitro model development
3.4.2.2 Activated astrocytes induced hydrogel contraction
Hydrogel contraction, as a marker of cellular reactivity, was also measured in both
untreated and TGF-beta treated astrocyte-seeded collagen gels on day 11 and day 14. On
average over both days, TGF-beta treatment led to gel contraction of 48.6± 2.77% (mean
± S.E.M.) compared to their original gel diameter; whereas untreated gels contracted by
9.14 ± 1.99% compared to their original diameter at both timepoints (Figure 3.15), p
<0.05 on both days).
Figure 3.15: Gel contraction in TGF-beta and untreated collagen hydrogels, seeded with
primary astrocytes Collagen hydrogels were seeded with primary astrocytes at 1x106 cells.mL-1;
half of which were treated with TGF-beta. Gel contraction was measured by taking photographs
of the gels in a 48 well plate at day 11 and day 14 post-seeding. Images were analysed using
FIJI; where gel area was compared with well area. For each data point, n=3. Data shown is
mean ± S.E.M. * denotes p <0.05
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3.5 Discussion
3.5.1 Characterisation of the BOSE 5110 Electroforce Biodynamic
System
It was hypothesised that the BOSE 5110 Electroforce Biodynamic system could be used
to apply clinically relevant loading scenarios to seeded collagen hydrogels; mimicking
spinal cord injury. This hypothesis was used in previous research to apply mechanical
insults to neural cell seeded collagen hydrogels in the context of spinal cord injury (Kirk,
2018). However, the previous study did not characterise the actual mechanical outputs of
the apparatus. To characterise the apparatus, mechanical outputs were recorded in air and
with gels introduced into the system. The optimal gel size was established.
3.5.1.1 BOSE 5110 Electroforce Mechanical Parameters with New Platen Fixtures
The original platen fixtures for the BOSE 5110 Electroforce system had slightly indented
central portion. To apply load and displacement with an even spatial distribution across
the hydrogel surface, and to prevent gels slipping, new platens were manufactured. The
volume and mass of these platens varied based on design specifications. The output
displacement and velocity of the apparatus with each platen were recorded. Platen
fixtures were attached to the motor platen, and a displacement profile comprising upwards
motion at a theoretical velocity of 3000 mm.s-1, and a displacement of 10 mm was
applied. A displacement of 10 mm was applied since this gave 1 mm at either end of
the displacement profile for uncontrolled movement without reached the limits (the total
theoretical working distance of the apparatus was 12 mm).
At the maximum output velocity (1440 mm.s-1), the effect of differences in platen
mass led to a minimal difference in displacement of 49 µm. This was not statistically
significant. As such, the mass of the platens will have little effect in the study, and any
can be used in future experiments.
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Displacement data closely matched between theoretical and experimental values. A
recoil effect was seen in displacement profiles, as described in previous research (Kirk,
2018). This was identified as an effect of collagen hydrogels, and hypothesised it was due
to elastic recoil of the gel. The results herein identified the recoil without any hydrogel
present (i.e. in air). Therefore, it was due to workings of the apparatus, regardless
of material present. One explanation is due to the abrupt change in momentum of the
apparatus at high velocities. The apparatus cannot immediately change from 1000 mm.s-1
to stationary, and instead recoil occurs.
In velocity data, the theoretical maximum velocity was 3000 mm.s-1 whereas
maximum recorded velocity was 1440 ± 1.27 mm.s-1. By contrast, in previous research
a velocity of 3000 mm.s-1 was stated but not tested (Kirk, 2018). Impact velocity is
important in NTSCI, and distinguishes it from TSCI. Further evaluation of theoretical
input and experimental output velocities of the BOSE 5110 Electroforce apparatus was
required over a range of velocities.
3.5.1.2 Using Hydrogels in the BOSE 5110 Electroforce System
The ideal gel would be substantial enough to minimise the effects of errors in measuring
gel height, and have sufficient mechanical properties to physically load and unload the
gels from the BOSE 5110 Electroforce apparatus without damage. A lower volume would
be beneficial in terms of maximising the use of reagents, and reducing the number of
animals required in primary cell experiments.
In an experiment varying the volume and diameter of gels, those with a height of
less than 2 mm were difficult to handle and were easily damaged when moving from the
well plate into the BOSE 5110 Electroforce apparatus. The minimum suitable volume
was 400 µL in a 48 well plate, or 470 µL in a 24 well plate. The low N number and use
of acellular gels in this experiment meant further testing was needed to confirm the gel
height requirement using repeated measurements of cellular gels. Since the 48 well plate
used lower reagent quantities per gel to achieve the height, 400 µL was carried forward
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due to its cost-effectiveness.
In cellular 400 µL gels from a 48 well plate, the mean height was 2.79 mm. In
cellular 300 µL, the mean height was 2.05 mm. If the gels were perfectly cylindrical the
difference would be 15% (based on the volume of a cylinder). A difference of 27% was
observed, where the gels were unlikely to be perfectly cylindrical. At least n = 4 gels were
measured per test, and at least 3 tests were carried out for each volume (i.e. n = 12). The
cellular hydrogels had a greater height than acellular hydrogels. This may be because the
cellular components in the gel facilitate fluid retention and therefore height is maintained.
Further, the initial study using acellular hydrogels had n = 1 per volume and well plate
variation. Conversely, the cellular hydrogel study had a greater number of gels created at
each volume. As such, the cellular study is more relevant and has greater power.
The volume of 300 µL gels in a 48 well plate used the least reagents but had sufficient
height, and hence was used in all future experimental studies.
3.5.1.3 Mechanical Outputs of the BOSE 5110 Electroforce System
Experiments were undertaken to characterise velocity and displacements outputs by
the BOSE 5110 Electroforce system, at a variety of theoretical velocities and working
distances. Further, the effect of incorporating gels into the system (as opposed to
experiments carried out in air) was evaluated. Bovine collagen was used as opposed to
rat collagen, in order to preserve the rat collagen reagent and save costs (bovine collagen
was cheaper). Further, the bovine collagen was purchased at a greater concentration (5
mg.mL-1), allowing evaluation of a more concentrated collagen concentration than used
previously (Smith, 2016; Kirk, 2018). Further, two collagen concentrations were tested:
2 and 5 mg.mL-1.
The mechanical properties of various densities of collagen hydrogels have been
examined in the literature, repeatedly showing that elasticity reduces with increased
density (Roeder et al., 2002; Ahearne et al., 2010; Lopez-Garcia et al., 2010). For
instance, in one study, 5 mg.mL-1 collagen gels had a shear modulus three to six times
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greater than 2 mg.mL-1 collagen gels (Valero et al., 2018). In this research, there was
no consistent difference in displacement, maximum or mean velocity of the BOSE 5110
Electroforce using 2 mg.mL-1 collagen gels compared to air. Differences were present
when using 5 mg.mL-1 collagen gels, at a working distance of 1.5 mm. At 1000, 100 and
10 mm.s-1, incorporation of 5 mg.mL-1 collagen hydrogels led to a significant reduction in
mean output velocity versus the theoretical input. No differences were observed between
air and 2 mg.mL-1 collagen hydrogels.
Throughout each test, displacement was tightly controlled. Maximum and mean
velocity values of each test had low standard errors of the mean. This indicated that
apparatus could apply precise and reproducible profiles to air and gels. The BOSE 5110
Electroforce apparatus used a displacement control setting to achieve this.
Maximum output velocity exceeded input velocity at 10, 1 and 0.1 mm.s-1, with
a greater effect at lower working distances. In these tests, the number of data points
collected during their duration was the same as at greater working distances (e.g. 2000
data points over 8 mm displacement; and 2000 data points over 1.5 mm displacement).
Due to limitations in the apparatus precision this resulted in an increase in noise.
Working distance affected velocity outputs at 1000 and 100 mm.s-1 input velocities.
For 100 mm.s-1, increasing the working distance from 1.5 to 8 mm led to an increase
in mean output velocity from 92.5 to 96.5 mm.s-1. At 1000 mm.s-1, increasing the
working distance led to a significant increase in mean output velocity from 128.6 to
866.5 mm.s-1. The reason for the greater working distance required at greater velocities
was the acceleration capacity of the device (as mentioned by Kirk (2018)), which was
not incorporated into the apparatus software when designing the theoretical experimental
profiles (Figure 3.16). According to the supplier’s website, the BOSE 5110 Electroforce
has a maximum deformation rate of 740 mm.s-1 (TAInstruments, 2016). The fact that
1000 mm.s-1 input velocity exceeded the suppliers expectations for the apparatus could
have contributed to the reduced accuracy of the instrument at such velocities; it may have
been out of the range of the apparatus. As such, 1000 mm.s-1 was not used in future
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Figure 3.16: Acceleration upwards (negative values) and downwards (positive values) elicited
by the BOSE 5110 Electroforce at 1000 mm.s-1 At a theoretical velocity of 1000 mm.s-1,
acceleration was recorded for both upwards and downwards motion at a range of working
distances.
experiments to prevent damage. For 100 mm.s-1, the mean velocity of 92.5 mm.s-1 at 1.5
mm was deemed sufficient for future studies.
One issue that arose during this experiment was gels falling off the flat platen. This
indicated that in future experiments the indented platen should be used.
The research so far has been in verification of the BOSE apparatus, i.e. checking
the device is working according to the manufacturers specification. Subsequent chapters
describe validation of the device, i.e. the utility of the device in the context of spinal
cord injury. It is not known whether work done, load, displacement, maximum velocity,
mean velocity or another factor will have the greatest effect on neural cell responses to
mechanical compression. These factors will be recorded in all future experiments so
outcomes can be established.
3.5.1.4 Comparison of the BOSE 5110 Electroforce with other Impactor Systems
Only one other hydrogel compression study has been carried out using the BOSE 5110
Electroforce, and this used an input velocity of 0.167 mm.s-1 (Koivisto et al., 2017). The
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findings of the research herein identified that the BOSE 5110 Electroforce apparatus was
both accurate and precise at such low velocities. However, the previously published study
did not describe the output velocity, its precision, accuracy or reliability (Koivisto et al.,
2017). Similarly, three studies using the BOSE 5110 Electroforce to test materials in
tension did not describe tuning values, or accuracy and precision of data (Avril et al.,
2013; Banks et al., 2014; Garcia and Stewart, 2016).
Other apparatus from the same manufacturer has been used in the scientific literature
for in-vitro compression experiments (Sparrey and Keaveny, 2011; Busby et al., 2013;
Bartlett et al., 2016b; Andriakopoulou, 2016). Across these papers, mechanical input
parameters varied. Strain rates tested ranged from 0.005 to 5. in two studies (Sparrey
and Keaveny, 2011; Busby et al., 2013). Another used a velocity parameter of 0.1 mm.s-1
(Andriakopoulou, 2016), and a final tested dynamic mechanical analysis (i.e. a variety
of velocities, all at a frequency of 1 Hz) (Bartlett et al., 2016b). None the these studies
reported precision, reliability or accuracy of the output mechanical parameters.
No in-vitro studies performed to date using any other device from any other supplier
reported impact mechanics or evaluation of the accuracy, precision or reliability of
impact apparatus (Cullen and LaPlaca, 2006; Cullen et al., 2007; Bar-Kochba et al.,
2016). Conversely, impact mechanics are more often reported for in-vivo studies. For
instance, one study using the University of British Columbia multi-mechanism injury
system reported both the input velocities and displacements, as well as output data (Lam
et al., 2014). These authors identified a small difference in input vs output displacement
of under 3%. The difference in impact velocity was greater, varying between 4.75 and
9.96%. This corresponds with results found in this study, where displacement was
consistently reached to a high level of accuracy, whereas variation between theoretical
input and experimental output velocities was greater.
A further study used a BOSE Testbench system to induce spinal cord injury in-vivo,
first tuning the apparatus using a silicone polymer to represent the spinal cord (Salegio
et al., 2016; Sparrey et al., 2016). The desired impact velocity in-vivo was 1000 mm.s-1,
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which was the maximum deformation rate of the system. However, experimental recorded
impact velocities were between 420 and 530 mm.s-1. This difference may have been due
to the fact that surrogate spinal cords were less stiff than the cord in-vivo (Sparrey et al.,
2016). The study does not comment on the velocities achieved during surrogate testing.
This highlights the importance of recording output velocities in every case.
It has been established that impact mechanics can affect spinal cord injury and neural
cell outcomes (see literature review sections 1.4.1.2 and 1.4.2.2). During in-vivo studies,
these effects have been noted and impact mechanics are reported. This is not the case for
in-vitro studies, where there is a paucity of understanding of the precision, accuracy and
reliability of impact apparatus. These factors must be understood to fully comprehend
the effects of changing impact mechanics on injury outcomes. Overall, the results
herein show the BOSE 5110 Electroforce apparatus is precise, can elicit reproducible
displacements both in air and in collagen hydrogels. The accuracy of the device is less
well-established with output velocities sometimes falling beyond 20% of the theoretical
values. However, the biological significance and consequences of this are unknown, since
neural cell responses to impacts at a variety of speeds have not been established. In
each test going forwards, output velocities will be recorded and neural cell responses
compared.
3.5.2 Evaluating Astrocyte Cell Populations
The aim of this section was to develop and characterise a reproducible type I collagen
hydrogel seeded with primary rat astrocytes (a relevant neural cell type). Three factors had
to be established; firstly the proportion of primary cells which were astrocytes, secondly
astrocyte growth in collagen hydrogels at the previously used density, and thirdly whether
the astrocytes could elicit known responses to a chemical stimulant causing reactivity
(TGF-beta). The cell population was evaluated using ethidium homodimer, a marker of
cell death, and GFAP immuno-labelling.
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3.5.2.1 Proportion of Astrocytes in Enriched Mixed Glial Populations
Mixed glial populations isolated from neo-natal rats contain astrocytes, microglia, and
oligodendrocyte cells. By shaking the mixed glial cells in low oxygen conditions at
250 rpm, the less strongly attached microglia and oligodendrocytes come away from the
surface and into suspension; whereas astrocytes remain attached (Mecha et al., 2011).
In astrocyte-enriched populations seeded onto coverslips, 89.7 ± 3.5% (mean ±
S.E.M.) of cells expressed GFAP. Previous studies have described that if 85 to 90% of
cells are stained with GFAP, then the population can be described as astrocytes (East et al.,
2009; Kerstetter and Miller, 2012; Smith, 2016). The proportion of cells expressing GFAP
in this study met the required threshold, and therefore the population were determined to
be astrocytes.
In this experiment, 11.7% of astrocytes stained with a dead cell marker (ethidium
homodimer) in 2D culture. In a similar 2D astrocyte study, cell death was estimated to be
7% (East et al., 2009). The results are similar, suggesting concurrency between studies.
Differences may be due to slight variations in primary astrocyte isolation protocols, in the
staining itself, or in image analysis. This study used ethidium homodimer to mark dead
cells and automated image analysis was carried out using FIJI. Conversely, the previous
study used propidium iodide and image analysis used Olympus Analysis Pro software.
Overall, the implications of this experiment are that there a similar proportion of
GFAP-expressing cells (astrocytes) to previous studies, and the cells behave as expected
in 2D culture.
3.5.2.2 Astrocyte Activation and Hydrogel Contraction
TGF-beta is a chemical known to induce reactive astrogliosis and glial scar formation in
astrocytes (Logan et al., 1994; Vogelaar et al., 2015). By culturing astrocytes in collagen
hydrogels with TGF-beta over a period of 14 days, the cell population and responses
were further evaluated. If the cells were in fact astrocytes, and behaved in a relevant
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manner, TGF-beta would have increased reactivity as measured by GFAP expression and
gel contraction.
When astrocytes were seeded into rat type I collagen hydrogels at 1x106 cells.mL-1,
neither the area labelled with GFAP nor number of dead cells (as determined by ethidium
homodimer staining) significantly increased over the course of 14 days (P >0.05). Over
the course of 14 days, total GFAP area per image significantly increased in TGF-beta
treated samples (P <0.05). The proportion of dead cells did not change over time (P
>0.05). Other studies found that in response to TGF-beta treatment, astrocyte GFAP
expression per cell significantly increased over 14 days; with increased ramifications
over the same time period (compared with untreated control cells) (East et al., 2009;
Kimura-Kuroda et al., 2010; Smith, 2016). Qualitative analysis of the images showed the
same trend of increasing ramification over a two week period (Figure 3.12). Furthermore,
another study using astrocytes in Matrigel showed TGF-beta treatment caused increased
density of hypertrophic processes, but no significant changes to cell death compared with
untreated control samples (Cullen et al., 2007). Overall, the effect of TGF-beta treatment
on astrocytes identified in this study was similar to published research in the literature;
with increased area of GFAP expression, increased ramification of astrocytes, and no
change in cell viability.
Ideally, ramification of astrocytes and GFAP area per cell would also have been
evaluated. This was not possible since many cells present seemingly did not express
GFAP, therefore complicating image analysis. This was either due to cells not being
GFAP-positive astrocytes, the antibody not penetrating the gel, or the astrocyte phenotype
producing a low level GFAP expression. Antibody diameter is in the range of 7 to 10 nm
(Dong and Shannon, 2000). Previous studies have found that for 1 to 2 mg.mL-1 rat type
I collagen gels, pore size ranged from 5 to 17 µm (Banerjee et al., 2008; Yang et al.,
2010). Even at collagen concentrations between 8 and 20 mg.mL-1, pore size was in the
range of 500 to 1000 nm (Antoine et al., 2015), therefore the antibody should have been
able to penetrate the gel. Previous experiments in this research indicated that in 2D, 90%
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of the cells expressed GFAP in 2D cultures, whereas in images from this 3D study, this
figure was not reached (images in Figure 3.12). Primary astrocytes are less reactive in
3D environments than in 2D (East et al., 2009). In 3D, astrocytes at the upper surface of
collagen hydrogels have the greatest reactivity and therefore GFAP levels (Smith, 2016).
During imaging, setting the laser power for this highly reactive surface meant that GFAP
expression in less reactive astrocytes deeper into the gel was not identified due to its
weaker signal. However, the nuclei were identified due to the 60 µm z-stack depth, and
Hoechst staining. As such, many cells were present which did not show GFAP expression.
The large number of cells present per image also meant GFAP area per cell could not be
accurately quantified. To overcome this in future studies, a smaller z-stack, 20 µm in
depth, will be used where only one plane of cells are present (East et al., 2009). Previous
research also identified that cells on the uppermost surface elicited the greatest response
to mechanical injury (Smith, 2016); perhaps due to the fact that these cells undergo the
greatest displacement. Therefore, in future studies only the upper surface cells will be
imaged. This will facilitate evaluation of GFAP expression per cell; which will allow for
gel contraction.
Gel contraction was measured at days 11 and 14 in this study. When astrocytes
become increasingly reactive, they elicit mechanical strain on the surrounding matrix,
causing it to contract. TGF-beta treated samples were contracted by 48.5% on days 11
and 14. Comparing this contraction with previous research; when astrocytes were seeded
at the same density in the same collagen hydrogel, contraction of approximately 40% was
found at day 1 (Smith, 2016). These values for contraction are similar, and the differences
identified may be due to the difference in time points, or differences in cell isolation
protocols. In future studies where mechanical insults are applied to collagen hydrogels,
gel area and subsequent contraction will be evaluated at every time point.
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3.5.3 Conclusion
Overall, each of the objectives set out in the aims were achieved (Table 3.2). Therefore
the methods used within this chapter are suitable for future studies to evaluate the effects
of varying input mechanics on astrocyte responses.
Table 3.2: Conclusions of Chapter 3: In-vitro model development
Aim Objective Result and Implications
D
ev
el
op
m
et
ho
do
lo
gy
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rm
ec
ha
ni
ca
li
m
pa
ct
s
Maximum velocity of BOSE
5110 Electroforce
Maximum velocity was 1440 mm.s-1. This
exceeds the manufacturers guidelines (740
mm.s-1) and therefore should not be used
in future experiments
Effects of new platens on
mechanical outputs
Minimal effect of new platens in terms of
mechanical outputs. Any platen would
suffice. The indented platen would prevent
gels slipping off.
Optimal gel volume A volume of 300 µL in a 48 well plate was
the minimum volume to allow handling
and gel height measurement.
Effect of incorporating collagen
hydrogels
Minimal observed effect of using the
BOSE 5110 Electroforce with gels or in
air.
Effect of working distance and
velocity with hydrogels
A working distance of at least 8 mm was
required to achieve 1000 mm.s-1. For all
other velocities (100, 10, 1, 0.1 mm.s-1), a
distance of 1.5 mm was sufficient to allow
the velocity to be reached.
C
ha
ra
ct
er
is
e
as
tr
oc
yt
e
po
pu
la
tio
n Evaluate percentage of
astrocytes from a mixed glial
population
Approximately 90% of cells expressed
GFAP in 2D culture.
Assess cell viability of
astrocytes in collagen hydrogels
Astrocytes remained viable and
non-reactive over two weeks in collagen
hydrogels.
Evaluate the effect of TGF-beta
treatment on astrocytes in
collagen hydrogels
TGF-beta treatment elicited astrocyte
reactivity (GFAP expression) and hydrogel
contraction, as expected.
Image astrocytes in collagen
hydrogels
A z-stack depth less than 60 µm should be
used to image astrocyte-seeded collagen
hydrogels in the future, to ensure only one
plane of cells is imaged.
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Responses of Neural Cells to Varying
Mechanical Inputs
4.1 Introduction
This chapter aims to evaluate responses to loading scenarios in NTSCI in-vitro, and
compare outcomes to TSCI. This chapter uses the BOSE 5110 Electroforce Biodynamic
to apply mechanical insults at varying velocities to astrocyte-seeded collagen hydrogels.
Cellular outcomes measured include astrocyte-mediated gel contraction (a measure of
reactivity), GFAP expression, cell ramifications, and both pro- and anti-inflammatory
cytokine release.
In TSCI, the pathological cascade can be split into primary and secondary injury.
Primary injury is the mechanical trauma itself, and secondary injury is a further, more
complex, cascade of events such as inflammation, glial scar formation and demyelination
(see Section 1.3.1, (Anwar et al., 2016; Morin, 2018)). In TSCI, the response is co-
ordinated by astrocytes and microglia (Anwar et al., 2016). Since NTSCI is not caused
by trauma, but instead by quasi-static compression of the spinal cord, this distinction
between primary and secondary injury cannot be made. There is little understanding
of how the pathology of NTSCI develops (Kurokawa et al., 2011; Yu et al., 2011;
115
Chapter 4. Responses of Neural Cells to Varying Mechanical Inputs
Karadimas et al., 2013; Newcombe et al., 2015; Zhou et al., 2015). In NTSCI, it is
unclear in the literature how mechanical compression of the spinal cord and neural cells
therein result in symptoms; whether this is due to the mechanical compression of cells
themselves, or due to other mechanisms such as compression of the vasculature leading
to hypoxia. Clinically, several days after high velocity injuries (TSCI), astrocytes undergo
hypertrophy and reactive astrogliosis to form the glial scar (Norenberg et al., 2004;
Sofroniew and Vinters, 2010). Further, there are elevated levels of GFAP in the serum of
patients with TSCI, indicating increased astrocyte reactivity (Ahadi et al., 2015). In-vivo
and in-vitro, increased astrocyte reactivity and increased GFAP expression are observed
in TSCI models (Cullen et al., 2007; Weightman et al., 2014; Smith, 2016; Sturdivant
et al., 2016; Kirk, 2018). In-vivo, astrocyte reactivity peaks at 1 to 4 weeks post-injury
(Hu et al., 2010; Kawano et al., 2012; Wanner et al., 2013). The effects of NTSCI on
astrocyte reactivity and GFAP expression have not been established in the literature.
There is evidence from both in-vitro and in-vivo studies that injury mechanics
affect spinal cord injury outcomes (sections 1.4.1.2 and 1.4.2.2). These studies have
predominantly focussed on TSCI, using either scalpel blades to induce injury, or high
strain rates and/or velocities (Sypecka et al., 2015; Smith, 2016; Kirk, 2018; Pandamooz
et al., 2019). There is a lack of consensus regarding which mechanical parameter(s),
specifically, are responsible for differences in injury outcomes in TSCI, and there is no
data for how injury mechanics induce or affect NTSCI. Some TSCI studies report that
displacement is the core factor in determining injury severity, independent of velocity
(Kearney et al., 1988; Kwo et al., 1989; Kim et al., 2009), whereas others state a
combination of factors, such as work done, are most important (Jakeman et al., 2000;
Seki et al., 2002; Lam et al., 2014). There is a gap in the literature regarding injury
mechanics in NTSCI, and directly comparing outcomes in such injuries with TSCI.
In-vitro models of spinal cord injury allow evaluation of an individual cell population
in isolation to understand intricacies of the injury (Abu-Rub et al., 2010; East et al., 2010;
Bar-Kochba et al., 2016). They offer greater control and minimisation of confounding
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factors compared with in-vivo studies. No parametric studies have been undertaken
evaluating the velocity of compression in the context of NTSCI, or directly comparing
with TSCI velocities. In two in-vitro studies of TSCI undertaken at the University of
Leeds, astrocyte GFAP expression was evaluated (Smith, 2016; Kirk, 2018). These
studies used either the BOSE 5110 Electroforce or the Infinite Horizon impactor. It
is worth noting that only the BOSE 5110 Electroforce apparatus allows control of
displacement and time (and therefore velocity); which are crucial in distinguishing TSCI
from NTSCI.
Kirk (2018) compressed simple disc-shaped collagen hydrogels using focal lesions
in the BOSE 5110 Electroforce, with a reported velocity of 3000 mm.s-1. After 24 hours,
Kirk found there were significantly more GFAP-labelled pixels per area than in non-
compressed controls. The number of GFAP-labelled pixels increased with displacement
depth, with 80% and 100% displacement exceeding lipopolysaccharide treated control
samples. Smith (2016) compressed aligned collagen hydrogels using focal lesions in
the Infinite Horizon (under load control to 2N). In the region closest to the impact site
GFAP-stained area per cell increased over 10 days, although these differences were not
statistically significant due to the small sample size. These results indicate that TSCI
can be modelled using astrocyte-seeded collagen hydrogels and mechanical impaction.
The question remains whether astrocyte compression at slow velocities could induce a
different phenotype, representing NTSCI.
The previous chapter has established the suitability of the BOSE 5110 Electroforce in
inducing controlled impaction on hydrogels. This chapter aimed to investigate the effect
of low velocity injuries to astrocytes seeded in 3D hydrogels. The displacement used was
70%, based on functional deficits observed in-vivo and in clinical studies (Penning et al.,
1986; Steurer et al., 2011; Yang et al., 2015; Iwahashi et al., 2016; Weber et al., 2016;
Kadanka et al., 2017; Martin et al., 2018; Witiw et al., 2018)
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4.2 Aims
The aims of this chapter were to characterise biological responses to loading scenarios
representative of NTSCI in-vitro (Figure 4.1). The results of this chapter will be used
to determine the mechanistic pathway and phenotype of astrocyte responses to NTSCI,
directly compared to TSCI. NTSCI and TSCI will be distinguished by the compression
velocity. Specific objectives for this chapter:
1. To evaluate how mechanical inputs affect primary neural astrocyte responses in the
context of spinal cord injury, comparing high and low velocities (TSCI and NTSCI,
respectively)
A Determine the accuracy of the BOSE 5110 Electroforce Biodynamic in
applying 70% displacement to astrocyte-seeded collagen I hydrogels at 0.1,
1, 10 and 100 mm.s-1
B Assess astrocyte responses to the various input velocities detailed above:
GFAP expression, gel contraction and cytokine release.
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Figure 4.1: Hypothesis and research questions asked in Chapter 4, relating to the whole study.
119
Chapter 4. Responses of Neural Cells to Varying Mechanical Inputs
4.3 Experimental Setup
4.3.1 Mechanical Compression of Astrocyte-Seeded Hydrogels
The aim of this study overall was to evaluate neural cell responses to varying mechanical
inputs; specifically using astrocytes seeded in collagen hydrogels, compressed in the
BOSE 5110 Electroforce system (section 2.3.1).
4.3.1.1 Rationale for Method Details
TSCI occurs in the range of metres per second (Wilcox et al., 2003). However, due
to the manufacturers guidelines and capability of the apparatus (as discussed in the
previous chapter), a maximum velocity of 100 mm.s-1 was used in this study for the
TSCI condition. The choice of lower velocities was to model NTSCI, rather than TSCI.
Matching the clinical velocity or strain rate of NTSCI in in-vitro models would mean
compression over months to years. This was not suitable for the timescale of this project,
nor the apparatus requirements. The absolute values of velocity for inducing NTSCI are
not established, but are inherently several orders of magnitude lower than those in TSCI.
As such, 0.1 mm.s-1 was the lowest velocity used, and was used to model NTSCI.
In this study, the indented motor platen was used to prevent gels slipping (platen D
figure 3.4, section 3.3.1.1), and the load platen was 10 mm in diameter (platen C figure 3.4,
section 3.3.1.1). The reason for the selection of the 10 mm diameter load platen was due
to the nature of compression in NTSCI. Previous TSCI studies have used a 2.5 mm and
3.34 mm diameter (Smith, 2016; Kirk, 2018). However, NTSCI is often multi-level, with
compression occurring at more than one vertebra (Park et al., 2010; Wu et al., 2013; Li
et al., 2015). Therefore, the compression is more likely to be diffuse as opposed to focal.
The diameter of the compression is important as it would alter the pressure transmitted to
the cells. For a given force, pressure would be greater with a smaller diameter, and vice
versa. Since NTSCI is multi-level, the diameter of compression is greater and therefore
pressure lower than in a TSCI where, for instance, a bone fragment from one vertebral
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level would induce injury.
4.3.1.2 Method Setup
These experiments aimed to evaluate astrocyte responses to being compressed at various
velocities to model NTSCI and TSCI. To achieve this, primary astrocytes were separated
from primary rat (P3 post-natal) mixed glia 14 days post-isolation (methods section
2.4.2.4). Cells from 8 rat pups were pooled to reduce the effects of inter-animal variation.
The cells were seeded into neutralised collagen hydrogels at a final concentration of
1x106 cells per mL of gel (see methods section 2.4.3). Each gel was 300 µL in volume
and gels were manufactured in 48 well plates. Four plates were set up, with one being
evaluated at each timepoint (day 1, 4, 11, and 14). Positive control gels were also seeded,
incorporating 10 ng.mL-1 TGF-beta. Each experiment was carried out twice.
The BOSE 5110 Electroforce apparatus was set up according to the details described
in section 3.3, but with an additional reservoir bottle attached to fill the chamber with
media (Figure 4.2). After measuring gel height, the chamber was filled with pre-warmed
media using a peristaltic pump. The reservoir bottle was attached to a sterile filter which
contained a 0.20 µm pore size for sterile air transfer. After compression, the chamber was
drained of the media before each sample was removed.
The gels were placed on to the motor platen, gel height measured, and the
bio chamber was filled with pre-warmed (37oC) HEPES (10 mM) supplemented
DMEM complete media at 80 mL.min-1. The gels were compressed in the BOSE
5110 Electroforce using a trapezoid experimental profile; with compression to 70%
displacement (based on gel height) at four velocities: 0.1, 1, 10 and 100 mm.s-1. The gels
were compressed, followed by a 30 second dwell, then decompressed at 1 mm.s-1. Media
was removed from the chamber, and the gel was removed and returned to the 48 well
plate. Control gels were placed into the apparatus, the bio chamber filled with media,
gel height measured, but not compressed. They remained in the apparatus for up to 5
minutes, before the bio chamber was emptied and gels were moved back into the 48 well
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Figure 4.2: Schematic diagram of the BOSE 5110 Electroforce apparatus connected to
peristaltic pump and reservoir bottle. Blue arrows denote direction of flow for filling the sealed
chamber. For emptying, the peristaltic pump was reversed.
plate along with fresh media. Neither negative nor positive (TGF-beta at 10 ng.mL-1)
control gels were removed from the plate, but media was changed. The plates containing
gels were cultured at 37oC, 8% (v/v) CO2 in humidified air. Every three to four days
media was replaced.
4.3.1.3 Compression Mechanics Calculations
Displacements and loads were recorded over time. Further, work done was calculated.
Work done is a function of load and displacement. To calculate work done, non-uniform
numerical trapezoid integration was carried out using the following equation (where x
was displacement, y was load; n was the timepoint gathered in each experiment; N was
the final time at the end of the experiment):
Work done = 1
2
∑N
n=1((xn+1 − xn)(yn + yn+1))
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4.3.2 Evaluation of Astrocyte Responses to Compression at Various
Velocities
A total of four gels were evaluated per condition at each of four timepoints over 14 days:
day 1, 4, 11 and 14 (n=20 gels per condition total per experiment). At each timepoint,
media was collected and frozen at -80oC, and a contraction assay was undertaken (section
2.4.4.8). Contraction assay data was analysed in Microsoft Excel, using two-factor
ANOVA with regression for unbalanced groups, and Tukey’s post-hoc test. A p-value
of less than 0.05 was deemed significant.
Further, at each time point, gels were fixed in 4% (w/v) PFA. Subsequently, wells
were covered with Parafilm, and plates were stored at 4oC until the end of the two-week
experiment.
Staining was undertaken after all gels had been fixed. Methods were the same
as in the previous chapter (section 3.3.2). Immuno-staining for GFAP, and ethidium
homodimer and Hoechst staining were undertaken. Then, hydrogels were moved from
the well plate onto slides. Coverslips were placed on top for a flat imaging surface.
Images were taken at 20x magnification on a confocal microscope. In the
microscope, the upper surface of each gel was identified as the point in the z plane where
cells first become visible. The centre point of the gel was identified by the midway point
between the edges of the gel (x and y directions). Images were only taken within a radius
of 3.5 mm in the x and y directions of the centre point to ensure they were within the
impacted region. Four z stacks were taken, one approximately at the centre of each
quadrant (as shown in figure 4.3). A z stack 20 µm deep, comprising of 7 individual
images, was taken at each position. Raw image files were saved, and maximum intensity
projection at each position were also exported. Laser settings were configured for the
brightest TGF-beta (10 ng.mL-1) treated samples on each day, and maintained for all the
gels from the same timepoint. Image analysis was undertaken in FIJI as per the methods
previously described (Section 2.4.4.7). Area per object of interest and circularity were
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extracted. Use of area per object, as opposed to overall area per image, accounted for
changes in hydrogel contraction between conditions. Subsequent statistical analysis was
carried out in Microsoft Excel using one-way ANOVA with Tukey’s post-hoc test, at a
significance level of p <0.05.
Figure 4.3: Location of imaging regions in hydrogels. A: The centre point (blue dot) was
determined using the midpoint between edges of the gel in the x and y planes. B: Four locations
were imaged (black dots), within 3.5 mm (x and y direction) from the centre of the gel to ensure
they were in the compressed regions. C: Each imaging location comprised a 20 µm z stack of 7
individual images.
4.3.2.1 Enzyme-linked immunosorbent assay (ELISA) for cytokine release
The general methods used for this section are described in Section 2.4.4.9. Two cytokines
were investigated: IL-6 (pro-inflammatory) and IL-10 (anti-inflammatory). For IL-
6, standard concentrations were 31.25, 62.5, 125, 250, 500, 1000, 2000 and 4000
pg.mL-1.The plate had 96 tests, and so not all conditions could be tested.
The following conditions and time points were excluded:
• Media from day 7
• Media from day 10
• The following experimental conditions:
– 70% compression at 10 mm.s-1
– 70% compression at 1 mm.s-1
The following conditions and timepoints were included in the ELISA assay:
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• Media from day 1
• Media from day 14
• The following experimental conditions:
– TGF-beta (10 ng.mL-1) treated (positive control)
– 70% compression at 100 mm.s-1
– 70% compression at 0.1 mm.s-1
– Control gels loaded into BOSE apparatus but not compressed
– Negative, untouched control
The same conditions as above were used in an IL-10 ELISA. In this test, standard
concentrations were 15.625, 31.25, 62.5, 125, 250, 500, 1000 and 2000 pg.mL-1.
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4.4 Results
Astrocyte-seeded collagen hydrogels were compressed to 70% of their gel height, at
velocities from 0.1 to 100 mm.s-1. Mechanical data from each compression was recorded
(displacement and load versus time). At day 1, 5, 11 and 14 after compression, a
contraction assay was carried out, and hydrogels were fixed. After the experimental
time course was complete, astrocytes were stained for GFAP using immunocytochemistry
(immunofluorescence).
4.4.1 Impact mechanics increased in proportion to input velocity.
Displacement profiles were consistent with input axial command values at all velocities
(Figure 4.4). Load and work done both increased with velocity. Load increased from 0.16
± 0.02 N (mean ± S.E.M.) at 0.1 mm.s-1 to 1.51 ± 0.10 N at 100 mm.s-1. The maximum
loads applied at 10 and 100 mm.s-1 were similar, at 1.45 ± 0.03 N and 1.51 ± 0.10 N
respectively. Work done ranged between 0.05 ± 0.02 mJ at 0.1 mm.s-1 to 1.12 ± 0.13 mJ
at 100 mm.s-1. Work done at 10 mm.s-1 was 0.78 ± 0.1 mJ. More detailed compression
mechanics data are included in appendix F.
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Figure 4.4: Displacement and load data over time for compression of astrocyte-seeded hydrogels at four velocities. Rat type I collagen
hydrogels (2 mg.mL-1) were seeded with rat primary astrocytes at 1x106 cells.mL-1. Each hydrogel was compressed to 70% of its height in
the BOSE 5110 Electroforce apparatus. Displacement (negative) and load (positive) over time were recorded.
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4.4.2 Astrocyte responses varied based on mechanical inputs
4.4.2.1 Hydrogel contraction was only observed in TGF-beta control samples
Photographs of gels were taken at day 1, 5, 11 and 14, and gel contraction was calculated
by their ratio between gel and well diameter. With TGF-beta treatment at 10 ng.mL-1,
gels contracted by a maximum of 61.99% over the time course (Figure 4.5). Across
all velocities tested, the maximum gel contraction was 25.43% (1 mm.s-1, day 14).
For apparatus (BOSE) control samples and negative control samples, maximum gel
contraction was 14.8% (day 5) and 15.40% (day 1), respectively. TGF-beta treated
samples contracted significantly more than all other conditions at day 5, 11, and 14 (p
<0.05).
Figure 4.5: Astrocyte-seeded hydrogel contraction over 14 days after treatment with TGF-beta
(10 ng.mL-1) or compression to 70% of gel height at various velocities. Test gels were
compressed using the BOSE 5110 Electroforce. Positive controls were treated with TGF-beta at
10 ng.mL-1. Control gels were placed into the BOSE 5110 Electroforce apparatus but not
compressed. Negative control gels were not removed from the wellplate. n = 4 per timepoint for
test gels, and n = 3 per timepoint for control gels. Asterisks denote statistical significance after a
two way ANOVA with Tukey’s post-hoc test (p <0.05).
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4.4.2.2 Astrocyte viability could not be assessed
Ethidium homodimer did not specifically label any cells, instead diffuse staining was seen
throughout each hydrogel imaged.
4.4.2.3 Astrocytes were activated 11 days after 100 mm.s-1 compression
A representative set of images of astrocyte-seeded collagen hydrogels compressed at
various velocities are illustrated in Figure 4.6. Compression at 100 mm.s-1 resulted in
increased ramification of astrocytes at days 11 and 14 compared with days 1 and 5. This
trend was not visible in the other velocities tested.
Astrogliosis was characterised by increased size and ramifications of astrocytes
Quantification of images of GFAP-stained astrocytes in collagen hydrogels allowed
evaluation of average size per object and circularity, indicating hypertrophy and reactive
processes, respectively. For average size per stained object, there were no significant
differences between conditions on day 1 (Figure 4.7). On day 5, the greatest object
area was in hydrogels that had been compressed at 100 mm.s-1, although this was not
significantly different from any other group. On day 11, the conditions of TGF-beta
treatment and compression at 100 mm.s-1 resulted in significantly greater area per object
compared with all lower velocities, along with apparatus and negative control conditions
(p<0.05). On day 14, the same trend was seen, with TGF-beta treatment and compression
at 100 mm.s-1 resulting in significantly greater area per object than 10, 1, 0.1 mm.s-1
compression velocities, apparatus control and negative control conditions (p <0.05).
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Figure 4.6: Sample images of GFAP labelled primary astrocytes seeded in collagen hydrogels,
after compression to 70% of gel height at various velocities. Rat type I collagen hydrogels (2
mg.mL-1) were seeded with rat primary astrocytes at 1x106 cells.mL-1. At the timepoints shown,
collagen hydrogels were fixed with 4% (v/v) PFA. Immuno-staining for GFAP was carried out.
Images taken at 20x magnification, scale bar 50 µm. Contrast in these images has been enhanced
for visualisation and printing purposes.
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Figure 4.7: Average area per stained object of GFAP-labelled rat primary astrocytes seeded in
collagen hydrogels. Positive control was 10 ng.mL-1 TGF-beta. Control gels were loaded in to
the apparatus but not compressed. Negative control remained in the multi-well plate. Image
analysis in FIJI. Mean ± S.E.M. One way ANOVA at each timepoint, and Tukey’s post hoc test (*
= p <0.05).
Figure 4.8: Circularity of GFAP-labelled rat primary astrocytes seeded in collagen hydrogels.
Positive control was 10 ng.mL-1 TGF-beta. Control gels were loaded in to the apparatus but not
compressed. Negative control remained in the multi-well plate. Image analysis in FIJI. Mean ±
S.E.M. One way ANOVA at each timepoint, and Tukey’s post hoc test (* = p <0.05).
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Circularity is the ratio between area and perimeter2 of each stained object, where a
value of 1 would be perfectly round (Chapter 2, section 2.4.4.7). The lower the circularity,
the less regular the shape.
There were no differences between conditions on day 1 (Figure 4.8). On day 5,
objects in the TGF-beta treatment condition had a greater circularity than all of the
compressed hydrogels, but this was not statistically significant (p >0.05). On day 11,
circularity was reduced in TGF-beta treatment and 100 mm.s-1 compression conditions
compared to all other conditions, but this was not statistically significant (p >0.05). On
day 14, TGF-beta treatment resulted in a significantly reduced circularity compared to
all other conditions (p <0.05). Circularity in the 100 mm.s-1 compression group was
significantly greater than TGF-beta treatment, but significantly less than lower velocities
and negative control conditions (p <0.05).
4.4.3 High velocity mechanical compression resulted in significant
IL-6 release, but no differences in slower velocity compression.
4.4.3.1 IL-6 release was observed at day 14 with 100 mm.s-1 compression only
A standard curve was plotted using the IL-6 standards with known concentrations (Figure
4.9). As per manufacturers guidelines, the log of concentration against log of absorbance
produced a linear regression.
Using the linear regression equation provided in the standard curve, IL-6
concentrations for experimental conditions could be evaluated (Figure 4.10). On day
1, TGF-beta treatment induced a significant increase in IL-6 expression compared to
all other conditions (p <0.05). On day 14, the same trend was seen with media from
TGF-beta treated cells containing significantly more IL-6 than the slow velocity (0.1
mm.s-1), apparatus and negative control conditions (p <0.05). Additionally, at day 14,
media collected from astrocyte-seeded hydrogels compressed at 100 mm.s1 contained
significantly increased IL-6 concentrations compared to slow velocity (0.1 mm.s-1),
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Figure 4.9: Standard curve of IL-6 ELISA. IL-6 standards were diluted to the concentrations
defined in the datasheet. A sandwich ELISA was undertaken, and absorbance at 450 nm was
tested. Data shown are mean ± S.E.M. (n=2 per data point).
apparatus and negative control conditions (p <0.05).
4.4.3.2 No significant differences in IL-10 release were observed under any
condition
A standard curve was plotted using the IL-10 standards with known concentrations
(Figure 4.11). As per manufacturers guidelines, the log of concentration against log of
absorbance produced a linear regression with correlation coefficient of 0.9686.
At day 1, there was a significantly greater concentration of IL-10 in the media from
astrocyte-seeded hydrogels which had been compressed at 0.1 mm.s-1, compared to those
compressed at 100 mm.s-1 (Figure 4.12, p <0.05). However, the concentration of IL-10
was not significantly different between these conditions and negative controls.
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Figure 4.10: IL-6 release from astrocyte-seeded collagen hydrogels days 1 and 14
post-compression. Data obtained using a sandwich ELISA with absorbance at 450 nm. Data
presented is mean ± S.E.M., n=6 per datapoint. Statistical significance (asterisks) was
determined using two-way ANOVA with Tukey’s post-hoc test (p <0.05).
Figure 4.11: Standard curve of IL-10 ELISA. IL-10 standards were diluted to the
concentrations defined in the datasheet. A sandwich ELISA was undertaken, and absorbance at
450 nm was tested. Data shown are mean values with standard error of the mean error bars (n=2
per data point).
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Figure 4.12: IL-10 release from astrocyte-seeded collagen hydrogels days 1 and 14
post-compression. Data obtained using a sandwich ELISA with absorbance at 450 nm. Data
presented is mean ± S.E.M., n=6 per datapoint. Statistical significance (asterisk) was
determined using two-way ANOVA with Tukey’s post-hoc test (p <0.05).
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4.5 Discussion
The aims of this chapter were to characterise biological responses to loading scenarios
representative of NTSCI in-vitro, in particular comparing them to TSCI responses.
The BOSE 5110 apparatus accurately applied mechanical insults to astrocyte-seeded
hydrogels at velocities from 0.1 to 100 mm.s-1. Load increased with velocity, indicating
a greater force imparted onto cells with increasing velocity. NTSCI and TSCI were
distinguished based on velocity. The key findings of this chapter were that astrocyte
responses varied based on impact velocity. With high velocity impacts (100 mm.s-1),
astrogliosis (increased size and ramification) of astrocytes was observed from day 11, in
conjunction with increased expression of the inflammatory cytokine IL-6. Conversely,
at all velocitiy less than 100 mm.s-1, no significant differences were observed in IL-6 or
IL-10 release, nor in astrocyte shape and morphology.
4.5.1 Low velocity insults and NTSCI pathology
At day 1, significantly more IL-10 was released from astrocytes compressed at a low
velocity than high velocity. However, no changes were observed compared to negative
controls. There were no differences in IL-6 release at slow velocities at the timepoints
tested. Similarly, there were no differences observed in astrocyte reactivity (GFAP
expression). Therefore, the phenotype observed in NTSCI was different to TSCI. Patients
with NTSCI experience a range of symptoms which are due to neurological tissue
damage. However, the pathological mechanisms are not fully understood. It is important
to evaluate each result of this chapter and their relevance to clinical NTSCI, which can
elucidate pathological mechanisms and drive future research. Clinically, NTSCI involves
prolonged compression of the spinal cord, over a timescale of weeks or months (Quinn,
2005; Karadimas et al., 2013). Herein, the compression was a one off event with a dwell
of only 30 seconds. The extended chronic timeframe in clinical NTSCI may lead to a
different phenotype in astrocytes to that observed herein. Use of an alternative apparatus
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such as the ComCell device, adapted to apply a single compression over long term culture
in multiple wells, may also fulfil this requirement (Matthews et al., 2001; Michalopoulos
et al., 2012).
One possible reason for the lack of changes in astrocytes to observed herein,
compared to clinical symptoms, is the duration of compression. Clinically, constant
compression is sustained, and over extended timescale. In-vitro herein, it was a one-off
event.
There have been no studies evaluating cytokine release in NTSCI patient populations.
However, due to the inherent features of NTSCI (plasticity and remodelling in low
velocity compression), it was hypothesised that there may be increased cytokine
expression involved in remodelling of neural tissue. The cytokine IL-10 is widely
described as an anti-inflammatory, cerebroprotective immunosuppressive cytokine (David
and Kroner, 2011; Gensel and Zhang, 2015; Burmeister and Marriott, 2018; Ren et al.,
2018; Jayaraj et al., 2019). It is involved in minimising cell death and inflammation, and
promoting remodelling after TSCI (as summarised by Ren et al. (2018)). For example,
Ishii et al. (2013) injected an IL-10 neutralising antibody into the CNS of mice after a
TSCI, and observed a suppression in motor recovery compared to control groups. Further,
a dichotomy in neural cell activation (pro- versus anti-inflammatory) has been described
in the literature based on chemical activation of microglia and astrocytes (Jang et al.,
2013a,b).
This study is the first to define astrocyte responses using cytokine release in a low
velocity in-vitro mechanical compression study in astrocytes in isolation. Cullen et al.
(2007) applied slow shear strain (1.s-1) to hydrogels seeded with astrocytes and microglia,
and did not observe any changes in astrocyte GFAP expression. The research herein
did not observe significant differences in IL-10 release or astrocyte reactivity after low
velocity (strain rate 0.142.s-1). injuries. This suggests either that these outcomes are not
core to responses to low velocity compression, or the pathology in NTSCI is not mediated
by reactive astrocytes alone, or that the mechanics of the compression tested in this study
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were insufficient to show any pathological phenotype. Clinical studies evaluating cytokine
release in patients with NTSCI would provide direction for outcomes in-vitro.
In the limited literature describing clinical and rat in-vivo studies of NTSCI, none
have evaluated GFAP expression (Kubota et al., 2011; Kurokawa et al., 2011; Zibly et al.,
2012; Long et al., 2013; Yang et al., 2015; Sun et al., 2016; Xu et al., 2017). In two studies
which evaluated GFAP levels in rabbit models of lumbar stenosis through herniated discs,
one found an increase in astrocyte reactivity at day 3 and 14 (Shunmugavel et al., 2013);
whereas the other did not find significant differences to sham controls at day 10 (Cho et al.,
2015). One study on post-mortem tissue from patients with NTSCI showed no glial scar
formation (Someya et al., 2011). Therefore, the effects of NTSCI on astrocytes in-vivo
have not been fully established. The study herein suggests direct mechanical compression
of astrocytes does not cause astrogliosis in NTSCI. In future clinical studies, astrogliosis
should be evaluated. This would allow evaluation of whether astrocytes are involved in
the injury process, to provide direction for future research.
The roles of distinct populations of neural cells have not been established in NTSCI
pathology. Astrocytes are core to the injury cascade in TSCI, but this research shows that
mechanical compression of astrocytes alone is insufficient to induce NTSCI phenotypes.
Clinically, this means in patients with NTSCI, direct mechanical compression of
astrocytes is not the factor which induces symptoms. One possible reason for this is
that cells other than astrocytes are damaged. Incorporation of other cell types into
the model such as macrophages or microglia could cause a different response. Being
immune cells, these cells classically have two types of activation: pro-inflammatory or
anti-inflammatory (axonal regeneration and repair) (Gensel and Zhang, 2015). Although
their roles have not been defined in NTSCI, their incorporation could result in greater pro-
or anti-inflammatory changes in the in-vitro model.
Ischaemia is hypothesised to be involved in NTSCI, and may be the factor which
results in damage to cells, as opposed to direct mechanical compression. When objects
compress the spinal cord from the ventral approach, the ventral median artery in the
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ventral median sulcus is first to be compressed. Compression of this major vessel
results in ischaemia to the cord, which could cause hypoxic cell death. If this is
the case, astrocytes may not be core to the pathology in NTSCI. Astrocytes may be
involved in releasing molecules to control angiogenesis, remodelling the spinal cord to
overcome ischaemia, and modifying vasculature permeability, which are secondary to
the vasculature compression in the neurovascular unit (Mishra, 2017; McConnell et al.,
2017). This would not be the same response as seen in TSCI, i.e. not a pro-inflammatory,
reactive astrogliosis response. Instead, this would be an anti-inflammatory phenotype,
which could be exacerbated by the presence of immune cells.
The inflammatory and pathological process in NTSCI is slow, and not similar to
acute spinal cord injuries (Beattie and Manley, 2011). TSCI is characterised by gross
structural damage, haemorrhage, immediate inflammatory cell infiltration, astrogliosis
and scar tissue formation (Anwar et al., 2016; Morin, 2018). Conversely, the slow velocity
of NTSCI means this gross damage and resulting pathology is not observed (Karadimas
et al., 2013, 2015). The findings of the research herein correspond with this difference
in pathology. Nevertheless, the changes observed in NTSCI were minimal compared to
those in TSCI. This may be due to a more complex pathological cascade in NTSCI, where
mechanical compression of astrocytes is not the core factor. Studies suggest microglia
initiate and control astrocyte response after neural injury (Shinozaki et al., 2017). The
injury cascade in NTSCI is hypothesised to be caused by hypoxia/ischaemia due to blood
vessel compression, resulting in oligodendrocyte apoptosis and subsequently neuronal
degeneration (Dolan et al., 2016). Therefore the use of this model with astrocytes alone
would be insufficient to fully model NTSCI.
Overall, the results of this chapter suggest that direct mechanical compression of
astrocytes at low velocities is not core to NTSCI pathology. In order to further explore the
pathology of low velocity mechanical compression, further complexities should be added
to the model. This should include cell populations such as microglia, oligodendrocytes
and neurones. The effects of hypoxia should also be tested by modification of culture
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conditions, and longer timepoints should be used. The use of the established in-vitro
model will allow evaluation of each of these additions in isolation and in combination
with one another. This, in turn, will increase understanding of the complexities of NTSCI,
which could aid in developing future treatments.
4.5.2 Astrocyte Outcomes in Other Velocities Tested
10 and 1 mm.s-1
Compression at the greatest velocity (100 mm.s-1) caused a significant increase in
GFAP labelled area per object at day 11 and 14. No such trend was observed at 10
mm.s-1 compression, or below. For all hydrogels compressed at velocities less than 100
mm.s-1, there were no significant differences to negative control samples or to one another.
These results suggest there is a threshold value, above which astrocytes become reactive,
but below which no changes in reactivity are observed. This threshold value cannot be
in load, since was similar between the two greatest velocities (10 and 100 mm.s-1, but
cellular outcomes were different. This may have been due to the recoil of the apparatus
at high velocities once the target displacement was reached (as described in Chapter 3),
resulting in data not forming one smooth peak.
Displacement was also the same for all samples. The two factors which differed
were velocity and load. Collagen hydrogels are viscoelastic materials (Antoine et al.,
2014). The same is true of the spinal cord (Bilston and Thibault, 1996; Ichihara et al.,
2003; Fradet et al., 2016). It is well established that at high velocities or strain rates,
viscoelastic materials have an increased stiffness (Dogliotti and Yelland, 1964; Hussein,
2018). Therefore, at high velocities, the maximum load recorded was greater and the
cells would have been subject to a greater force. It is difficult to decouple these factors
experimentally.
Few studies have evaluated the effects of changing velocity on astrocyte outcomes
in the context of spinal cord injury. Cullen et al. (2007) evaluated the effect of increasing
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shear strain rate on astrocytes, and found that the greatest strain rate tested resulted in
increased GFAP expression at 2 days post injury, whereas lower strain rates did not. The
strain rates used were 30.s-1, 10.s-1 and 1.s-1. By contrast, the strain rates used herein were
142.s-1, 14.2.s-1, 1.42.s-1 and 0.142 .s-1. Only at the greatest strain rate (equivalent to 100
mm.s-1) were similar changes in astrogliosis observed. The results of the Cullen study
study as well as the research herein suggest a threshold in velocity or strain rate, above
which astrogliosis occurs, but below which astrocytes remained quiescent.
In terms of mechanics, slow velocity compression of a viscoelastic material allows
it to change shape and stress to reduce (stress-relaxation). This would occur clinically,
but only up to a threshold value of depth. After this depth, the spinal cord would not
be able to relax further as it would have filled any surrounding space in the vertebral
column. This would mean that increased stress was then applied directly to the cells.
This could be tested in-vitro by using a greater displacement depth. Compression of 70%
of the original gel height was chosen based on clinical studies showing that spinal cord
compression greater than 15 to 50% of the cross-sectional area is required for symptoms
to occur (Penning et al., 1986; Matsunaga et al., 2008; Iwahashi et al., 2016; Kadanka
et al., 2017; Lim et al., 2017). It is possible that when applying forces to astrocytes alone,
without other cells and components such as vasculature, a greater compression could be
required to elicit cellular responses.
100 mm.s-1, TSCI
This study found that high velocity (TSCI) impacts resulted in a larger area of GFAP
staining per each stained object on day 11 and 14, along with increased ramifications of
astrocytes at day 14. The larger area of GFAP per object can be interpreted as astrocytes
being larger or expressing more GFAP, which is indicative of astrogliosis. Similarly,
increased ramifications of astrocytes also indicate an astrogliotic response. Astrogliosis
is characterised by an upregulation of GFAP, increased number of processes and process
hypertrophy (Hol and Pekny, 2015). In TSCI, the degree of astrogliosis is a marker of
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injury severity (Wanner et al., 2013). Reactive astrocytes form the glial scar, a physical
barrier to neuronal regeneration. This has been observed clinically (Norenberg et al.,
2004; Sofroniew and Vinters, 2010) as well as in various experimental models (Cullen
et al., 2007; Kawano et al., 2012; Wanner et al., 2013; Weightman et al., 2014).
At day 14, there was an increase in IL-6 release, a pro-inflammatory cytokine. These
results indicated the high velocity impact at day 1 (primary injury) resulted in a secondary
injury comprising inflammatory response and astrogliosis at day 11 and day 14. It is worth
noting that intensity of GFAP staining could not be measured in this study due to over-
exposure of some images because of variation in staining intensity, but this could be used
in future studies as another marker of astrogliosis.
IL-6 is a pro-inflammatory cytokine core to the secondary inflammatory injury
cascade in TSCI (Okada, 2016; Paterniti et al., 2015). In a mouse study, blocking the IL-6
receptor in-vivo resulted in attenuation of astrogliosis and the secondary injury (Okada
et al., 2004; Tan et al., 2013). The finding herein of increased IL-6 expression after high
velocity mechanical compression indicates that a secondary injury comprising astrocyte
inflammation was induced.
Two previous studies at the University of Leeds used the same cell type in the
same collagen hydrogel system, and evaluated GFAP (Smith, 2016; Kirk, 2018). Kirk
(2018) compressed the hydrogels with a focal, high velocity impact in the BOSE 5110
Electroforce apparatus. Findings from that study were that after 24 hours, i.e. within
the primary injury timeframe, there were significantly more GFAP positive pixels in each
image than negative controls. The area of GFAP staining per cell was not described.
Therefore, differences in GFAP staining could have been due to an increased number of
cells present. A measure of luminescence, indicating ATP levels, also indicated increased
metabolism 24 hours after impaction, which again could indicate an increased number
of cells. The research herein normalised GFAP staining per object (i.e. normalising
based on the number of cells), and did not find significant differences at day one post-
impaction. It is worth noting that the Kirk study used the same primary antibody for
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GFAP at the same concentration, facilitating comparison. Kirk evaluated cytokine release
at 4 and 24 hours post-impaction, and found significantly more IL-6 in media from
astrocyte-seeded hydrogels than media only controls. However, with increasing impact
displacement, IL-6 levels decreased. The differences between the research herein and the
Kirk study may have been due to differences in methodology, including the focal nature of
the lesion, varying displacement depth, timepoints evaluated and differences in analysis
methodology.
Smith compressed the hydrogels with a focal impact, using the Infinite Horizon
impactor (Smith, 2016). Similarly to the Kirk study, the Smith study also evaluated
astrocyte responses using the same GFAP primary antibody at the same concentration
as the study herein. The velocity of the impaction device could not be controlled. Instead,
load control was used, applying a 2 N load. In test sample collagen hydrogels, where a 2
N input was defined, the output was 3.95 N. Accuracy of the device was not determined
in the impacted samples, but was likely to be poor as reflected in the load input and output
discrepancy. Upon impaction, material in the centre of the impact site was lost, but could
not be seen as debris. This could have indicated the material was retained in the sample
and pushed to the edge of the impaction site. At day 1, 5, and 10 post-impaction, there
was increased GFAP-stained area per cell closest to the impaction site (although these
differences were not statistically significant). The difference was greatest at day 10, but
there was only one sample tested at this datapoint. No ELISA data was presented in the
Smith study. The research herein identified increased GFAP staining per cell at day 11
and day 14. These findings are supported by the Smith study, in spite of limitations such
as accuracy, and differences in the methodology used.
No studies have used organotypic spinal cord slices with varying mechanical insults
to evaluate astrocyte reactivity. A weight drop method has been used to induce TSCI, but
reactivity of astrocytes was not established (Krassioukov et al., 2002; Pandamooz et al.,
2019). Weightman et al. (2014) used an organotypic spinal cord slice in combination with
a scalpel blade to induce TSCI. Optical density was used as a measure of the amount of
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fluorescent GFAP labelling, and this was increased in the nearest 100 µm to the lesion
at 6 days post-injury. This corresponded with hypertrophic astrocytes with elongated
processes, although these were not quantified. In more distant locations, astrocytes had
a quiescent morphology and reduced GFAP labelling was observed. Astrogliosis in the
Weightman study was observed at an earlier timepoint than the study herein (7 vs 11 days).
This may be due to the presence of other cell types within the slices, which enhanced the
astrogliotic response; such as microglial infiltration to the injury site and activation. The
drawbacks of spinal cord slice studies are that astrocytes cannot be evaluated in isolation,
therefore it is unclear whether responses were elicited by astrocytes themselves or as part
of a more complex cascade involving other cell types.
Various in-vivo studies have evaluated the impact of mechanical factors on injury
outcomes, however none have evaluated the effect of impact mechanics on astrogliosis
specifically. Interestingly, Kim et al. (2009) evaluated the effects of three impacts speeds
using different impactors on spinal cord injury, with a matched displacement. For the
three velocities tested (100, 200 and 400 mm.s-1), there were no significant differences in
injury outcomes (behavioural or histological). This suggests that above a threshold, the
value of which is below 100 mm.s-1, velocity is not the most important factor in outcomes.
A similar outcome was described by Lam et al. (2014) who used two displacements and
three velocities (8, 80 and 800 mm.s-1). Lam describes a threshold between impact depth
and speed in determining injury outcomes. The load and work done imparted onto the
spinal cords was not described in either study, so it is not possible to say whether the
outcomes themselves were definitely due to differences in velocity. By contrast, Scheff
et al. (2003) used three forces: 1, 1.5 and 2N, to induce spinal cord injury. There was a
significant increase in injury severity in terms of behavioural outcomes and injured tissue
area between groups, but there was also a significant difference in displacement as well
as load. Therefore, it was not possible to determine if the effects were due to increased
load in isolation.
Overall, the trend within the literature is that injuries with a greater mechanical
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impact result in worse functional outcomes and greater area of injured tissue. The most
important mechanical factor itself is debated, and difficult to isolate due to the inherent
complexities of in-vivo models. None of the studies have assessed the effect of impact
mechanics on astrogliosis specifically.
The results of this study herein support those of aforementioned research at the
University of Leeds, addressing their limitations, and filling research gaps in in-vivo
studies. The present study indicates that astrocytes alone in collagen hydrogels can model
TSCI with high velocity impaction. High velocity TSCI-like primary injury astrocytes
in collagen hydrogels stimulates a delayed secondary injury response incorporating
astrogliosis, increase GFAP expression, and pro-inflammatory IL-6 release. The
secondary injury cascade has been established herein, but no differences were observed
at the primary injury stage. It would be of use to evaluate cell viability and metabolism at
early timepoints in particularly, as this has been shown in a similar model to characterise
the primary injury response (Kirk, 2018).
4.5.3 Conclusion
Progress made in this chapter in relation to the aims are described (Table 4.1). The results
have the following implications in terms of causal mechanisms for TSCI and NTSCI:
• TSCI pathology is caused by high velocity mechanical compression of astrocytes:
this primary mechanical trauma results in the secondary injury cascade of
astrogliosis and inflammation.
• Reactive astrogliosis after mechanical insults is non-linear, with a threshold not
based on displacement alone or load. Work done or velocity are core factors in
distinguishing TSCI.
• The causal mechanism for NTSCI is not slow velocity mechanical compression of
astrocytes.
145
Chapter 4. Responses of Neural Cells to Varying Mechanical Inputs
• Further study is required using the same model with increased complexity and more
cell types to fully characterise NTSCI.
Table 4.1: Conclusions of Chapter 4: Responses of Neural Cells to Varying Mechanical Input
Aim Objective Result and Implications
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Q Seed collagen I hydrogels with
astrocytes
Hydrogels were successfully seeded with
primary rat astrocytes
Compress hydrogels to 70%
displacement at 0.1, 1, 10 and
100 mm.s-1
The BOSE 5110 Electroforce was used to
accurately apply high and low velocity
mechanical insults to astrocyte-seeded
collagen hydrogels
Evaluate astrocyte responses for
TGF-beta treatment (positive
control)
TGF-beta treatment caused IL-6 release on
day 1 and day 14; hydrogel contraction
from day 5 onwards; and astrogliosis on
day 11 and 14 (reduced circularity, and
increased area of GFAP per cell).
Evaluate high velocity (100
mm.s-1) astrocyte responses
Compression at a velocity of 100 mm.s-1
caused increased area of GFAP expression
per cell at day 11 and day 14, and IL-6
release at day 14.
Evaluate lower velocity (10 and
1 mm.s-1) astrocyte responses
Compression at velocities of 10 mm.s-1 or
less did not significantly change GFAP
expression. This is in spite of similar load
between 100 and 10 mm.s-1 velocities.
Evaluate low velocity (0.1
mm.s-1) astrocyte responses
Compression at 0.1 mm.s-1 resulted in
significantly more IL-10 release than
compression at 100 mm.s-1, however
neither of these were significantly different
to controls. No changes were observed in
GFAP labelling.
Evaluate astrocytes responses
for negative controls
No differences were identified between
apparatus and negative controls, i.e. in the
assays used, there was no effect of
physically removing the hydrogels from
the plate and loading them in to the BOSE
5110 Electroforce apparatus.
146
Chapter 5
In-vivo NTSCI model development
5.1 Introduction
This chapter developed an in-vivo model of NTSCI based on a modification of a previous
method used for TSCI, using a balloon catheter in rats. Three factors were considered to
modify the method: directionality of the lesion (i.e. ventral as opposed to the traditional
dorsal injury), the degree of stenosis required particularly in relation to balloon volume,
and to adapt the method to allow inflation over a longer timeframe.
Whether NTSCI is caused by metastatic tumours in the vertebral body, osteophytes,
or disc herniation, the origin of the mechanical insult is most often ventral to the cord
(Ferrara, 2012; Tetreault et al., 2015; Martin et al., 2018). This is important since the
spinal cord is not symmetrical about the z axis, i.e. the ventral and dorsal halves of the
cord are different both geometrically and functionally. This is true of white matter, grey
matter, and overall shape (Watson et al., 2009). For instance, the ventral surface of the
spinal cord has the anterior median fissure, and the surrounding white matter is home to
the reticulospinal and spinothalamic tracts, which are important in balance and sensory
information (Sengul and Watson, 2015; Mitchell et al., 2016).
In spite of the clinical relevance, lesion directionality is often overlooked in TSCI and
NTSCI in-vivo. Methods such as impaction or material implantation induce injury from
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the dorsal approach. If a ventral approach could be developed, it would be important to
understand how the histology of a traumatic lesion from the ventral approach differs from
traditional dorsal methods.
A balloon catheter model for TSCI (such as used by Vanicky et al. (2001)) has
been adapted to induce a ventral lesion by Institute of Experimental Medicine, Czech
Academy of Sciences of the Czech Republic (henceforth IEM), although this is currently
unpublished. A partial laminectomy is undertaken at T10, and a 2 French (2F) Fogarty
balloon catheter is introduced and advanced ventrally and then cranially by 1 cm to spinal
cord level T8/9. This means the catheter is theoretically ventral or ventro-lateral to the
spinal cord. Existing research collaborations between academics at the University of
Leeds, and IEM (Prague) facilitated development of the model herein. The findings of the
research group at IEM (Prague) are currently unpublished. Therefore, this chapter first
evaluates the histopathology of a TSCI ventral balloon catheter lesion in the rat spinal
cord, at one week post injury. The purpose of this study was to assess the histology of
such a lesion compared to the wider literature, and determine if the lesion was ventral.
In terms of developing the ventral balloon lesion model for NTSCI, stenosis
progression is important. The pathology of NTSCI develops as stenosis increases:
initially with an asymptomatic phase, followed by symptom onset and then deterioration
(Karadimas et al., 2012, 2013). Understanding stenosis and cord compression extent in
the animal model could further elucidate pathological mechanisms. Clinically, increasing
canal stenosis is associated with an increased risk of developing symptomatic NTSCI
(Penning et al., 1986; Steurer et al., 2011; Iwahashi et al., 2016; Weber et al., 2016;
Kadanka et al., 2017; Martin et al., 2018; Witiw et al., 2018). If there is a threshold for
cord compression to initiate symptoms this has not been established in the literature. It is
particularly important to investigate canal stenosis and cord compression from the ventral
approach, as this is where NTSCI originates from clinically.
To understand compression extent and stenosis, the geometry of both the injury-
causing device and the rat vertebral canal must be established. In both NTSCI and TSCI
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studies, these values are not often reported. In TSCI balloon catheter studies, the volume
of injury-causing object varied between approximately 13 mm3 (equating to 13 µL) at
spinal cord level C5/6, and 10 to 50 µL at spinal cord level T8/9 (Vanicky et al., 2001; Kim
et al., 2004; Lonjon et al., 2010; Chung et al., 2013). One study using the same 2F Fogarty
balloon catheter as used in the current study described a diameter of 2.5 mm with a volume
of 15 µL (Lonjon et al., 2010). However, the method to ascertain this dimension, and the
corresponding balloon diameter for any volume other than 15 µL, were not described. A
figure in another study using the same balloon catheter showed that the balloon diameter
is 2.9 to 3 mm (Vanicky et al., 2001). This dimension must be taken as an estimate,
as the value was interpreted from a photograph using crude measurement techniques.
These volumes did not correspond with cord compression, and it is not known whether
similar volumes would induce functional and histological changes in slow velocity NTSCI
lesions.
Yang et al. (2015) carried out a rat study wherein a polymer was introduced at the
thoracic level which increased in volume to a maximum of 8.4 mm3. This induced spinal
cord compression of 70%, and caused functional deficits. The timeframe of material
expansion was not established. Conversely, Kim et al. (2004) used a similar polymer at
the cervical level. The volume change described was 24% increase over 24 hours, but the
dimensions of the polymer were not defined. This resulted in 11% cord compression but
no functional deficits. Few other spinal cord injury studies in-vivo describe the resulting
canal stenosis, and how that affects functional or histological outcomes (Hu et al., 2011;
Kurokawa et al., 2011; Long et al., 2013; Xu et al., 2017).
There is a paucity of data describing the relationship between canal stenosis and
outcomes in TSCI and NTSCI. In NTSCI, canal stenosis is particularly important as
the increasing stenosis over time is core to the injury progression. The relationship
between the geometry of the rat vertebral canal, compared with volume and geometry
of the balloon catheter is a critical step in model development, and as such had to be
characterised. This data could be used to determine canal stenosis in future studies of
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NTSCI.
Martin et al. (1992) used the balloon catheter model in a traumatic injury study,
but noted that the method could be modified to characterise progressive spinal cord
compression by inflating the balloon progressively and leaving in place for longer
timeframes. This has not yet been attempted in the literature. To model NTSCI in-vivo,
the injury extent must increase over a temporal profile over weeks to days in a rat. Due
to the time scale of this research, a temporal profile of injury lasting up to three days in a
rat was selected. This means the device inducing the injury must be able to be implanted,
as the animal could not be under anaesthetic for three days whilst inflation took place. A
ventral balloon catheter model has been used to model TSCI in-vivo, and has the capacity
to be adapted for NTSCI studies.
It was hypothesised that the balloon catheter system could be adapted for NTSCI
studies. The system had to be able to be implanted (i.e. able to be sterilised, reasonable
size), and the diameter of the balloon had to increase in a controlled manner over time after
implantation. The geometry of the balloon could be tailored in terms of cross-sectional
area of the vertebral canal, as defined in the previous experiment.
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5.2 Aims
The aims of this chapter were to develop methods to model NTSCI in-vivo. This links to
the overall aim of the project, to evaluate responses to NTSCI in-vitro and in-vivo (Figure
5.1). Specific objectives for this chapter:
1. To develop a clinically-relevant model of non-traumatic spinal cord injury in-vivo;
with increasing canal stenosis over an extended time frame (i.e. days) and using a
ventral lesion:
A Characterise histology of balloon catheter inflation ventral lesion in traumatic
spinal cord injury (rat, T8/9 spinal cord level).
B Evaluate rat spinal column anatomy, in particular the diameter of the vertebral
canal at thoracic vertebral levels T6 to T13.
C Assess 2F Fogarty balloon inflation volume with increasing diameter.
D Develop method for 2F Fogarty balloon inflation model for a non-traumatic
injury context.
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Figure 5.1: Hypothesis and research question in Chapter 5, relating to aims of the whole study.
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5.3 Experimental Setup
5.3.1 Ventro-Lateral Balloon Spinal Cord Lesion
Four Wistar rats, 250 to 300g were operated upon in the Institute of Clinical and
Experimental Medicine in Prague, using a currently unpublished ventral balloon catheter
TSCI lesion model. This was modified from a previous dorsal balloon catheter model
(Vanicky et al., 2001). In brief, a right-sided laminotomy was performed at T10, and
a 2F Fogarty balloon catheter was introduced on the right hand side of the spinal cord,
and advanced cranially, up to 1 cm below the proximal end of the balloon, so the centre
of the balloon was at spinal cord level T8/9 (vertebral level T7/8). The balloon was
inflated in-situ during surgery with either 12.5 µL or 15 µL of water using a Hamilton
syringe (n=2 for both conditions). The balloon was left in place for 5 minutes before
being fully deflated and removed. The incision was then closed using non-resorbable
sutures. One week after injury, animals were perfused and spinal cords excised and their
gross morphology briefly examined. Cords were then stored in 30% (w/v) sucrose with
0.1% (v/v) sodium azide at 4oC for up to four months. Subsequently, spinal cords were
embedded into OCT and frozen using a dry ice and ethanol slurry. Cryo-blocks were
stored at -80oC. The blocks were sectioned serially at 40 µm, and stored at -20oC.
Sections every 1 mm were stained with haematoxylin & eosin to evaluate cross-
sectional area of the tissue. Subsequently, sections were stained using immuno-labelling
for GFAP (staining astrocytes) and CS-56 (staining chondroitin sulphate proteoglycans).
These markers are upregulated in TSCI (Norenberg et al., 2004; Sofroniew and Vinters,
2010; Wanner et al., 2013; Hol and Pekny, 2015; Tachi et al., 2015; Alizadeh et al.,
2019; Muir et al., 2019). For each animal, this comprised three regions: the lesion
epicentre, and rostral, and caudal to the epicentre. Three sections per animal were
imaged at each location using a confocal microscope, and the microscope settings were
maintained throughout. Images were subsequently analysed using an automated macro in
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FIJI (ImageJ) to evaluate the proportion of area which was stained. This was normalised
as a percentage to the tissue cross-sectional area as determined using the H&E sections.
5.3.2 Evaluation of Rodent Anatomy: Computed Tomography Scan
5.3.2.1 Methods
CT scanning of a rodent spine was undertaken for guiding in-vivo experiments and gaining
understanding about the anatomy of the vertebral column. Scans were undertaken using
an Xtreme CT, with images taken along the length of the thoracic and lumbar spine in
the transverse plane. Measurements were taken in the plane of the CT scan and in the
anatomical plane using the ‘volume viewer’ plugin, allowing slices to be made in any
orientation. Transverse slices were viewed, however due to spinal curvature the images
obtained from the CT scan were out of plane, i.e. the whole vertebral foramen was not
in plane on the individual image. The images were tilted using FIJI so that the entire
vertebral foramen was in-plane and not tilted (Figure 5.2).
Figure 5.2: Evaluation of transverse out-of-plane measurements from microCT images of a
rodent spine. Left: x = 0, y = 0, z = 0; shows the image taken from the CT scan. Neither the full
dimensions of the vertebral canal, nor the spinous process could be visualised. Right: x = 16, y =
-2, z = 0; shows the same level now in plane, with the entire spinous process and vertebral canal
surrounded by bone.
Measurements from the thoracic and lumbar vertebrae were taken using FIJI (Figure
5.3). In order to estimate the cross-sectional area of the vertebral foramen, it was assumed
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to be an ellipse, and was therefore calculated by the equation below:
Ellipse Area = r1× r2× pi
Figure 5.3: Dimensions of the rodent spine taken from CT scans. Transverse plane dimensions
were evaluated in thoracic and lumbar regions. A: width of vertebral foramen; B: depth of
vertebral foramen.
5.3.2.2 Experimental Setup
One cadaveric adult female Wistar rat was used to spare resources. The rodent was placed
in a supine position, and scanned using the Xtreme CT, with a resolution of 40 µm on
each image. The scan incorporated 126.6 mm (the length of the animal from neck to tail
regions) and 3088 slices. The region from T2 to L6 was evaluated.
5.3.3 Evaluation of Balloon Catheter System
5.3.3.1 Methods
The specification and dimensions of the 2F balloon catheter, and other catheters, needle
and cannulae used in this study are detailed below (Table 5.1). The balloons are designed
to inflate uniformly and symmetrically in every direction (Lifesciences, 2019).
Prior to inducing the lesion in-vivo using a 2F balloon catheter, the volume-diameter
relationship of the balloon had to first be established. Air was removed from the system
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and replaced with water using a needle and 10 mL syringe with a small volume of sterile
water. The needle formed a tight seal with the inner catheter walls. Air was drawn back
through the syringe to form a vacuum, then water was added. Further manipulation of
volume was carried out using a 50 µL Hamilton syringe, 30G needle and sterile water.
Balloon diameter was measured by affixing the balloon to a graticule, and viewing under
a dissection microscope.
Subsequently, a system was developed and characterised to inflate the balloon over
a period of days which was suitable for in-vivo implantation. The balloon catheter was
either attached to 3 French polyethylene tubing with an osmotic pump or 21G needle;
or the 2F balloon catheter was affixed to a 22 gauge venous cannula. Air was replaced
with sterile water in each system, and sterile water was used to inflate the balloons. The
diameter of the balloon was measured as above, using a graticule and microscope.
Table 5.1: Specification of catheters, cannulae and needles used in this study NB balloon liquid
volume is not available as they are not tested for this purpose
Item Inner diameter
(mm)
Outer diameter
(mm)
Edwards 2F balloon catheter (deflated) Unknown 0.667
Edwards 2F balloon catheter (inflated) Unknown 4 (maximum)
Osmotic pump tubing requirement 0.76 N/A
Polyethylene (PE-60) tubing 0.76 1.14
Sentrawin 22G cannula tubing 0.41 0.72
21G needle 0.51 0.82
30G needle 0.31 0.16
5.3.3.2 Experimental Setup
Balloon Catheter Volume and Diameter
For initial balloon volume and diameter characterisation, two setups comprising a 5
cm length of 2F balloon catheter affixed to 5 cm of 3F PE-60 polyethylene tubing were
manufactured. The seal between catheter and tubing was created using silicone 3140, and
left to dry overnight. A 21G needle was inserted into the open end of the PE-60 tubing,
and air was replaced with water in the system using a 10 mL syringe. In both systems, the
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balloons were fully inflated to check patency. In the first system, the balloon was deflated
until the sides of the balloon just became straight again (A and B in Figure 5.4). In the
second system, the balloon was deflated fully. Subsequently, in both systems the needle
was detached from the 10 mL syringe and attached instead to an airtight 50 µL Hamilton
syringe filled with sterile water and no air bubbles. The balloon was affixed to a graticule
and placed under a dissection microscope. Volume increments of 1 µL were added to the
balloon and the diameter was measured, up to a total volume of 50 µL. Subsequently, the
balloon was deflated in 5 µL increments, and the diameter was recorded.
Figure 5.4: Photographs of balloon component of 2F balloon catheter at various stages. A:
completely deflated, B: sides of the device just straight, C: inflated with 15 µL. Scale bar 1 mm.
Measurements taken using a graticule and microscope setup.
Setup of Injection Port for Balloon Catheter NTSCI System
The balloon catheter/PE-60 catheter system (as previous, but a total of 10 cm of catheter
and 10 cm of PE-60 tubing was used) was manufactured. Again, air was replaced with
sterile water. The balloon was inflated to its maximum, and then deflated until the sides
of the balloon were just straight. This was then attached to an osmotic mini pump (Figure
5.5).
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Figure 5.5: Schematic diagram showing the setup of balloon catheter with an osmotic pump
system Air was removed from the catheter tubing and replaced with sterile water before affixing
the osmotic pump (also filled with sterile water). A total catheter length of 15 cm was affixed to
an Alzet 1002 osmotic mini-pump using silicone 3140 cured at room temperature overnight. The
whole system was submerged in phosphate buffered saline at 37oC for inflation experiments
The pump was filled with 100 µL sterile water, and this was confirmed by measuring
the concurrent change in mass of the pump before and after adding water. The pump was
primed in PBS at 37oC for 24 hours before being sealed overnight to the catheter system
using silicone 3140. The pump-catheter system was submerged in PBS at 37oC for at
least one week. The balloon diameter was measured prior to incubation, and then at 10,
25, 50, 100 and 168 hours (1 week).
An injection port was developed using either the PE-60 system with a 21G needle
inside; or by affixing the injection port to a 22G venous cannula (Figures 5.6 and 5.7,
respectively). In this latter setup, a length of 15 cm of 2F balloon catheter tubing was
attached to a 22G venous cannula using silicone 3140 which was dried overnight at room
temperature. To insert the catheter into the cannula, a 21G needle was pushed into the
end of the cannula to widen it slightly, to allow the 2F balloon catheter to fit inside. Seals
were made with silicone 3140. An airtight seal within the luer slip of either the needle or
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venous cannula was developed.
Figure 5.6: Schematic diagram showing the setup of balloon catheter with 3F tubing Air was
removed from the catheter tubing and replaced with sterile water. A total balloon catheter length
of 10 cm was affixed to 10 cm of 3F polyethylene tubing. A 21G needle was then inserted into the
3F catheter. Joins were affixed with silicone 3140 and cured overnight.
In repeat injection studies using the injection port, the 22G venous cannula system
was set up as above. The luer slip was blocked using the materials defined in the previous
test. Patency of the system was tested, the balloon was inflated to maximal volume (40
µL), and then deflated until the sides of the balloon were just straight. Then, the system
was affixed to a graticule under a dissection microscope. A 30G needle attached to 50
µL airtight Hamilton syringe was inserted through the injection port. A set volume was
dispensed. The needle was subsequently removed. Balloon diameter was measured at
each step.
5.3.3.3 Developing an Injection Port
In order for the balloon to retain its diameter and volume once implanted, the whole
catheter system had to be closed to the air and without leaks. To develop a model where
repeat injections could be applied to the balloon catheter system over a period of days, an
injection port needed to be developed. Two setups were tested: 2F balloon catheter with
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Figure 5.7: Schematic diagram showing the setup of balloon catheter with cannula system and
an injection port This setup was tested with materials to create a seal in the distal end of the
setup. Air was removed from the catheter tubing and replaced with sterile water before inflation
experiments were undertaken. System modified from previous publication (Fiebig et al., 2013).
PE-60 tubing and a 21G needle; or 2F balloon catheter with 22G venous cannula. The
material used for the port had to allow needle puncture, but then seal after the needle was
removed. A previous study developed an injection port system using a venous cannula
with an a rubber material inside it (Fiebig et al., 2013). The method used in this previous
study was adapted.
The inside diameter of both the 22G cannula tubing, and 3F polyethylene tubing,
were too narrow to allow any repeat injections; one injection, even with a 30G needle,
would have completely disrupted the port. As such, the cannula luer slip was left attached
the system. For the 3F tubing, a 21G needle was inserted into the tubing and attached
using silicone 3140. This gave two options for forming an injection plug, the luer slip tips
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of either the cannula or 22G needle.
Sylgard and silicone 3140 both alone and in combination were tested. Discs of
Sylgard were punched out of a larger sheet using borers of various diameters. These
were then pushed into the luer slip tips of both systems. A disc with a diameter of 4.23
mm fitted into the tips, and formed a visible seal around the diameter. When injecting
through the material, it did not dislodge upon insertion or removal of the needle. The
discs were pushed 2 mm down into the luer slip tips. The 2 mm gap above the discs
was filled with silicone 3140, taking care to remove air bubbles, as a secondary means to
ensure a closed system (Figure 5.7). This was left to cure overnight at room temperature.
Both the cannula and 3F catheter/needle system were sealed using the combination
of Sylgard and silicone 3140. The two materials allowed needle puncture and injection
without excess force. When the needle was removed, the puncture hole immediately
sealed and no backflow of the injected solution was noted. The needle within the 3F
catheter system had the capacity to easily puncture the catheter tubing without the user
knowing. Further, the needle and 3F tubing system had three joins, which introduced more
opportunities for leaks. Therefore, only the 22G cannula system was carried forward.
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5.4 Results
5.4.1 Tissue damage and reduced cross-sectional area at the injury
epicentre was observed in all animals
Ventral traumatic spinal cord injuries were introduced in four rats at T9 spinal cord level
(approximately) using a 2F balloon catheter, which was inflated with either 12.5 or 15
µL water. The balloon was left in place for five minutes, then subsequently deflated and
removed. The animals were perfused one week after surgery, and subsequently spinal
cords were sectioned at 40 µm and stained with H&E.
The spinal cords did not appear flattened or deformed after dissection. Lesion sites
could be identified by faint red bands on the tissue.
Many of the sections were damaged, but without cellular response, indicating
damage occurred after perfusion. The tissue from one of the two animals injured with
a volume at 12.5 µL was too damaged to clearly identify the lesion.
In the remaining three animals there was a clear lesion site, with a reduced volume of
tissue in each transverse section area. The balloon component of the catheter was 5.5 mm
long. As such, the evaluation of cross-sectional area of 10 mm should have been sufficient
to identify the lesion caused by the balloon. There was a difference in cross-sectional area
between the two injury volumes of 12.5 and 15 µL. (Figure 5.8). At the epicentre, there
was approximately 11% less tissue in the 15 µL injury group compared with 12.5 µL.
The H&E stain used did not distinguish between healthy spinal cord parenchyma,
inflammatory cell infiltration, or scar tissue. Therefore, the absolute values for cross-
sectional area of the spinal cord at the injury site may be lower than those determined by
this study.
For the lesion of 12.5 µL, there was minimal tissue remaining at the epicentre.
However, at 2 mm rostral or caudal to the lesion, the grey and white matter of the cord
could be distinguished, with only the dorsal white matter having been damaged (Figure
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Figure 5.8: Transverse cross-sectional area of TSCI rat spinal cord, normalised to 5 mm
rostral from the injury epicentre. Animals underwent a T10 laminectomy and balloon catheter
insertion and inflation at T8/9, with a volume of either 12.5 (n=1) or 15 µL (n=2).
Cross-sectional area was determined using 40 µL sections, 1 mm apart, stained with
haematoxylin and eosin. Subsequently, area was determined using an ImageJ macro.
5.9). At 5 mm rostral and dorsal to the epicentre, there was a lesion present within the
dorsal funiculus of the white matter, in a circle or oval shape. This was also present at 8
mm rostral and dorsal, although the lesion was smaller.
For the lesion of 15 µL, there was significant tissue damage at the epicentre, and both
2 mm rostral and caudal to the lesion (Figure 5.9). At these points, white matter and grey
matter could not be distinguished. At 5 mm rostral and caudal to the epicentre, the white
and grey matter of the cord could be distinguished, although there was still considerable
damage to the dorsal region. At 8 and 10 mm rostral to the epicentre, a circular/oval lesion
could be observed in the dorsal white matter, similar to that seen at 5 and 8 mm rostral in
the 12.5 µL lesion (Figure 5.10).
In total, lesions could be observed a total distance of 16 mm rostrocaudally for the
12.5 µL lesion, and 18 mm rostrocaudally for the 15 µL lesion.
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Figure 5.9: Sample cross-sections of spinal cord from TSCI balloon catheter lesions with two volumes. Animals underwent a T10
laminectomy and balloon catheter inflation at T8/9 with a volume of 12.5 or 15 µL. Animals were perfused one week after the injury.
Sections 40 µm thick were stained with H&E. Negative distance values denote rostral to the epicentre, and positive distance values denote
caudal. Scale bar = 1mm.
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The balloon component itself was 5.5 mm long, with rostral catheter 2 mm further.
The catheter and deflated balloon were 667 µm in diameter. The circular/oval lesion
observed in injuries induced by both volumes extended beyond this 2 mm. These circular
cavities were larger closer to the injury epicentre, with a smaller diameter the further
from the epicentre. At 9 mm rostral to the lesion epicentre for a 15 µL lesion, the
cavity measured approximately 500 µm laterally, and 750 µm dorso-ventrally (Figure
5.10). Here, the cavity was contained some cells with a yellow colour indicated ongoing
necrosis. At 8 mm rostral to the 12.5 µL lesion, the cavity measured approximately 220
µm laterally, and 260 µm dorso-ventrally (Figure 5.11). Here, there was no yellow colour
observed, instead the tissue comprised loose connective tissue matrix with some cells,
indicating necrosis had already taken place.
Vacuoles were observed in white matter both rostral and caudal to the lesion
epicentre (Figure 5.12). These were present in lateral and ventral regions of the white
matter, where the dorsal white matter was no longer present.
At the lesion epicentre, three tissue types were present (Figure 5.13). At the
penumbra of the spinal cord in cross-section, a small amount of conserved white matter
remained. Within the main cross-sectional area of the spinal cord, there were two further
types of cells. The central region contained high density cells. Between this high density
region and the white matter were regions containing no cells or debris, and loose regions
of debris with macrophage infiltration.
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Figure 5.10: H&E image of lesion cavity 8 mm rostral from lesion epicentre in 15 µL
balloon-induced TSCI. Animals underwent a T10 laminectomy and balloon catheter inflation at
T8/9 with a volume of 15 µL. Animals were perfused one week after the injury. Sections 40 µm
thick were stained with H&E. Scale bar for each image is in µm.
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Figure 5.11: H&E image of lesion cavity 8 mm rostral from lesion epicentre in 12.5 µL
balloon-induced TSCI. Animals underwent a T10 laminectomy and balloon catheter inflation at
T8/9 with a volume of 12.5 µL. Animals were perfused one week after the injury. Sections 40 µm
thick were stained with H&E. Scale bar for each image is in µm.
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Figure 5.12: Vacuoles in white matter rostral to TSCI lesion epicentre. Animals underwent a
T10 laminectomy and balloon catheter inflation at T8/9 with a volume of 15 µL. Animals were
perfused one week after the injury. Sections 40 µm thick were stained with H&E. Scale bar for
each image is in µm.
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Figure 5.13: Lesion epicentre one week after TSCI induced by balloon catheter. Animals underwent a T10 laminectomy and balloon
catheter inflation at T8/9 with a volume of 15 µL. Animals were perfused one week after the injury. Sections 40 µm thick were stained with
H&E. Scale bar for each image is in µm. Two types of cell or tissue regions can be identified, a high density cellular infiltrate (above
row), and a loose matrix of macrophages and debris (below row), and
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5.4.1.1 Traumatic balloon injury resulted in increased GFAP and CSPG expression
at the injury epicentre
It is worth noting that due to damage to the tissue during histological preparation, N =
1 for a balloon volume of 12.5 µL. This meant that statistical analysis using two-way
ANOVA could not be undertaken and volumes could not be compared (Figure 5.14A).
Instead, results were pooled and one-way ANOVA was carried out with Tukey’s post-hoc
test, comparing spinal cord regions. There was a greater area of GFAP staining at the
epicentre than either rostral or caudal to the lesion (p <0.05, Figure 5.14B). In rostral and
caudal regions, GFAP labelling was observed predominantly at the edge of the cord, i.e.
the white matter (Figure 5.15). At the injury epicentre GFAP labelling was observed in
both the central fibrotic region as well as in the remaining white matter.
Figure 5.14: Proportion of tissue stained with GFAP in balloon catheter induced TSCI.
Animals underwent a T10 laminectomy and balloon catheter inflation at T8/9 with a volume of
12.5 (N=1) or 15 (N=2) µL. Animals were perfused one week after the injury. Sections 40 µm
thick were stained with GFAP and the stained area (determined using FIJI) was given as a
percentage of the total area determined using H&E staining. Three sections per animal were
stained at each location. Data is mean (± S.E.M for 15 µL).
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Figure 5.15: Representative images of GFAP staining in ventral balloon catheter-induced
TSCI. Animals underwent a T10 laminectomy and balloon catheter inflation at T8/9 with a
volume of 12.5 or 15 µL. Animals were perfused one week after the injury. A total of three
sections 40 µm thick were stained and imaged at each location. In overview images, scale bar is
1 mm, in 20x images, scale bar is 100 µm
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Similarly to GFAP, pooled data for CS-56 expression was required for statistical
analysis due to N=1 for 12.5 µL (Figure 5.16A). Using a one-way ANOVA, there was a
significantly greater area stained with CS-56 at the epicentre than at rostral and caudal
regions (p <0.05, Figure 5.16B). There was minimal observable CS-56 staining in rostral
and caudal regions, and staining was only present in the central grey matter (Figure 5.17).
Conversely, at the epicentre there was strong specific staining for CS-56 in the central
fibrotic regions as well as in the remaining white matter at the edge of the tissue.
Figure 5.16: Proportion of tissue stained with CS-56 in balloon catheter induced TSCI.
Animals underwent a T10 laminectomy and balloon catheter inflation at T8/9 with a volume of
12.5 (N=1) or 15 (N=2) µL. Animals were perfused one week after the injury. Sections 40 µm
thick were stained with CS-56 and the stained area (determined using FIJI) was given as a
percentage of the total area determined using H&E staining. Three sections per animal were
stained at each location. Data is mean (± S.E.M. for 15 µL).
172
Chapter 5. In-vivo NTSCI model development
Figure 5.17: Representative images of CS56 staining in ventral balloon catheter-induced
TSCI. Animals underwent a T10 laminectomy and balloon catheter inflation at T8/9 with a
volume of 12.5 or 15 µL. Animals were perfused one week after the injury. Sections 40 µm thick
were stained with CS56 to identify chondroitin sulphate proteoglycans. In overview images, scale
bar is 1 mm, in 20x images, scale bar is 100 µm
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5.4.2 Vertebral foramen area was greatest at T7/8
For in-vivo experiments, a greater understanding of rat spinal anatomy was required to
identify appropriate compression extent. Further, the balloon catheter system required
evaluation and development prior to implantation. Prior to developing methodology for
in-vivo experiments, it was useful to first develop an understanding of the spinal anatomy
of the rat. This was undertaken by a CT scan of a rat post-mortem (methods in section
5.3.2). The thoracic region of the spine had an anatomical curvature which could not be
straightened due to rigor mortis (Figure 5.18).
The width of the vertebral foramen generally decreased from T2 to L6, with
exceptions at T13, L1, and L3 (Table 5.2). The depth of the vertebral foramen increased
from T2 to T7, and then decreases to L6. Cross-sectional area was on average 7.9 ± 0.21
mm2 for the thoracic region, and 4.5 ± 0.86 mm2 for the lumbar region. The maximum
cross-sectional area was 8.9 mm2 at T7/8.
Figure 5.18: 3D renditions of 2D CT scans of rat skeletal anatomy. Rendered in ImageJ, scale
bar = 5 mm. Sagittal view (left, yz plane); frontal view (right, xy plane).
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Table 5.2: Rodent vertebral dimensions, from the second thoracic to last lumbar vertebrae. Dimensions from female Wistar rat CT scan,
with image analysis using the FIJI volume viewer plugin VF = vertebral foramen, D = depth; W = width, CSA = cross-sectional area
(assuming the vertebral foramen is an ellipse)
Vertebral level
T2 T3 T4 T5 T6 T7 T8 T9 T10 T11 T12 T13 L1 L2 L3 L4 L5 L6
M
e
a
s
u
r
e
m
e
n
t
VFW
(mm)
4 3.8 3.6 3.5 3.3 3.3 3.3 3.5 3.1 3.3 3.4 3.8 3.8 3.6 3.3 3 2.5 2.2
VFD
(mm)
2.5 2.5 2.6 3.1 3.1 3.4 3.4 3 2.9 2.8 2.5 2.8 2.6 2.1 1.9 1.6 1.4 1.2
CSA
(mm2)
7.9 7.5 7.2 8.4 8.0 8.9 8.9 8.4 7.2 7.2 6.6 8.3 7.7 5.9 4.8 3.6 2.7 2.1
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5.4.3 2F balloon volume-geometry characterisation could be fitted to
a polynomial curve
Methods used in this section are described in section 5.3.3. An initial experiment was
undertaken to assess how adding volume to the balloon catheter system affected balloon
diameter. Subsequently, a similar study was undertaken in the sealed system with repeat
injections over time.
This part of the study evaluated how additional volume affected balloon diameter
using a 2F balloon catheter, PE-60 tubing and 21G needle attached to 50 µL Hamilton
syringe. Starting with a completely empty balloon (inflation 2, A and B, Figure 5.4 in
Section 5.3.3.2) resulted in a lag before inflation began. Ultimately, the same maximum
diameter was achieved in both systems. The reported maximum diameter of the balloon
was 4 mm, with a cross-sectional area of 12.57 mm2 (section 5.3.3). The maximum
diameter achieved was 4.1 mm, with a cross-sectional area of 13.36 mm2 (Figure 5.19).
At a volume of 15 µL, the catheter diameter was 2.8 mm. In both tests, inflation
and deflation matched one another. Fitting the mean of these datapoints to a polynomial
trendline gave the following output equation describing balloon diameter (y) in terms of
volume (x), with an R2 value of 0.98:
Y = −0.017x2 + 0.149x+ 0.738
5.4.3.1 An osmotic pump was not sufficient to inflate the balloon
This part of the study used a 2F balloon catheter, affixed to PE-60 tubing, which was in
turn affixed to an Alzet osmotic pump (Figure 5.20). Based on the equation corresponding
balloon volume and diameter, and knowing the dispensing rate of the pump from the
manufacturers details (0.25 µL per hour) it was estimated that after one week inflation
(168 hours), 42 µL would have been added into the balloon. This would have resulted in
a theoretical diameter of approximately 4 mm (Figure 5.21). However, over the course of
one week attached to the pump, the balloon diameter did not increase.
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Figure 5.19: Volume-diameter inflation and deflation mechanics of a 2F balloon catheter. A 2F
balloon catheter was inflated in 1 µL increments up to a volume of 50 µL, measuring diameter
using a graticule and microscope. The system was then deflated in increments of 5 µL, similarly
measuring diameter. Inflation/deflation 1 began when the sides of the balloon were straight.
Conversely, inflation/deflation 2 began when the balloon was completely empty.
Figure 5.20: Annotated photograph of osmotic pump setup with balloon catheter. The osmotic
pump (Alzet 1002 model) had to be connected to 3F polyethylene tubing; which was subsequently
connected to the 2F balloon catheter. Seals were made using silicone 3140. The osmotic-pump
3F catheter tubing seal is not annotated in the photograph, but this join was also sealed with
silicone 3140.
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Figure 5.21: Predicted and measured balloon diameter of 2F catheter connected to osmotic
mini pump. The whole system was placed in PBS at 37oC for one week, with regular
measurements of the balloon diameter. Predicted balloon diameter values were based on a
previous study using a Hamilton syringe to add volume to the same catheter system.
5.4.3.2 Over 3 injections, 7.5 µL (a total of 22.5 µL) matched the end diameter of
2.8 mm
The catheter and 22G venous cannula system, with injection port, was used for this part
of the study (Figure 5.22). The aim was to understand how repeat injection of various
volumes resulted in changes in balloon diameter. The injection process (inserting needle,
adding volume, removing needle) was repeated three times. Volumes dispensed ranged
from 6 µL to 10 µL per injection. The aim was to achieve a diameter of 2.8 mm (matching
that used in previous studies) after three repeat injections, equating to T9 vertebral canal
stenosis of approximately 75%. This was achieved using a volume of 7.5 µL per injection
(Figure 5.23). Diameter was maintained when the needle was removed from the system,
but dropped when the needle was subsequently added back into the system.
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Figure 5.22: Annotated photograph of injection port setup with balloon catheter.
Figure 5.23: Balloon catheter diameter when inflated with various volumes over repeat
injections with an injection port. The 2F balloon was subsequently inflated using repeat
injections through the slip tip injection port using various volumes. Diameter was measured with
an aim of 2.8 mm after three repeat injections. Results shown are from one catheter setup only,
except for 7.5 µL where two setups were tested.
179
Chapter 5. In-vivo NTSCI model development
5.5 Discussion
It was hypothesised that a ventral balloon catheter lesion (method developed by IEM,
Prague, Czechia) could induce TSCI, and be adapted to induce injury over a longer
timescale (NTSCI). This hypothesis was tested by evaluating the histopathology of lesions
in a rat (T8) using the ventral balloon catheter lesion in a TSCI context. Subsequently,
work was carried out to define the optimum compression extent of the system by
evaluating both rat vertebral column dimensions, and geometry of the balloon itself with
changing volume. Tests were then carried out in-vitro to adapt the balloon catheter for
use in NTSCI implantation studies, evaluating the diameter of the balloon over a period
of two to three days. Three days in a rat is equivalent to approximately three months in
man, mimicking the prolonged timescale of NTSCI (Andreollo et al., 2012; ?).
Balloon catheters have been used in dorsal TSCI studies, to induce histological and
functional deficits at T8 to T9 spinal cord level. A laminotomy or partial laminectomy is
performed at spinal cord level T10, and a 2F Fogarty balloon catheter is introduced, then
advanced cranially 1 cm to reach spinal cord level T8 to T9 (as confirmed by imaging by
Martin et al. (1992); Chung et al. (2013)). Benefits include only a partial laminectomy or
laminotomy, and no need to stabilise vertebrae using forceps, which minimises soft and
bone tissue damage. Further, the lesion site itself is closed, which more closely mimics
the human condition. This is in contrast to weight drop or impactor studies where the
lesion site is open. The lesion severity for both early (5 days) and chronic (up to 7 weeks)
outcomes can be controlled using the volume of the balloon, and a dose response curve for
the dorsal balloon lesion has been established (Martin et al., 1992; Vanicky et al., 2001;
Lonjon et al., 2010; Chung et al., 2013). At spinal cord level T8/T9, a volume of 15 µL
was determined to cause an injury which had the capacity to both improve or deteriorate
(Vanicky et al., 2001).
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5.5.1 Ventro-Lateral Balloon Spinal Cord Lesion
A ventral TSCI was induced at spinal cord level T8/9 using a balloon catheter lesion,
in four animals. Two of these had a lesion with a volume of 12.5 µL, and two with 15
µL. All four animals survived the surgery. Both volumes of 12.5 and 15 µL showed a
clear histological lesion site. Functional testing was not carried out herein, and further
characterisation of ventro-lateral balloon catheter traumatic spinal cord lesions are being
undertaken by collaborators in Prague.
In this study, transverse sections of spinal cords at one week post-injury showed
significant disruption to the central canal, white matter and grey matter for both balloon
volumes at the lesion epicentre. Due to tissue damage during perfusion or histological
preparation, one of the animals injured with 12.5 µL had to be excluded from histological
assessment. In the animal with a 12.5 µL lesion there was a greater area of normal white
matter parenchyma at the epicentre than in the two animals with a 15 µL lesion.
The cross-sectional area of the spinal cord was evaluated within 10 mm of the
epicentre (5 mm rostral, 5 mm caudal). This distance was decided based upon the balloon
length itself (5.5 mm). The greater balloon volume induced a larger lesion size (i.e.
smaller cross-sectional area) at the epicentre ± 1 mm rostro-caudally. No statistics could
be undertaken due to the N of 1 in the 12.5 µL group. Evaluating the images of the
spinal cord, damage was greater in the 15 µL lesion group both at the epicentre and over
a wider rostro-caudal distance from the epicentre. However, this was not reflected in
the cross-sectional area results since the H&E staining used does not distinguish normal
and damaged tissue, only the presence of tissue. Alternative stains such as fast blue
could distinguish white matter parenchyma from other tissues (grey matter parenchyma,
connective tissue, inflammatory cell infiltrates).
Remaining cellular material in the spinal cord contained high density inflammatory
and fibrotic cells centrally, whereas the surrounding tissue contained cystic cavities with
cellular debris and macrophages. Similar findings were observed in dorsal weight drop
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contusion models of TSCI and balloon catheter models, with ablation of grey matter,
presence of cellular debris, minimal haemorrhage, and development of a cystic cavity at
one week (Mao et al., 2016; Sutherland et al., 2016). In dorsal TSCI balloon catheter
studies, a similar pathology was identified, with increasing tissue disruption and lesion
extension with greater volumes (Vanicky et al., 2001; Lonjon et al., 2010; Chung et al.,
2013). Where white matter was present in a transverse section with significant tissue
damage, vacuolisation was apparent. This was also in keeping with other dorsal TSCI
balloon catheter studies (Martin et al., 1992; Chung et al., 2013).
Across all three animals, there was a greater proportion of tissue stained with GFAP
and CS-56 at the epicentre than rostrally and caudally. There was no difference observed
in GFAP or CS-56 staining between balloon volumes; this is likely to be due to the low
N numbers in each group. The increase in GFAP-stained area directly reflects reactive
astrogliosis at the lesion epicentre, which was not present in the rest of the spinal cord.
Reactive gliosis is core to the pathology of TSCI both clinically and in-vivo, as part of the
formation of the glial scar (Norenberg et al., 2004; Sofroniew and Vinters, 2010; Wanner
et al., 2013; Hol and Pekny, 2015; Alizadeh et al., 2019). Although several studies have
used a 2F balloon catheter to induce TSCI in rats, only two have incorporated evaluation
of reactive gliosis or the fibrotic scar (Martin et al., 1992; Chung et al., 2013). In both
of these studies, fibrotic scar formation and an increase in GFAP area was observed at
the lesion epicentre, but not quantified in either case. The findings of the research herein
validate that the ventral 2F balloon catheter method of causing TSCI can induce reactive
astrogliosis at the injury epicentre, whilst the rest of the spinal cord remains quiescent, in
keeping with the wider TSCI literature.
In the research herein, a greater area was stained with CS-56 at the epicentre than at
intact rostral and caudal regions. Chondroitin sulphate proteoglycans (CSPGs, stained by
CS-56) are a core component of the glial scar, and are produced by reactive astrocytes and
other spinal cord cells after injury (Buss et al., 2009; Anderson et al., 2016; Sofroniew,
2018). For example, after hemisection injury in a rat model, CS-56 expression increased
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between day 4 and day 14 (Tachi et al., 2015), corresponding with glial scar formation.
The CSPG molecules are components of the perineuronal nets which usually surround
neurones, and restrict plasticity (Sobel, 1998; Kwok et al., 2011; Burnside and Bradbury,
2014; Haggerty et al., 2017; Irvine and Kwok, 2018). Such is the effect of over-expression
of CSPGs in spinal cord injury to inhibit neuronal regeneration, that enzymes which digest
CSPGs have shown potential in treatment (Bradbury et al., 2002; Muir et al., 2019). The
findings of increased CSPG expression at the injury epicentre compared to intact rostral
and caudal levels further validate the experimental model.
Lesion extension was observed rostral and caudal to the injury epicentre,
predominantly comprising a cystic cavity with cellular debris in the dorsal funiculus of
the white matter. The extent of lesion extension in both groups was greater than the
length of the balloon itself, and therefore was due to biological extension as opposed to
mechanically induced by the balloon. Lesion extension was greater in the 15 µL group
compared with the 12.5 µL group, although statistics could not be undertaken. This
finding is in keeping with previous studies where a greater volume of the balloon induced
a longer (rostro-caudal) lesion (Vanicky et al., 2001; Lonjon et al., 2010; Chung et al.,
2013). A similar shape and location cavity was observed in these previous studies where
the balloon catheter TSCI model was used in a dorsal lesion (Martin et al., 1992; Lonjon
et al., 2010; Chung et al., 2013). There are several explanations for the location of this
cavity being in the dorsal funiculus rather than ventrally. The cavity could be inherent to
the severe balloon-induced TSCI, independent of whether the injury itself was dorsal or
ventral. Alternatively, the cavity could be dependent on direction and the balloon could
have been positioned dorsally instead of ventrally in all of the animals tested. Finally, the
cavity could be as a result of damage occurring during balloon insertion or removal, as
opposed to inflation of the balloon. These explanations could be tested in future studies
using imaging techniques to identify balloon position, or by creating an injury with a
smaller volume to identify better the position of the balloon at the lesion epicentre. Ideally,
in future studies, the catheter should remain in place in the spinal canal until the end of
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the experiment (perfusion). This would prevent damage occurring when the catheter is
removed.
Due of the extent of tissue disruption at the lesion epicentre, it was not apparent
whether the injury induced was in fact ventral or dorsal to the spinal cord. The low number
of animals per group in this study mean that this study could not fully characterise the
lesion. Further work is being carried out by the developers of the method at IEM, Prague.
In this study, a lesion was clearly present in all four animals, which was similar to that
seen in other TSCI studies. Therefore, the balloon catheter method was appropriate for
inducing spinal cord injury in a rat model.
In relation to the volumes used, a 12.5 µL lesion resulted in less tissue damage than
a 15 µL lesion. However, statistical analysis could not be fully undertaken due to the N of
1 in the 12.5 µL group. Vanicky et al. (2001) deduced that a 15 µL lesion was optimal as
it allowed for determining both deterioration and improvement of the lesion. For reasons
of continuity with this study and the wider literature, future NTSCI studies will match the
diameter of a 15 µL 2F balloon catheter. It will be important to determine the geometry
of this volume balloon in relation to the vertebral canal.
5.5.2 Evaluation of Rodent Spinal Anatomy to Provide Direction for
in-vivo Studies
Several studies have used balloon catheters to induce spinal cord injury, relying on
increasing volume to compress the spinal cord. In the previous TSCI balloon catheter
study, both volumes tested (12.5 µL and 15 µL, at spinal cord level T8/9, vertebral level
T8) caused a histological defect, but the compression extent was unknown. In NTSCI,
compression extent increases over time. Initially, this does not result in symptoms, but
after compression exceeds a tissue threshold, tissue damage and symptoms result. The
exact value of this threshold is not well established clinically. Compression extent is
determined by the area of the injury-causing object in relation to the geometry of the
vertebral column. Understanding these two measurements is important to determine
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compression extent. This study carried out a CT scan of a rat vertebral column in order to
better understand compression extent.
Lumbar measurements were compared with a previously published study to
determine accuracy of the findings herein (Jaumard et al., 2015). Jaumard used a different
subspecies and gender of rat, and only evaluated the lumbar spine. Therefore percent
changes through the lumbar spine were compared instead of absolute values (normalised
to L1) (Figure 5.24). It is worth noting that the rat spinal cord terminates at approximately
L3 to L4 (Hebel and Stromberg, 1976; Gelderd and Chopin, 1977).
Figure 5.24: Assessment of reproducibility and validation of lumbar vertebral canal width
dimensions. Left: mean ± 95% CI measurements of lumbar vertebral canal width, over technical
repeats (n=3). Right: comparison of proportional changes in vertebral canal width in the lumbar
vertebrae compared with L1/2 compared with previously published data (Jaumard et al., 2015)
The 95% confidence intervals for all data ranged from 0.003 to 0.201 mm.
Dimensions were evaluated in the original x-plane of the CT scan; as well as altering
the x-plane position to mimic the anatomical plane. Using dimensions from the original
CT plane caused a consistent over-estimation of vertebral canal width of 5 ± 3% (mean
± SEM), and an under-estimation of vertebral canal depth of 9 ± 2%, compared with
a previous study (Jaumard et al., 2015). Conversely, when measurements were taken
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in the anatomical plane, changes were -1 ± 1% for vertebral canal width and -3 ±
2% vertebral canal depth compared with the previous study. This gives confidence that
measurements were accurate to within 5% of previously reported values. Furthermore,
the narrow confidence intervals on technical repeats using this method are indicative
of its reliability. The experiment was used to gain an approximate understanding of
vertebral canal dimensions, which can guide future studies. As such, only one animal
was evaluated. For a more thorough investigation, more animals would be required.
Data of dimensions of the rat spinal cord exists, as does information on how the
vertebral levels and spinal cord levels align (Hebel and Stromberg, 1976; Watson et al.,
2009). By comparing this information with the vertebral canal measurements herein, on
average 75% of the vertebral canal is occupied by spinal cord (Table 5.3). Shrinkage of
the spinal cord measurements was minimised through the use of CryoJane tape (Watson
et al., 2009). Nevertheless, shrinkage could have still occurred and therefore the value of
75% described above may be an underestimate. Further, this is only an approximation as
the strain, age and gender of animals used for each piece of information may differ. If
vertebral canal stenosis to 25% of cross-sectional area induces symptoms, the spinal cord
must occupy more than 75% of the total cross-sectional area. These findings should be
further validated through experiments.
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Table 5.3: Dimensions of vertebral canal and spinal cord in the lower thoracic region. Alignment between vertebral and spinal cord
level calculated from Hebel and Stromberg (1976). Vertebral canal measurements were obtained herein. Spinal cord measurements taken
from frozen sections in Watson et al. (2009).
Level Cord Dimensions Vertebral Canal Dimensions Comparison
(Watson et al., 2009) (Hebel & Stromberg, 1976)
Vertebral Spinal
cord
Lateral
(mm)
Ventro-dorsal
(mm)
Cross-
sectional area
(mm2)
Lateral
(mm)
Ventro-dorsal
(mm)
Cross-
sectional area
(mm2)
Cord vs Canal
(%)
T5 T6 3.18 2.53 6.32 3.50 3.10 8.52 74.15
T6 T7 3.03 2.29 5.45 3.30 3.10 8.03 67.83
T7 T8 2.87 2.34 5.27 3.30 3.40 8.81 59.86
T8 T9 2.86 2.34 5.26 3.30 3.40 8.81 59.65
T9 T10 2.92 2.39 5.48 3.50 3.00 8.25 66.46
T10 T11 2.86 2.45 5.50 3.10 2.90 7.06 77.94
T10 T12 3.37 2.48 6.56 3.10 2.90 7.06 92.96
T11 T12 3.37 2.48 6.56 3.30 2.80 7.26 90.45
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5.5.2.1 Implications of Findings for NTSCI Studies
TSCI is induced by a high velocity high impact mechanical insult to the spinal cord,
resulting in gross haemorrhage and tissue damage from the primary injury, which is
followed by a secondary injury cascade (Rowland et al., 2008; Alizadeh et al., 2019).
Conversely, NTSCI is characterised by chronic compression of the spinal cord with
increasing stenosis. There is no clear distinction between primary and secondary injury
(Karadimas et al., 2015).
One method used in the literature to induce NTSCI in-vivo is by inserting a polymer
into the vertebral canal, which absorbs water and increases in volume, resulting in spinal
cord compression over an increased timeframe compared to TSCI (Kurokawa et al., 2011;
Hu et al., 2011; Long et al., 2013; Xu et al., 2017). Only two rat NTSCI studies directly
evaluated the change in geometry of the polymer and functional deficits. Yang et al.
(2015) measured the cross-sectional area (x and z planes) of a polymer at T8/9 to increase
from 2 to 8.4 mm2, and corresponded this with a decrease in spinal cord cross-sectional
area of 70%, and both functional and histological changes. However, the timeframe over
which the material expansion occurered was not noted. Kim et al. (2004) used a similar
method at C5/6 and with an increase in volume from 10.4 to 13 mm3 over 24 hours, spinal
cord cross-sectional area reduced by 11%, and no functional deficits were observed over
5 weeks. These studies give some insight into the degree of spinal cord compression
required to elicit functional deficits in animal models of NTSCI. The timeframe required
to induce NTSCI as opposed to TSCI is not established in these, or other studies.
There is a paucity of literature describing canal stenosis and the resulting functional
deficits. To better understand the effect of compression extent in NTSCI, four ideal canal
stenosis points should be incorporated at distinct timepoints:
• 0% canal stenosis, equivalent to 0 mm2 at T7/8: Baseline value
• 25% canal stenosis, 2.20 mm2 at T7/8: based on the evaluation of spinal cord and
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vertebral column area in Table 5.3, this should cause minimal compression of the
spinal cord itself.
• 50% canal stenosis, 4.41 mm2 at T7/8: clinical studies have identified that
somewhere between 25 and 50% spinal cord compression induces symptoms. If
the spinal cord takes up 75% of the vertebral canal, these values equate to between
43.75 and 62.5% canal occlusion. However, Kim et al. (2004) found that 48%
occlusion of the vertebral canal did not cause functional deficits. To further
investigate whether 50% canal occlusion does cause damage to the spinal cord and
symptoms, canal stenosis of 50% should be further investigated.
• >75% canal stenosis, 6.61 mm2 at T7/8: The final canal stenosis value of 75%
exceeds the minimum symptomatic canal occlusion identified in man. Ideally,
this maximum canal occlusion should match that of previous traumatic 2F Fogarty
balloon catheter studies, i.e. using a balloon inflated with 15 µL.
These canal occlusion values need to be characterised in terms of 2F Fogarty balloon
catheter volume. Further, a method had to be developed to inflated the balloon in
the NTSCI context must be able to achieve this increase in cross-sectional area over a
relevant time frame in the range of days in a rat, which corresponds to months in humans
(Andreollo et al., 2012; ?).
5.5.3 Evaluation of Balloon Catheter Implantation System
As described previously, understanding compression extent relies on both vertebral canal
and balloon volume dimensions in balloon catheter models of spinal cord injury. Balloon
catheters have been previously used in in-vivo models of traumatic spinal cord injury in
both rats and rabbits, with several rat studies at the T8/9 spinal cord level (Martin et al.,
1992; Vanicky et al., 2001; Sedy et al., 2008; Lonjon et al., 2010; Pedram et al., 2010).
The volume and corresponding diameter of the balloon has not been fully characterised
in these studies.
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The initial, deflated balloon diameter was 0.667 mm (according to manufacturers
details). This equates to 8% of T7/8 vertebral canal. This is greater than the ideal of
0%, but should not compress the spinal cord, and therefore, is suitable for the first cross-
sectional area of 0% defined in the previous section. Volumes of 12.5 and 15 µL, used in
the preliminary traumatic injury study, equated to 63 and 72% canal stenosis respectively,
and caused significant disruption to the spinal cord.
The herein study showed that in a T7/8 (T8/9 spinal cord level) ventro-lateral
lesion, 15 µL produced a consistent histological defect similar to TSCI. For improved
understanding of the model, balloon diameter had to be characterised with respect to
volume. Using a simple inflation study, the setup described had a diameter of 2.8 mm at a
volume of 15 µL. A diameter of 2.8 mm with a volume of 15 µL is similar to the 2.5 mm
(Lonjon et al., 2010) and approximate 3 mm (estimated from Figure 2 in Vanicky et al.
(2001)) previously reported. This volume equated to a cross-sectional area of 6.16 mm2,
and approximate percent vertebral canal stenosis of 72% based on previous experiment.
This value of canal stenosis is slightly less than that defined in the previous subsection for
maximal compression. However, using the cross-sectional area of 6.16 mm2 (volume of
15 µL) will facilitate comparison between outcomes in previous studies.
To achieve the intermediate 25 and 50% canal stenosis, and model NTSCI as opposed
to TSCI, the balloon system had to be adapted to inflation over time as opposed to one
acute inflation.
5.5.4 Development of NTSCI Balloon Catheter Method
Use of the osmotic pump would have been optimal to induce NTSCI, since it would mean
the balloon inflated slowly over the course of days without manual input. However, when
the osmotic pump was attached to the balloon catheter, the balloon did not inflate. The
pressure needed to keep the balloon inflated is inversely proportional to the radius. With
a low radius, the osmotic gradient produced by the osmotic pump to expel fluid was less
than the pressure required to fill the balloon, and thus it did not expand.
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As an alternative method, an injection port was developed and connected to the
balloon catheter. Injection ports have been used in venous injection studies (Fiebig et al.,
2013; Figueiredo et al., 2015). The injection port facilitated manual filling of the balloon
over a controlled time course. Repeat injection mechanics were first established in-vitro
to determine how much volume was required per injection over three repeat injections
to achieve a final diameter of 2.8 mm, matching that of the previous experiment. Three
injections of 7.5 µL each was optimal of the conditions tested. The total volume injected
into the system (22.5 µL) was greater with repeat injections than with a single injection
(15 µL) due to loss from the system upon needle insertion. This loss may have been due
to air in the system that could not be removed, or due to pressure differentials within the
syringe and balloon causing the balloon to deflate slightly.
Using three injections, the increase in cross-sectional area and canal stenosis were as
follows:
• 0 injections, 0.38 mm2, 8% canal stenosis
• 1 injection, 2.38 mm2, 28% canal stenosis
• 2 injections, 4.52 mm2, 53% canal stenosis
• 3 injections, 6.25 mm2, 73% canal stenosis
5.5.5 Conclusion
This chapter has completed work towards the aims previously described (Table 5.4). This
includes characterisation of a TSCI ventral balloon catheter lesion in relation to the wider
literature. The work described herein has evaluated the dimensions of the vertebral canal
in order to give direction for future NTSCI stenosis studies. Further, the 2F balloon
catheter system has been evaluated and a method has been developed to used this system
in an NTSCI context.
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Table 5.4: Conclusions of Chapter 5: In-vivo model development
Aim Objective Result and Implications
D
ev
el
op
in
-v
iv
o
m
od
el
s
of
ve
nt
ra
lN
T
SC
I
Characterise
histology of balloon
catheter ventral
lesion in TSCI
A volume of 15 µL caused a more severe lesion than 12.5
µL, in terms of increased tissue disruption over an
increased rostro-caudal length.
GFAP and CS-56 expression increased at the epicentre
compared to the closest intact rostral and caudal region;
this indicated glial scar formation as expected.
It could not be determined whether the injury was
induced ventrally or dorsally to the cord, due to the
extent of tissue damage and low N Number.
Future studies should match the diameter of a 15 µL 2F
balloon, to facilitate comparison with other research.q
In NTSCI studies, the catheters should not be removed
from the spinal canal during the study itself, only at
dissection. This will allow evaluation of the balloon
injury itself as opposed to any damage caused by
removing the catheter.
Evaluate the
diameter of the rat
vertebral canal from
T6 to T13
Vertebral canal stenosis extent and the effects on spinal
cord compression and functional effects are not
established in the literature for TSCI or NTSCI.q
At spinal levels T8, T9 and T10, vertebral canal
cross-sectional area was 8.81, 8.25 and 7.06 mm2.
Assess 2F Fogarty
balloon inflation
volume with
diameter
In a simple inflation study adding 1 µL at a time to the
balloon catheter, a volume of 15 µL equated to a
diameter of 2.8 mm. Assuming the balloon is a sphere,
this is a cross-sectional area of 6.16 mm2.q
There was an effect of having the balloon system
completely empty before inflation, compared to filled
with water before balloon inflation. Future studies should
begin with the system filled with water.
Future NTSCI studies should aim to recapitulate the
same ultimate cross-sectional area as 15 µL in a
traumatic balloon lesion (6.16 mm2).
Develop method for
2F Fogarty balloon
inflation model for a
non-traumatic injury
context
An osmotic pump could not inflate the balloon.q
Three injections of 7.5 µL through an injection port
resulted in cross-sectional areas corresponding to 8%,
28%, 53% and 73% canal stenosis at T7/8 (the latter of
which was 6.16 mm2).
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6.1 Introduction
Understanding of the pathology of non-traumatic spinal cord injuries is limited. This is
in contrast to traumatic spinal cord injuries, where a core primary and secondary injury
cascade have been established (Rowland et al., 2008; Alizadeh et al., 2019). This study
concentrated on developing a rat model of NTSCI, incorporating a ventral graded lesion
which increased in extent over time. To achieve this, a balloon catheter was implanted
into the vertebral canal using a ventro-lateral method, and balloon was inflated based on
the stenosis extents described in the previous chapter. This took place with one increase
in stenosis (inflation) per day, over a total of three days.
There are three key factors characterising NTSCI, and distinguishing it from TSCI,
as described by Karadimas et al. (2015):
1. No acute mechanical insult, slow velocity compression
2. Absence of gross haemorrhagic necrosis
3. Chronic and progressive nature (likely induces compensatory mechanisms)
Clinical cadaver studies on patients with NTSCI are limited in number, since NTSCI
is secondary to other underlying diseases and is not the cause of death. Those which
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have been undertaken focus on cervical NTSCI (spondylotic myelopathy). In cadaver
studies, glial scars are not reported (Someya et al., 2011). The hypothesised pathological
mechanism in NTSCI is cord compression resulting in compression of the vasculature
structure and resulting in ischaemia (Shingu et al., 1989; Kameyama and Hashizume,
2003; Baptiste and Fehlings, 2006). However, experimental studies supporting this are
lacking (Karadimas et al., 2015). One study evaluating six post-mortems of patients with
metastatic cord compression observed demyelination, apoptosis of oligodendrocytes and
neurones, and cystic necrosis in severe compression (Newcombe et al., 2015). There is
also evidence of neuroinflammation, corresponding to symptom severity (Yu et al., 2011;
Du et al., 2018). The mechanism of how slow velocity spinal cord compression results in
physiological changes remains unclear, as do the cellular and tissue outcomes themselves.
Animal studies allow greater evaluation of histological and functional changes in
NTSCI. Long et al. (2013) implanted an agarose gel polymer into the epidural space
at spinal cord level C5/6 in a rat. The polymer had been modified to expand to seven
times its original volume over three timescales: immediately; over two hours; or over
one day. In the instant compression group, within 24 hours the BBB score had reduced
to 6. Conversely, for the other two groups the BBB score was 15.6 after 24 hours,
and 17 after one week. In terms of histological outputs, in the immediate compression
group, haemorrhage, central canal deformation and oedema were observed within 24
hours. Conversely, in the two gradual compression groups, spinal cord central canal
deformation was observed but haemorrhage, necrosis, and oedema were not. These
NTSCI histological findings have been reported in other in-vivo studies using a screw
or line around the spinal cord, finding spinal cord compression, white matter degradation
and vacuolisation, and central canal deformation (Kubota et al., 2011; Sun et al., 2016).
Although the methods and spinal cord levels are different to those used herein,
previous NTSCI studies highlight that with the same compression extent, and different
timeframes (TSCI vs NTSCI), functional and histological outcomes are different.
There are limitations to previous NTSCI in-vivo models, including the timeframe
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being too long (line around the spinal cord), too fast and difficult to control (expanding
material), and too invasive (screw). Further, the capacity to induce a lesion from a ventral
aspect would show greater affinity with clinical NTSCI (Ferrara, 2012; Tetreault et al.,
2015; Martin et al., 2018).
In the balloon catheter model, these factors are all controlled: a moderate timeframe,
control over the balloon inflation via volume, and minimally invasive, requiring only a
partial laminectomy. Further, the balloon catheter model has also been used in a dorsal
and traumatic method to evaluate the efficacy of novel treatments, including mesenchymal
stem cells, curcumin, and induced pluripotent neural progenitor cells in a hydrogel
construct (Lonjon et al., 2010; Ruzicka et al., 2018, 2019). In a traumatic context, the
method is well established and reproducible.
It was hypothesised that NTSCI could be modelled in rats using an implanted balloon
catheter and cannula injection port, which was characterised in the previous chapter.
Upon implantation of the balloon catheter, there would be minimal functional deficit.
After each inflation of the balloon, functional deficit would increase in magnitude. A
functional deficit would be sustained over the duration of the study. Further, histological
findings from the compressed spinal cord would not show gross haemorrhage, oedema,
parenchyma ablation, or necrosis, and instead show compression and a change in shape
of the spinal cord with damage predominantly affecting the white matter.
6.2 Aims
The aims of this chapter were to characterise responses in the in-vivo model of NTSCI,
in order to better understand the pathobiological mechanisms in NTSCI. The aims of this
chapter are in the context of the whole project (Figure 6.1). Specific objectives of this
chapter:
1. To assess the histological and functional outcomes which occur after long term
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spinal cord compression in-vivo:
A Surgical implantation of the balloon and subsequent inflation over 3 days, and
monitoring for 14 days post-maximal inflation.
B Characterise functional deficits using BBB scale.
C Characterise histological outputs using H&E and immunohistochemistry.
i. Shape and area of tissue at the lesion site
ii. Changes to the spinal cord parenchyma
iii. Evaluation of astrocyte reactivity using GFAP and CSPG staining
iv. Assess demyelination using myelin basic protein (MBP) labelling
v. Changes to the vasculature using RECA1 labelling
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Figure 6.1: Hypothesis and research question in Chapter 6, relating to aims of the whole study.
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6.3 Experimental Setup
6.3.1 Surgical Approach and Behavioural Analysis
The study described herein had three aims: to determine whether the balloon catheter
system could be implanted without host response, to determine whether a ventral
lesion could be reliably established, and to characterise whether the balloon catheter
system could be used to produce a non-traumatic spinal cord injury (histologically and
functionally).
A total of ten female Wistar rats (200 to 250 g) were operated upon in two cohorts.
A total of three animals were shams, and their balloon catheters were not inflated. The
patency of each balloon catheter was tested immediately prior to implantation. Those
implanted into injury group animals were patent at this point.
The balloon-catheter system was implanted so that the balloon position was
approximately T8/9 spinal cord level (vertebral level T7/8, Figure 6.2). Additionally,
for a transcutaneous injection port, another 1 cm incision was made at the shoulder blade
level. Blunt dissection was used to separate the skin from connective tissue in the thoracic
region, and up to the rostral incision. The catheter was affixed in place at T10 using
resorbable Vicryl sutures into the spinal column musculature. Tubing connecting the
balloon to the injection port was fed subcutaneously from T10 to the incision between the
shoulder blades. The port was fed through the skin here and held in place using Vetbond
surgical adhesive. Subsequently, the skin was closed using Prolene sutures. In sham
animals, the port was positioned subcutaneously rather than transcutaneously.
The balloon catheter length was 15 cm, with the cannula and port being an additional
5 cm. The balloon was inflated with 7.5 µL per day on days 1, 2 and 3 post-surgery.
each animal was anaesthetised briefly using 5% isoflurane in oxygen at 2 L.min-1.
Subsequently, the animal was moved on to a face mask with 2% isoflurane in oxygen
at 2 L.min-1. A 50 µL airtight Hamilton syringe was filled with sterile water, and a 30G
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needle was attached. The needle was pushed through the silicone seal on the injection
port, and the volume required was injected into the system in one smooth motion. The
needle was removed, any observations were noted, and isoflurane was turned off. Once
the animal had recovered from anaesthesia, they were returned to their home cage.
Figure 6.2: Schematic diagram of key stages in balloon catheter implantation surgery for
inducing spinal cord injury. Surgery was undertaken in female adult Wistar rats. A: the native
tissue in the surgical region. B: Laminectomy was performed at T10, and balloon catheter
inserted ventro-laterally in the vertebral canal caudally up to 1 cm below the caudal end of the
balloon (previously marked on the catheter). The catheter was held in place by resorbable
sutures around a silicone bubble. C: The catheter was fed up to the region of the shoulder blades
subcutaneously, where a further incision was made in the skin to allow for the injection port. The
port was fitted using sutures and vetbond adhesive.
For the total duration of the experiment, functional locomotor behaviour was
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evaluated using the open-field BBB score system (Appendix E). For the first six days,
this was undertaken daily in the mornings, prior to balloon inflation in the afternoons.
For example, the third balloon inflation occurred on day 3 post-initial surgery, then the
subsequent BBB test was undertaken on the morning of day 4. Subsequently, the test
was carried out every other day until 14 days post maximal inflation (18 days post initial
surgery), when animals were terminated using an overdose of intra-peritoneal anaesthetic,
perfused with PFA and spinal cords dissected.
6.3.2 Histological Analysis
At 2 weeks post-injury, animals were trans-cardially perfused and fixed with 4% (w/v)
PFA. Spinals cords were excised and stored in 4% (w/v) PFA for a further 24 hours,
before being stored in 30% (w/v) sucrose and 0.1% (v/v) sodium azide for up to 3 months
before histology was undertaken.
For histological evaluation, spinal cords were cut into transverse slices
approximately 2 mm thick, which were then embedded into OCT and stored at -80oC.
Transverse slices were serially sectioned at 40 µm using a cryostat, and stored at -20oC.
H&E staining was undertaken every 1 mm along the length of the spinal cord to evaluate
cross-sectional area and identify the injury site.
Subsequently, immunohistochemistry was undertaken at three regions: rostral to the
injury epicentre, at the injury epicentre, and caudal to the injury epicentre. Sections
were stained with GFAP (astrocytes), CS-56 (chondroitin sulphate proteoglycans), MBP
(myelin), and RECA-1 (endothelial cells). Three sections were imaged at each region
per animal using a confocal microscope, and the laser settings were kept the same
between all images. These images were then analysed using FIJI (ImageJ). An automated
macro determined the area stained with each antibody, and this area was calculated as a
percentage of the overall tissue area observed on the nearest H&E stained section. Dura
and other meninges were present on some of the sections, but were excluded from analysis
by only evaluating objects less than 0.01 mm2.
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6.4 Results
6.4.1 Changes and mass and complications observed were different
in shams and injured animals
Of the ten animals operated upon, none required bladder expression until the third balloon
inflation (diameter 2.8 mm, total volume 22.5 µL), i.e. neural circuits controlling bladder
expression were not damaged until this point. After this, three of the animals (animals
4, 5 and 6) required bladder expression twice daily for up to 10 days. One of these
(animal 6) had haematuria for 2 days following maximal inflation. The greatest reduction
in weight was seen in animal 6 (-13.0%, day 6, Figure 6.3A), who had the smallest mass
initially (207 g on day of surgery). The weight of the injured animals reduced by -3.73
± 1.93% by day 6 (mean ± S.E.M.), corresponding with 4 days post maximal inflation
(Figure 6.3B). The other injured animals weighed at least 215 g on the day of surgery, and
maximum weight loss was -7.95%. After 9 days post-surgery, the mass of the animals
recovered to pre-operative levels, and exceeded pre-operative levels for the remainder of
the timecourse.
A total of 5 of the 7 injured animals (6, 7, 8, 9 and 10) in the injury group had
irritation around their port (Figure 6.4). These were either destroyed by the animal, or cut
off manually, and the wound sutured closed. This occurred between one and two weeks
post-surgery.
At perfusion, all of the injured animals’ catheters remained within the vertebral canal.
The Vicryl sutures had not degraded substantially and were still visible. At perfusion, all
of the balloons were intact. One had a volume of 4.5 µL remaining, with a diameter of
1.7 mm.
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Figure 6.3: Percent change in weight of animals after spinal cord injury using repeat
injections and balloon catheter lesion. Animals underwent a T10 laminectomy and balloon
catheter implantation rostral to this level. Day 0 was post-surgery, but prior to balloon inflation.
Day 1 had one balloon inflation, day 2 had two inflations, day 3 onwards had the maximal three
inflations. A: individual animals, 1, 2 and 3 were shams. B: grouped into sham and injured, mean
± S.E.M.
Figure 6.4: Annotated photograph of animal 12 days after balloon catheter repeat injection
surgery. Animals underwent a T10 laminectomy and balloon catheter implantation rostral to this
level. Animals showed signs of skin irritation around the injection port from day 3 post-surgery.
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6.4.2 Open field locomotor score reduced with concurrent inflations,
but the scores varied
Motor function declined for each of the injured animals with each inflation (as measured
by the open field BBB test, Figure 6.5A). Animals were grouped based on functional
deficits observed (Figure 6.5B):
• Sham (no inflation): animals 1, 2 and 3
• Mild injury: animals 7, 8, 9 and 10
• Severe injury: animals 4, 5 and 6
Figure 6.5: Minimum open field locomotor scores of animals after balloon catheter spinal cord
injury. Animals underwent a T10 laminectomy and balloon catheter implantation rostral to this
level. Day 0 was post-surgery, but prior to balloon inflation. Inflations were undertaken 1x per
day on day 1, 2, and 3. Sham animals had the balloon inserted but not inflated (animals 1, 2 and
3). A: individual animals. B: grouped by BBB score, mean ± S.E.M.
Initially, one day after surgery (0 inflations), the mean BBB score was 18.0 ± 0.406
for all ten animals. This equated to a functional deficit of rotated paw position at lift off
only. On day 2 (1 inflation for injury groups), mean BBB score remained similar at 17.4
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± 0.50. In severely injured animals, the second inflation caused a reduction of 5 points on
the motor scale, and the third inflation reduced the BBB score to either 0 or 1, indicating
complete hindlimb paralysis. Recovery then took place over the remaining timecourse
of the experiment. In this severe injury group motor function plateaued at a BBB score
of 11 or 12; denoting full range of motion of hindlimbs and weight-supported plantar
stepping, but with no or occasional co-ordination (respectively). In animals with a mild
injury, the second inflation caused a reduction of approximately 2 points to a BBB score
of 16; denoting toe clearance only occurring 51-94% of the time, as well as paw rotation
at lift off. This remained constant at the 3rd inflation. Over the following two weeks,
motor function recovered to almost normal in the mild injury group. Sham animals did
not show decreased motor function after two or three inflations.
6.4.2.1 No consistent functional differences were observed between left and right
hindlimbs across injury groups
In sham injuries, there was a slight effect observed of greater function in the left hindlimb
than the right, but the variation was high (Figure 6.6). This effect was greater in animals
with a mild injury, and was observed between days 1 and 8 post-surgery. For severely
injured animals, this effect was only observed at day 6 post-surgery.
6.4.3 Severe injury resulted in a greater degree of compression and
histological damage than mild injury and sham groups
Sections taken every 1 mm were stained with H&E and their area evaluated. The results
of both studies were pooled together using the same groups described above. Animal 5
had to be excluded due to damage during dissection.
The transverse area of the spinal cord in shams was significantly greater than both
injury groups (Figure 6.7, p <0.05). The transverse area of the spinal cord in severe
injuries was significantly less than mild injuries (p <0.05). The greatest reduction in
cross-sectional area was observed at the epicentre for each group. The severe injury group
204
Chapter 6. Outcomes of NTSCI in-vivo Studies
Figure 6.6: The difference between left and right hindlimb open field locomotor scores after
NTSCI. Animals underwent a T10 laminectomy and balloon catheter implantation rostral to this
level. Day 0 was post-surgery, but prior to balloon inflation. Day 0 was post-surgery, but prior to
balloon inflation. Inflations were undertaken 1x per day on day 1, 2, and 3. Grouped by
maximum functional deficit. N=3 for sham, N=4 for mild injury, N=2 for severe injury.
had approximately 36% spinal cord compression compared to an intact sample, and the
mild injury group had 21% spinal cord compression.
Cross-sections of the spinal cord at the injury site allowed evaluation of both catheter
position and descriptions of the injury (Figure 6.8). In all groups, at the epicentre, the
white matter on the lateral right funiculus was compressed. This compression was greater
in mild injury groups, where the spinal cord tissue was a ’C’ shape, compared to a slightly
flattened oval of the sham group. In these two groups the ’H’ shape of the grey matter
remained observable, although was distorted in the mild injury group. The severe injury
group had even greater compression, affecting the dorsal and ventral funiculi, and the
grey matter. The ’C shape’ could be observed rostral and caudal to the severe lesion. In
the mild injury, and to a lesser extent in the sham injury, different areas were affected
rostrally and caudally. Caudal to the lesion the area of compression was more ventral,
whereas rostral to the injury the area of compression was more dorsal.
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Figure 6.7: Cross-sectional area of NTSCI rat spinal cord, normalised to 5 mm rostral from
the injury epicentre. Animals underwent a T10 laminectomy and balloon catheter implantation
at T8/9. This balloon was inflated over the course of three days to match a volume of 15 µL.
Sham animals (n=3) had implantation but no inflation. The injured animals were grouped into
mild (n=4) and severe (n=2) based on BBB score. Cross-sectional area was determined using 40
µm sections, 1 mm apart, stained with haematoxylin and eosin. Subsequently, area was
determined using an ImageJ macro.
Lesion extensions observed rostro-caudally in this study were 10 ± 0.58 mm (mean
± S.E.M) for sham animals, 14.5 ± 1.26 mm for animals with a mild injury, and 15.0
± 1.0 mm for animals with a severe injury. These differences between groups were not
significantly different (p >0.05).
Overall, after NTSCI, the spinal cords were deformed but the majority of the
parenchyma was intact, indicating no gross haemorrhagic necrosis had occurred. Spinal
cords after a severe injury had vacuoles at the epicentre of lesion in white matter, and in
nearby tissue (Figure 6.9). Further, at epicentre of severe injuries there was loss of grey
matter parenchyma and inflammatory cell infiltrate. In these severe lesions, from 2 mm to
5 mm caudal to the lesion, a dorsal white matter cavity was observed (Figure 6.10A). The
cavity was present at up to 6 mm caudal to the injury and 6 mm rostral. These findings
were not observed in any animal in the sham or mild injury groups (Figure 6.10B).
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Figure 6.8: Sample transverse sections of spinal cord from NTSCI balloon catheter lesions. Animals underwent a T10 laminectomy and
balloon catheter inflation at T8/9 over three days, with a maximum diameter to match a volume of 15 µL. Sham animals had the balloon
implanted but not inflated. Animals were perfused two weeks after the injury. Sections 40 µm thick were stained with H&E. Negative
distance values denote rostral to the epicentre, and positive distance values denote caudal. Scale bar = 1mm.
207
C
hapter6.O
utcom
es
ofN
T
SC
Iin-vivo
Studies
Figure 6.9: Histological H&E stained images from the epicentre of a severe NTSCI lesion. Showing cellular infiltration (above), and
white matter vacuoles (below). Animals underwent a T10 laminectomy and balloon catheter implantation at T8/9, and inflation to match
a diameter of a volume of 15 µL. Animals were perfused two weeks after the injury. Sections 40 µm thick were stained with H&E. Scale
bar for each image is in µm.
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Figure 6.10: Further histological H&E images from NTSCI lesions. A: cystic cavity 2 mm caudal to the lesion epicentre, severe lesion.
B: white matter in mild injury epicentre. Animals underwent a T10 laminectomy and balloon catheter inflation at T8/9 over three days,
with a maximum diameter to match a volume of 15 µL. Sham animals had the balloon implanted but not inflated. Animals were perfused
two weeks after the injury. Sections 40 µm thick were stained with H&E. Scale bar for each image is in µm.
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There was a positive trend between minimum motor function score and minimum
transverse cross-sectional area, although this was not linear (Figure 6.11). When ranked,
the Spearman correlation coefficient was 0.633, and the p value was 0.05.
Figure 6.11: The relationship between minimum open field locomotor score (BBB) and
minimum cross-sectional area (CSA) of the spinal cord. Animals underwent a T10 laminectomy
and balloon catheter inflation at T8/9 with a maximum diameter of 2.8 mm. Sham animals had
the system implanted but not inflated. Minimum cross-sectional area was determined using image
analysis of H&E stained transverse spinal cord sections. Linear trendline shown. N=2 for severe,
N=4 for mild, N=3 for sham.
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6.4.4 Differences were observed in GFAP and myelin labelling at the
epicentre of severe NTSCI injuries
6.4.4.1 NTSCI induced increased GFAP staining in severe injuries only
In mild and sham groups, the proportion of tissue stained with GFAP at all three regions
was similar (Figure 6.12). This is in contrast to the severe group, where a greater
proportion of GFAP staining was observed at the epicentre than at rostral and caudal
regions. This corresponded with a loss of central grey matter at the severe epicentre
(Figure 6.13). There was an N of 2 for the severe group, leading to a large S.E.M. and no
statistical significance between these groups.
Figure 6.12: Proportion of tissue stained with GFAP in NTSCI lesions. Animals underwent a
T10 laminectomy and balloon catheter inflation at T8/9 over 3 days. Animals were perfused two
weeks after the maximal inflation, and were grouped based on the functional deficit obtained. A
total of three sections were stained and imaged for each animal at each location, mean ± S.E.M.
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Figure 6.13: Representative images of GFAP staining in ventral balloon catheter-induced
NTSCI. Animals underwent a T10 laminectomy and balloon catheter inflation at T8/9 over 3
days, then perfused two weeks after maximal inflation. Animals were grouped based on their
functional deficit. In overview images, scale bar is 1 mm, in 20x images, scale bar is 100 µm. 20x
images were taken of the right lateral white matter.
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6.4.4.2 NTSCI did not cause substantial changes in chondroitin sulphate labelling
Chondroitin sulphate proteoglycans (CSPGs, stained by CS-56) are a core component of
the glial scar in TSCI. For all regions and injury severity groups, less than 10% of the
tissue was stained with CS-56, with no significant differences (Figure 6.14). This lack of
staining can be observed in representative images (Figure 6.15).
Figure 6.14: Proportion of tissue stained with CS-56 in NTSCI lesions. Animals underwent a
T10 laminectomy and balloon catheter inflation at T8/9 over 3 days. Animals were perfused two
weeks after the maximal inflation, and were grouped based on the functional deficit obtained. A
total of three sections were stained and imaged at each location. Data is mean ± S.E.M.
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Figure 6.15: Representative images of CS-56 staining in ventral balloon catheter-induced
NTSCI. Animals underwent a T10 laminectomy and balloon catheter inflation at T8/9 over 3
days, then perfusion two weeks after maximal inflation. Animals were grouped based on the
functional deficit. In overview images, scale bar is 1 mm, in 20x images, scale bar is 100 µm
(right lateral white matter).
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6.4.4.3 Severe NTSCI injury resulted in moderate demyelination at the injury
epicentre
For animals in the sham group, the area stained with myelin was similar at all three
locations (Figures 6.16 and 6.17). In mild and severe groups, there was a slight reduction
in the area stained with MBP at the epicentre, but this was not statistically significant
(N=2 for severe injury, Figure 6.16).
Figure 6.16: Proportion of tissue stained with MBP in NTSCI lesions. Animals underwent a
T10 laminectomy and balloon catheter inflation at T8/9 over 3 days. Animals were perfused two
weeks after the maximal inflation, and were grouped based on the functional deficit obtained. A
total of three sections were stained and imaged at each location. Data is mean ± S.E.M.
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Figure 6.17: Representative images of MBP staining in ventral balloon catheter-induced
NTSCI. Animals underwent a T10 laminectomy and balloon catheter inflation at T8/9 over 3
days, and were perfused two weeks after the maximal inflation. Animals were grouped based on
the functional deficit obtained. In overview images, scale bar is 1 mm, in 20x images (right hand
side white matter), scale bar is 100 µm
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6.4.4.4 Severe NTSCI caused narrowing of the vasculature, with no difference to
the number of vessels
For RECA-1 labelling, two outcomes were measured: the average size of each stained
object (vessel), and the number of stained objects counter per unit area.
In terms of the number of vessels counted per each spinal cord section (normalised
to the tissue area), there were no observable differences between locations and groups
(Figure 6.18). Conversely, for the average size of vessels, there was a decrease at the
epicentre for severely injured animals only (Figure 6.19). This difference was observable
on images from this region compared to others (Figure 6.20).
Figure 6.18: Number of RECA-1 stained objects in NTSCI spinal cords normalised to area.
Animals underwent a T10 laminectomy and balloon catheter inflation at T8/9 over 3 days.
Animals were perfused two weeks after the maximal inflation, and were grouped based on the
functional deficit obtained. A total of three sections were stained and imaged at each location.
Data is mean ± S.E.M.
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Figure 6.19: Average size of each object stained with RECA-1 from NTSCI spinal cords.
Animals underwent a T10 laminectomy and balloon catheter inflation at T8/9 over 3 days, then
were perfused two weeks after the maximal inflation, and grouped based on the functional deficit
obtained. A total of three sections were stained and imaged at each location. Data is mean ±
S.E.M.
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Figure 6.20: Representative images of RECA-1 staining in ventral balloon catheter-induced
NTSCI. Animals underwent a T10 laminectomy and balloon catheter inflation at T8/9 over 3
days. Animals were perfused two weeks after the maximal inflation. Animals were grouped based
on the functional deficit obtained. In overview images, scale bar is 1 mm, in 20x images, scale
bar is 100 µm
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6.5 Discussion
The aims of this chapter were to evaluate behavioural and histological outcomes in a
newly developed rat model of NTSCI; in order to better understand NTSCI pathology.
The key factors were to produce an injury which increased over a duration of days,
as measured by an increasing functional deficit. The histopathological findings of the
injury should have been distinct from TSCI, showing no haemorrhage or cystic cavity,
but instead compression of the cord.
Surgery was undertaken on a total of 10 female Wistar rats. Each underwent a partial
laminectomy at T10, and ventro-lateral 2F balloon catheter implantation with the balloon
component being at T8 spinal cord level. The catheter was attached to an injection port,
which was positioned trans-cutaneously at the shoulder blades. For sham animals this was
implanted subcutaneously. In injury animals, the injection port was used to add a volume
of 7.5 µL to the balloon on day 1, day 2, and day 3 after surgery. This was determined
in the previous chapter to have an overall balloon diameter matched 15 µL standard
inflation. Functional outcomes were measured using the BBB open field locomotor score.
Two weeks after the initial surgery, animals were perfused and spinal cords dissected for
histological analysis. Injured animals were subsequently grouped into mild and severe
injury groups based on behavioural outcomes.
Based on previous in-vitro experiments, the first inflation of 7.5 µL theoretically
corresponded with a balloon cross-sectional area of 2.5 mm2; the second 4.6 mm2 and the
third 5.2 mm2. This final cross-sectional area matched that of a 15 µL volume in a simple
one inflation study, and spinal canal stenosis of between 70 and 75%.
6.5.1 Outcomes from injured animal groups
The experiment aimed to understand whether a functional deficit could be attained
using a balloon catheter-injection port model of NTSCI; so motor function was scored
using the BBB scale. Further, histology of the spinal cords gave insights into overall
220
Chapter 6. Outcomes of NTSCI in-vivo Studies
histoarchitecture, and changes to both astrocytes and vasculature.
6.5.1.1 Lesion location and extension
The position of the balloon catheter insertion could be determined by evaluating the
histology of serial transverse spinal cord sections. In sham, mild, and severe injury groups
the balloon was predominantly ventral or ventrolateral (right hand side) at the site of
insertion. At the injury epicentre, the balloon was lateral to the spinal cord on the right
hand side. The rostral tip of the catheter was lateral or dorsolateral. None of the animals
showed a dorsal lesion. The method therefore shows potential in inducing a ventral injury.
6.5.1.2 Functional deficits and histological damage
Functional deficits and histological damage were different in the mild and severe groups.
In both groups, locomotor recovery occurred. Spontaneous recovery of locomotor
function after spinal cord injury has been observed frequently in rodent models and is
thought to be due to axonal sprouting (Ballermann and Fouad, 2006; Kjell et al., 2013;
Hilton et al., 2016; May et al., 2017).
In the severe group motor function declined over the first three days, whilst the
balloon was being inflated. With each inflation there would have been increasing
compression of the spinal cord, resulting in an increasing functional deficit. The greatest
change in deficit came with the third inflation where the animals were paralysed in their
hindlimbs. This recovered over the course of the subsequent two weeks, but only to
weight supported stepping, no co-ordination was observed. In future studies, it would be
of interest to have animals which are perfused at various timepoints to evaluate lesions in
the spinal cord with each inflation, and how these develop over time.
It is not possible to determine which tracts were damaged in order to cause the
functional deficits obtained in each group, since the compression affected all areas of
the spinal cord at the epicentre as opposed to a local injury. Further, the position of the
balloon was lateral at the epicentre, more ventral caudal to the epicentre, and dorsal at the
laminectomy site. Therefore at different spinal cord levels, different tracts were damaged.
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This latter point is true for mild and sham injury groups as well as the severe group.
In this severe injury group, there was no consistent difference observed between left
and right hindlimbs, indicating that both the left and right hemisections of the cord had
been damaged equally. This finding was supported by lesion histology, where, at the
lesion epicentre, there was observable damage in the left and right hemisections of the
spinal cord, with observable loss of grey and white matter.
The maximum deficit observed in the mild injury group of co-ordinated stepping
with paw dragging and external rotation was less marked than that of the severe group
(no co-ordination), but greater than the sham group (trunk instability only). This occurred
two days later than the minimum function observed in the sham group (day 3 compared
to day 1), indicating that this was not due to the surgery alone and was in part due to
balloon inflation. Histologically, this group had a C shaped lesion with damage to the
right lateral white matter. This right-sided pathology resulted in a consistent functional
difference, with the right hindlimb performing worse than the left. There was a concurrent
reduction in cross-sectional area of approximately 30% at the lesion epicentre. In spite of
the significant deformation of the shape of the spinal cord in this mild injury group, the
functional deficits were not severe.
At the epicentre, the difference in cross-sectional area between the mild and severe
injury groups was just 12%. Both groups showed significant spinal cord compression. It
is of interest that the mild injury group did not gain a substantial hindlimb dysfunction,
whereas the severe group did. Clinically, significant stenosis can be observed without
functional deficit (Watanabe and Parke, 1986; Boden et al., 1990a; Steurer et al., 2011;
Weber et al., 2016). The findings of this study suggest that there is a threshold value over
which damage to the histoarchitecture of the spinal cord results in more marked functional
deficits.
Correlating the minimum cross-sectional area of the spinal cord with the minimum
BBB score gave a Spearman correlation coefficient of 0.63 (p = 0.05), indicating moderate
to good correlation. This confirms that there is an association between decreasing cross-
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sectional area and minimum BBB score, as observed in the results. The Spearman
correlation is most suitable for this type of data since the BBB scale is non-linear (i.e. the
difference between each score in the scale is not proportional (Fouad et al., 2013)), and
the data has an non-linear distribution (i.e. is non-parametric), with a small sample size
in each group. Plotting the minimum cross-sectional area with the minimum BBB score
suggests a non-linear trend with threshold value in cross-sectional area (i.e. spinal cord
compression), below which results in significant deficits (Figure 6.11 in section 6.4.3).
Comparing functional outcomes of NTSCI herein with TSCI lesions in other studies
allows greater insight into the pathological mechanism. In a traumatic dorsal balloon
lesion studies with a volume of 15 µL, hindlimb paralysis was observed with motor
recovery over two weeks (Vanicky et al., 2001; Urdzikova et al., 2006; Sedy et al., 2007).
In these TSCI studies at two weeks post-injury, extensive movements of all three joints
of the hindlimb were observed, but no sweeping or stepping. The severe NTSCI lesion
group in this research therefore had greater motor recovery than a similar TSCI lesion,
despite matching the spinal cord compression extent (Vanicky et al., 2001; Urdzikova
et al., 2006; Sedy et al., 2007). The reason for this may be inherent to the slow velocity of
increasing compression in NTSCI, allowing adaptation and plasticity in the spinal cord.
Clinically, neural remodelling in the sensori-motor network has been observed in patients
with NTSCI at the cervical levels (Karadimas et al., 2015; Zhou et al., 2015; Bernabeu-
Sanz et al., 2019). The increased speed of TSCI means that such plasticity and adaptive
changes intrinsically cannot take place.
6.5.1.3 Lesion histopathology
GFAP expression and astrogliosis
Immunohistochemistry markers used herein (GFAP, MBP, CS-56, RECA-1) can help
elucidate mechanisms of injury in the balloon-catheter induced NTSCI. It is worth noting
that although trends were observed, particularly in the severe injury group, none were
statistically significant due to the low N number (N=2) and, as such, high variation.
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Therefore, all discussion and potential mechanisms of injury described below require
further study with an increased number of animals.
In this study, there was an observed increased in the proportion of tissue stained
with GFAP at the epicentre of severe injuries compared to all locations in sham and mild
injured animals. The reasons for this may be two fold: either due to threshold-driven
astrogliosis at the injury epicentre, with the threshold explaining why differences were
observed in severe groups but not mild groups; or due to the lack of grey matter in the
severe injury group epicentre region, thereby resulting in an altered ratio of grey and white
matter, and a difference in GFAP labelling.
Few studies have evaluated GFAP labelling and astrogliosis after NTSCI. In TSCI,
astrogliosis occurs immediately after the primary injury and is core to glial scar formation
(Cullen et al., 2007; Kawano et al., 2012; Wanner et al., 2013; Weightman et al., 2014).
In NTSCI, primary and secondary injury are not easily distinguished due to the ongoing
quasi-static compression of the spinal cord. In rabbit models of disc herniation leading to
lumbar stenosis, two studies described an increase in GFAP levels compared to controls
(Klironomos et al., 2011; Shunmugavel et al., 2013); however this is not quantified
and the representative images used do not show such a clear trend. The experiments
undertaken herein had insufficient N numbers to show significant differences, but can act
as an important pilot study to guide further research. The research herein suggests that
when NTSCI is induced to compress the spinal cord to such an extent that grey matter
parenchyma is disrupted, astrogliosis of the remaining astrocytes results. The reasons for
this and long term outcomes require further research, i.e. using more animals for a greater
statistically powered study or lower the variance observed, and longer timepoints.
Chondroitin sulphate expression, perineuronal nets and plasticity
In the intact spinal cord, CSPGs are one component of perineuronal nets, which surround
neurones (Kwok et al., 2011; Burnside and Bradbury, 2014; Haggerty et al., 2017; Irvine
and Kwok, 2018). The chondroitin sulphate components can be sulphated in various
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patterns, and the CS-56 antibody predominantly labels 6-sulphated chondroitin sulphate
(C6S) (Miyata et al., 2012).
Perineuronal nets have a role in modulating neural plasticity (Sorg et al., 2016),
which is a key distinguishing factor of NTSCI to TSCI (Karadimas et al., 2015; Zhou
et al., 2015; Bernabeu-Sanz et al., 2019). As such, it could be hypothesised that a change
would be observed in CSPG expression in NTSCI, to modulate plasticity. There have been
no studies evaluating CSPGs or perineuronal nets after NTSCI. In this study, there were
no observable differences in CS-56 labelling in any group. In all cases, less than 9% of the
spinal cord was stained with CS-56. In the cortex, one study in mice identified a reduction
in C6S with age (Miyata and Kitagawa, 2016), and suggested that this corresponded with
a reduction in plasticity; i.e. that an increase in C6S is associated with increase plasticity.
The research herein was the first to evaluate the expression of C6S in NTSCI, and found no
observable difference compared to contorls. However, the expression was only evaluated
from low magnification images, using the whole transverse cross-section of the spinal
cord. Greater differences may have been observed if the grey matter alone was assessed
at high magnifications; since the grey matter is where the perineuronal nets are established
(Irvine and Kwok, 2018). Further, it is possible that in NTSCI there are other mechanisms
involved in neural plasticity, beyond a difference in C6S, which is why no changes in C6S
were observed herein. Other markers of perineuronal nets molecules, such as Wisteria
floribunda agglutinin (WFA) or aggrecan, could be used. The mechanisms of plasticity in
NTSCI and changes to perineuronal nets require further study.
MBP staining and demyelination
Reviews of the pathology of chronic spinal cord compression frequently discuss
ischaemia and subsequent demyelination as mechanisms of injury (Baptiste and Fehlings,
2006; Dolan et al., 2016). This is supported by experimental studies. For example,
Shunmugavel et al. (2013) induced lumbar stenosis in rats by inserting a silicone block
at L4 and L6, and identified demyelination at the injury site as measured by fast blue
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intensity. Other models of NTSCI using a line surrounding the spinal cord and a thoracic
screw method have also observed demyelination (Kubota et al., 2011; Sun et al., 2016).
Similarly, in human studies of chronic compression of the spinal cord, apoptosis of
oligodendrocytes was observed using various immunohistochemical markers (Yamaura
et al., 2002; Newcombe et al., 2015).
The results of the study herein identified a slight reduction in the proportion of tissue
stained with MBP for mild injured animals at the epicentre, and a greater reduction in
severe injured animals. These differences were not statistically significant due to the low
N number. In spite of this, they correspond to the wider literature of NTSCI, supporting
the role of demyelination in pathogenesis.
RECA-1 and changes to the vasculature
In NTSCI, compression of the spinal cord is hypothesised to lead to compression of
the vasculature, resulting in ischaemic damage to cells. For example, Xu et al. (2017)
implanted a water-absorbent polymer at C6, and evaluated changes to the neurovascular
unit, including endothelial cells, using electron microscopy. The results, including
increased vacuoles in endothelial cells, small gaps in tight junctions, and neuronal
degeneration, indicated that chronic compression in NTSCI results in significant damage
to the neurovascular unit. This reduction in the local vascular supply is core to the
pathology of NTSCI (Karadimas et al., 2013; Long et al., 2014).
Alongside narrowing of the vasculature due to compression, further changes
hypothesised to be involved in NTSCI are an increase in permeability of the blood
spinal cord barrier (Karadimas et al., 2013, 2015). (Karadimas et al., 2013) implanted
a water-absorbing polymer at C6 in to induce NTSCI in a rat model. At 10 weeks after
implantation, injections with Evans Blue were carried out to assess blood spinal cord
barrier permeability, followed by histological assessment for various markers. The key
findings of the study were an increase in blood spinal cord barrier permeability (i.e.
a loss of barrier integrity), a reduction in the number of RECA-1 stained endothelial
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cells, and, in a subsequent paper, a reduction in laminin staining (Karadimas et al., 2015).
This indicated that at 10 weeks post-injury, there were fewer intact endothelial cell-lined
vessels, and vessles were more permeable.
Kurokawa et al. (2011) carried out an experiment using a water-absorbing polymer
model of NTSCI, evaluating ischaemia by injecting fluorescent microspheres into the
bloodstream and subsequently evaluating the fluorescence per gram of tissue at the injured
spinal cord level (12 weeks post injury). There was 20% less fluorescence in compressed
spinal cord compared to healthy control specimens, indicating circulatory disturbance and
ischaemia. The Kurokawa study did not assess the number or size of blood vessels.
In this study, a difference in the number of objects stained with RECA-1 (normalised
to area) was not observed. Instead, a reduction in the average size of objects stained with
RECA-1 was observed, at the epicentre for the severe injury only. This corresponds to a
reduction in diameter, i.e. narrowing, of the vessels at the severe injury epicentre. As with
the other immuno-stains used herein, this difference was observed but not statistically
significant due to the low N number. The biological significance is supported by the other
studies of NTSCI.
Across the wider literature and the research herein, chronic spinal cord compression
in NTSCI results in clear effects to the spinal cord vasculature. Together, the studies
suggest that in the short term after NTSCI there are the same number of vessels which
become narrow, and then by latter time points this results in vascular remodelling, a
reduction in number of vessels, and increased vascular permeability.
NTSCI Functional Threshold
In the severely injured animals, localised regions of necrosis and cellular infiltration were
observed, along with white matter vacuoles extending beyond the lesion itself. In terms
of immunohistochemistry, a reduction in MBP staining and an increase in GFAP staining
was also observed in the severe group. These findings were not observed in mild or sham
groups. Such pathological findings have only been reported in one other NTSCI study,
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which used a flat screw to compress the spinal cord (Sun et al., 2016). In the Sun study,
once the cord was compressed by over 40%, reactive gliosis, white matter demyelination
and missing tissue were observed at the injury epicentre. In more mild injuries, where the
spinal cord was compressed by less than 40%, observations were compression/flattening
of the cord with white matter vacuoles observed in some studies but not others (Kim
et al., 2004; Kubota et al., 2011; Lee et al., 2012; Long et al., 2013; Sun et al., 2016).
This finding of a threshold value was also reflected in the functional data described above.
Once the spinal cord is compressed to above this threshold value, as occurred in the severe
but not mild injury groups, the normal histoarchitecture of the cord is lost and functional
deficit becomes significantly more severe. The difference in cross-sectional area between
mild and severe groups was just 12%. The results from this study indicate that in this
model, the threshold lies within the range of these two groups, between 32% and 44%
spinal cord compression. This value is in keeping with previous clinical studies, where
the threshold for symptoms is between 25 and 50%, with variation between populations
and vertebral levels (Penning et al., 1986; Matsunaga et al., 2008; Steurer et al., 2011;
Iwahashi et al., 2016; Weber et al., 2016; Kadanka et al., 2017; Lim et al., 2017; Martin
et al., 2018; Witiw et al., 2018).
6.5.2 Outcomes from sham surgery
A functional deficit was observed in sham animals at day 1 post-surgery, but this recovered
by day 7. The only maintained functional abnormality was postural instability. There
was no consistent difference between left and right hindlimbs. These findings indicate
minimal damage to the spinal cord through implanting the balloon system, which was
corroborated by histological analysis. The postural instability observed may have been
due to damage to the lateral white matter on the right hand side of the spinal cord due to
the balloon at the epicentre, due to damage caused caudally to the epicentre during balloon
insertion, or as a result of musculoskeletal disruption during the partial laminectomy at
T10. It is not possible to fully understand this based on the histology and behavioural
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assays undertaken. Future studies should include a laminectomy only group to further
evaluate this finding.
6.5.3 Limitations of outcome measures
At termination in this study, only one balloon system could be extracted intact. This
balloon had deflated due to loss of pressure within the system. The decompression of the
spinal cord due to deflation or damage to the balloon-port system may have facilitated the
functional recovery observed in mild and severe injury groups. In spite of this, a lasting
functional deficit occurred, indicating an injury to the spinal cord.
The functional deficit obtained was only measured using the open field BBB scoring
system. This has disadvantages in user bias, a lack of quantitative data, and the non-
linear nature of the scale (Martinez et al., 2009; Fouad et al., 2013; Sharif-Alhoseini and
Rahimi-Movaghar, 2014). Further studies should fully characterise the functional deficit
obtained through the use of kinematic analysis. Other measurements such as sensory
function using the von Frey filament test would add further information about the injury
modality. These tests should be undertaken at least once prior to surgery to evaluate the
motor deficit caused by surgery itself.
The BBB scale cannot distinguish NTSCI from TSCI, nor dorsal from ventral
lesions, due to its broad nature and the overlap in function between spinal cord tracts. It
can only determine if the animal is injured, and some element of injury severity although
this latter point is subject to bias by human scorers (Molina et al., 2015). The histology
could determine NTSCI/TSCI and ventral/dorsal. In these preliminary tests, the BBB
scale was used as a crude measure of function after inflation to check if the animal was
injured. More thorough evaluation of the sensori-motor function of the animals would be
required for future studies.
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6.5.4 Technical Challenges
6.5.4.1 Variation in inflation volume
In spite of using the method and technique, animals in the mild and severe injury groups
had different functional and histological outcomes. The reasons for this may be in
variation in the surgical method: insertion technique or balloon inflations.
The 2F Fogarty catheter was manufactured for laparoscopic embolectomy surgery,
and as such contains a radio-opaque wire to evaluate position and location of the device.
This has been made use of in a previous rat spinal cord injury study using the apparatus,
where the position of the catheter was confirmed using a microCT scan (Su et al., 2015).
This could be carried out in future studies to ensure the correct spinal level and improve
reproducibility of the study. Additionally, inflation of the balloon with a radio-opaque
agent instead of water would allow the entire balloon to be visible with imaging. The
agent used would need to be non-toxic, so that if the animal destroys their injection
port either ingestion or expulsion of the agent within the body would not cause negative
outcomes.
Alternatively, the rate of balloon filling and volume used could be measured more
precisely. A volume of 7.5 µL was attempted to be added to the balloon each day,
manually using a very fine syringe. This could have lead to human error due to the
very small volume required, and backflow from the balloon into the syringe could have
occurred. Similarly, the rate of injection of volume was not highly controlled. A
microprocessor controlled injector such as a Nanolitre device, or a sampling device as
used in the previous Vanicky et al. (2001) study could be used to add volume into the
balloon more precisely.
The rate of balloon inflation in SCI was shown to be important in study undertaken
by Sedy et al. (2009). These authors used a dorsal balloon catheter lesion and inflated
the balloon with a total of 15 µL, but used various timesteps: immediate 15 µL (total
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time 2 seconds), 3 x5 µL (total time 30 seconds), or 3 µL followed by 6 x 2 µL (total
time 3 minutes). Heart rate and lung function were evaluated, as well as pulmonary
oedema. With faster balloon inflations, heart rate dropped significantly and the rate of
pulmonary complications increased, due to insufficient time to adapt the sympathetic
tone (eg changes in blood pressure and blood volume distribution). This may explain
the differences observed in this study. Herein, the rate of inflation was not controlled,
and therefore may have been substantially quicker in the first group than the second. This
could explain the change in breathing pattern observed in animals with a severe injury.
The Sedy study did not assess the histological or behavioural outcomes of the different
injury groups.
6.5.4.2 Port system
The use of a trans-cutaneous injection port allowed inflation of the balloon over various
timepoints, to model NTSCI. All of the animals showed irritation around the sites of their
injection port, which occurred up to one week after surgery for mild injured animals,
and once some motor function was restored for severely injured animals. Ultimately,
the majority of the animals destroyed their injection ports themselves or they had to be
manually removed due to risk of infection, thereby deflating the balloon due to loss of
fluid.
In future studies, the port itself could be placed subcutaneously for injury animals
as well as control animals. Other studies have used subcutaneously implanted injection
ports, with injection through the skin and port at each timepoint (de Wit et al., 2001;
Fiebig et al., 2013; Figueiredo et al., 2015; Gossman et al., 2017). An alternative could be
to implant the port subcutaneously with one or two sutures in the skin. When injection is
required, a single suture could be cut to reveal the port for injection; then the suture could
be replaced. Subcutaneous port implantation would reduce skin irritation which will be
particularly important in control animals, allow longer study periods, allow housing in
pairs and preclude the need for large cages which take up more space and are more costly.
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It would also allow for improved evaluation of the system after perfusion, since the system
should remain intact. This method was not chosen for the study herein since the repeated
opening of the wound and subsequent suturing could have lead to infection or damage to
the skin.
6.5.5 Conclusion
Referring back to the three characteristics of NTSCI distinguishing it from TSCI, as
described by Karadimas et al. (2015) of no acute mechanical insult, absence of gross
haemorrhagic necrosis, and chronic nature: this model fulfils each three of these
objectives. The injury was induced slowly over the course of three days with continuing
balloon inflation, and the histology revealed minimum parenchyma disruption or necrosis,
even in the severe injury group.
The results described in this chapter (summarised in Table 6.1) act as a pilot study
to exemplify that the method developed does induce a measurable NTSCI. There are
limitations to the study, including the low N number and variation seen between injury
groups, which require further assessment.
The variation between groups led to injured animals being split into mild and severe
groups. The work shows that histologically, a greater lesion was observed with the mild
than sham group; but no significant differences were observed in functional outcomes.
Conversely, even greater damage and functional deficit in the severe group. Therefore, the
results suggest a threshold value in spinal cord compression after which non-recoverable
damage is observed. This should be further investigated. Overall:
Volume injected 6∝ Balloon inflation ∝ Behavioural and histological outcomes
The method developed and used herein resulting in an NTSCI lesion with
a functional deficit and histological differences to sham controls, with a reduced
invasiveness compared to screw or line NTSCI methods. Now that the model has
been developed using these measures, more refined evaluation of the pathology can be
undertaken in future studies.
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Table 6.1: Conclusions of Chapter 6: Outcomes of NTSCI in-vivo Studies
Aim Objective Result and Implications
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si
on Implant balloon
catheter port
system into rats,
inflate balloon
over 3 days and
monitor animals.
Surgery was undertaken in 10 animals, all survived the
surgery and subsequent balloon inflations.
Animals lost between 5 to 10% of their body weight in the
first week after surgery, but this recovered to pre-injury levels
by day 9 to 10.
Irritation was observed around the injection port between one
and two weeks post-surgery, meaning they had to be
removed at this point.
Characterise
functional
deficits using
BBB scale.
Injured animals were categorised based on their minimum
BBB score; where severely injured animals had a minimum
BBB of less than 2
In mild and severe groups,motor function was at its
minimum on day 3, and recovered significantly to day 9.
In the mild injury group, there was a trend for the right
hindlimb to have an increased functional deficit to the left
hindlimb, but variation was high.
The functional deficit observed in the severe group recovered
more than a concurrent TSCI study using the same balloon
diameter.
Shape and area of
tissue at the
lesion site
An obvious reduction in cross-sectional area was observed at
the injury epicentre, with significant differences between
injury groups.
Cross-sectional area and minimum BBB score had a
moderate to good correlation, with data suggesting a
threshold value for compression and severe deficits.
Changes to the
spinal cord
parenchyma
Global compression of the spinal cord was observed in mild
and severe injury groups, with loss of grey matter,
inflammatory cell infiltrate, and white matter vacuolisation in
the severe group only.
Immuno-
staining of
lesions
Due to low N numbers and high variation, none of the
changes observed in IHC were statistically significant.
Glial scar
evaluation using
GFAP & CSPG
A trend of increased GFAP staining at the epicentre for
severe lesions only. No changes for CSPG labelling, i.e. no
astrogliosis.
Myelin staining
using MBP
A trend of demyelination at the epicentre of severe lesions
only.
Vasculature
changes using
RECA1
A trend of more narrow vessels at the epicentre for severe
lesions only, no changes to the number of vessels.
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Slow velocity, chronic compression of the spinal cord results in NTSCI. The underlying
cause of the compression can vary, with metastases and degenerative bone spurs causing
over 50% of cases (New et al., 2014). The prevalence of NTSCI is estimated to be greater
than or equal to that of traumatic injuries, and the incidence is predicted to increase
with an ageing population (Razdan et al., 1994; Noonan et al., 2012; Lee et al., 2014).
Further, in patients with NTSCI, treatment is limited and involves surgical interventions
of decompression and fixation (NHS, 2010; NICE, 2015, 2016).
Slow and progressive occlusion of the spinal cord in NTSCI does not result in gross
haemorrhage or parenchyma disruption (which are seen in traumatic injuries), instead
post-mortem observations include demyelination, changes to the vasculature and change
in spinal cord shape (Someya et al., 2011; Karadimas et al., 2013). The pathways involved
and contribution of each cell type are not understood. In patients, it is impossible to
decouple the mechanical injury from other factors, such as compression of the vasculature
and ischaemia. Therefore, there is a need to develop experimental models of NTSCI, in
order to further understand the pathological mechanisms, and evaluate specific parameters
in detail.
It was hypothesised that the mechanisms of NTSCI could be elucidated by the
development of in-vitro and in-vivo models. For the in-vitro model, this study built on the
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work of previous studies and aimed to utilise collagen hydrogels seeded with neural cells
and compressed at various velocities in a BOSE 5110 Electroforce. The cells of choice
were astrocytes, since they are core to the TSCI cascade but their role in NTSCI was
unknown. For the in-vivo model, this aimed to use a balloon catheter method (previously
used in a TSCI context) to induce a ventral NTSCI lesion in a rat. The outcome measure
for this is would be a functional deficit, and pathology different to that observed in TSCI.
7.1 General discussion: outcomes in NTSCI and TSCI
7.1.1 In-vitro models
Compared with in-vivo models and clinical scenarios, in-vitro models allow greater
control of conditions, including the matrix environment, cell populations, and
environmental factors. Each of these can be manipulated and the effects observed.
Collagen hydrogels retain cell adhesion motifs and provide a 3D environment, supporting
cells and facilitating interactions with the matrix, ultimately resulting in a better
representation of physiological conditions (Caliari and Burdick, 2016). Furthermore,
collagen hydrogels have been used to assess neural cell responses in a 3D environment,
including after impaction in a TSCI context (East et al., 2010, 2012; Bar-Kochba et al.,
2016; Smith, 2016; Kirk, 2018). As such, these hydrogels were the basis of the in-vitro
model developed herein.
7.1.1.1 Development of in-vitro model
The research carried out in this thesis builds on two previous studies at the University
of Leeds (Smith, 2016; Kirk, 2018). The first of these studies (Smith, 2016) used
the Infinite Horizon impactor to apply load-controlled local insults to astrocyte-seeded
collagen hydrogels. Future work identified in the Smith study was to investigate the use of
other impactors. The second of these studies (Kirk, 2018) used a BOSE 5110 Electroforce
to apply velocity and displacement-controlled local insults to the same type of gels, seeded
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with astrocytes or microglia. The future work described in the Kirk study was to optimise
and validate the cell populations, and fully characterise the BOSE apparatus in terms of
inputs and outputs, different mechanisms of injury and platen fixtures.
The work described in chapter 3 of this thesis built on these two studies and fully
characterised the capacity of the BOSE 5110 Electroforce instrument to apply mechanical
insults at various velocities with new platen fixtures; as well as characterising the astrocyte
population. Findings from this chapter validated the cell population in terms of response
to TGF-beta treatment as a positive control for astrogliosis. Furthermore, the use of
new platens in the impactor device had no impact on the maximum output velocity.
The maximum velocity of the device obtained herein was 1000 mm.s-1, in contrast to
previous research which stated a velocity of 3000 mm.s-1 was used (Kirk, 2018). Greater
evaluation of the capacity of the impactor device was undertaken, and it was observed
that a maximum velocity of 100 mm.s-1 should be used for the optimum accuracy. This
was significantly less than clinically observed velocities in TSCI (Wilcox et al., 2003),
and this was a limitation of the research herein.
Further, chapter 3 characterised astrocytes isolated from mixed glial populations,
in 2D and in 3D, under both physiological and pathological conditions. In 2D,
approximately 90% of cells expressed GFAP, and therefore the cells could be identified
as astrocytes (East et al., 2009; Kerstetter and Miller, 2012; Smith, 2016). Further,
the astrocytes remained viable and non-reactive over two weeks in collagen hydrogels,
as demonstrated by no significant differences in the proportion of cells labelled with
ethidium homodimer, nor changes in the area stained with GFAP. Conversely, TGF-beta
treatment (10 ng.mL-1) of the astrocyte-seeded hydrogels, resulted in increased astrocyte
reactivity: an increase in area stained with GFAP of 227% between days 1 and 14. These
findings reflect an astrogliotic response, and were in keeping with the wider literature
(Logan et al., 1994; Cullen et al., 2007; East et al., 2009; Kimura-Kuroda et al., 2010;
Vogelaar et al., 2015; Smith, 2016).
The chapter also evaluated wider experimental parameters, such as the optimal gel
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volume and imaging protocols for the cells. The implications of this chapter were that
the BOSE 5110 Electroforce was suitable for applying controlled mechanical insults at
various velocities to collagen hydrogels, and that astrocytes behaved as expected in the
same collagen hydrogels. Therefore, a model for in-vitro NTSCI had been established,
and could be used to evaluate pathological mechanisms.
7.1.2 Evaluation of astrocyte outcomes after TSCI and NTSCI in-
vitro
In chapter 4, astrocyte-seeded hydrogels were compressed at various velocities, and
cellular outcomes were established.
After high velocity compression (100 mm.s-1) astrocytes had a significantly reduced
circularity from day 11 (i.e. were more ramified), a significantly greater area stained
with GFAP per cell from day 11, and expressed a significantly greater quantity of IL-6
compared to negative controls on day 14 (p <0.05). In spite of the previously described
mismatch between clinical velocity and velocities used in-vitro, the phenotype observed in
astrocytes when compressed at 100 mm.s-1 showed signs of astrogliosis and inflammation,
which are both markers of secondary injury observed in TSCI clinically and in in-vivo
studies of TSCI (Norenberg et al., 2004; Hu et al., 2010; Sofroniew and Vinters, 2010;
Wanner et al., 2013; Ahadi et al., 2015; Anwar et al., 2016; Morin, 2018).
No previous studies have characterised mechanical impacts in-vitro in the context
of NTSCI. In lower velocity impacts, the findings of astrogliosis and inflammation were
not replicated, with no significant differences in any assay with a velocity of 10 mm.s-1
or lower. In NTSCI, the pathological cascade is poorly understood, and therefore the
markers used were exploratory, and based on expected findings from TSCI lesions. Few
in-vivo models of NTSCI report GFAP expression, and those which did report contrasting
findings (Shunmugavel et al., 2013; Cho et al., 2015). The research herein suggests
that astrocyte reactivity was not induced by direct mechanical compression of astrocytes
alone in low velocity NTSCI contexts, but was induced in high velocity TSCI. In NTSCI,
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compression of the vasculature is hypothesised to result in ischaemia (Karadimas et al.,
2013). Therefore, the pathology may be linked to ischaemia or changes to the neuro-
vascular unit. Further, the responses of other cell types to low velocity NTSCI insults are
yet to be established. Based on the findings of the in-vivo studies described in chapter 5
and 6, the model can be tailored to elucidate further mechanisms (see section 7.1.4).
The findings of this chapter elucidate the mechanical origins of TSCI. At 10 mm.s-1,
the load imparted and transferred onto the hydrogels was the same as at 100 mm.s-1 but
outcomes were different. Previous studies have a lack of coherence on the predominant
injury mechanics important in determining TSCI outcomes (Kearney et al., 1988; Kwo
et al., 1989; Jakeman et al., 2000; Seki et al., 2002; Kim et al., 2009; Lam et al., 2014).
Based on the differences in mechanics and cellular outcomes between impact velocities,
this study found that neither load nor the displacement extent were not the predominant
factor affecting cellular outcomes. The remaining factors therefore were work done, or
velocity. These two factors were interlinked due to the viscoelastic nature of the collagen
hydrogel material: for a given displacement changing strain rate affected stiffness and
therefore load and energy (Dogliotti and Yelland, 1964; Hussein, 2018). Therefore in this
hydrogel system, the effects of load, work done, and velocity could not be uncoupled.
There were limitations to the assays used, including a lack of resources leading
to not all timepoints or experimental conditions being tested using the IL-6 and IL-10
ELISA. Further, the lack of evaluation of cell viability in the study, which would be
of interest in future studies. The lack of control of environmental conditions such as
temperature, atmospheric gas levels meant long-term culture under compression more
relevant to NTSCI could not be undertaken.
Overall, this chapter confirmed that the BOSE 5110 Electroforce instrument could
induce TSCI and NTSCI-like velocities onto astrocyte-seeded collagen hydrogels. Clear
differences in physiological responses were observed with different velocities. No
significant changes were observed in low velocity insults, whereas astrocytes became
reactive with an inflammatory phenotype at the highest velocity. This was characterised
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by an increase in IL-6 production, an increase in the size of cells (hypertrophy), and
a reduction in their circularity (ramification) at days 11 and 14 post-injury. Astrocyte
reactivity as a result of mechanical compression was not core to the NTSCI cascade.
7.1.3 In-vivo models
In-vivo models are more complex than in-vitro models, incorporating tissue architecture,
multiple cell types, surrounding tissues and biological systems in-situ. There are
various considerations in developing a new in-vivo model, including the species: ease
of husbandry, ethical requirements, and physiological and pathological similarities to
humans (Hassannejad et al., 2016). In this study, rats were chosen as the animal model,
since they are widely used in TSCI research, are relatively low cost, and of sufficient size
to undertake spinal cord surgery (Talac et al., 2004; Zhang et al., 2014; Kjell and Olson,
2016). Chapters 5 and 6 described the development and outcomes of a novel in-vivo
model of NTSCI.
7.1.3.1 Development of an in-vivo model of NTSCI
In the wider scientific literature of in-vivo models of spinal cord injuries, no models of
NTSCI could be modified to induce an injury from the ventral approach in a suitable
timescale without a highly invasive approach (Kim et al., 2004; Kubota et al., 2011;
Kurokawa et al., 2011; Lee et al., 2012; Sun et al., 2016). The ventral directionality
of NTSCI is important, since the spinal cord is asymmetrical ventrally/dorsally, and most
clinical injuries occur from the ventral aspect (Watson et al., 2009; Ferrara, 2012; Tetreault
et al., 2015; Martin et al., 2018). One method which had the potential to induce a ventral
NTSCI was a balloon catheter method (Martin et al., 1992; Vanicky et al., 2001), although
this had not been previously attempted. A further important factor in developing a model
of NTSCI was control over canal stenosis. Clinically, there are three stages to stenosis and
symptoms: a latent phase without symptoms, symptom onset, and symptom deterioration
(Karadimas et al., 2012, 2013). However, the degree of stenosis required to initiate each
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phase are poorly characterised (Penning et al., 1986; Steurer et al., 2011; Iwahashi et al.,
2016; Weber et al., 2016; Kadanka et al., 2017; Martin et al., 2018; Witiw et al., 2018).
Chapter 5 aimed to address these gaps in the literature and develop a clinically-relevant
model of NTSCI with increasing stenosis over a time frame of days, using a ventral lesion.
The first aim of the chapter was to evaluate the histology of a ventral balloon catheter
spinal cord lesion, using a traumatic injury. TSCI in rats has been modelled using a 2F
balloon catheter in various studies (Martin et al., 1992; Vanicky et al., 2001; Lonjon et al.,
2010; Chung et al., 2013). By using a slightly different technique to insert the balloon
laterally and subsequently ventrally to the spinal cord, it was hypothesised a similar lesion
could be established. A total of 4 animals were operated upon, where a balloon catheter
was inserted into the vertebral canal at the T10 vertebra, and subsequently positioned and
inflated at T7/8 spinal cord level. The volume used was 12.5 µL for 2 animals, and 15 µL
for the other 2 animals. One week after this, spinal cords were excised and histology was
performed. The spinal cord of one of the animals injured with a volume of 12.5 µL was
damaged during tissue processing, and could not be assessed, leaving an N of 1 for this
group.
Histological outcomes after TSCI in-vivo via balloon catheter
With both volumes, there was clear disruption to the tissue parenchyma at the injury
epicentre. This damage extended rostrally and caudally, beyond the length of the inserted
catheter itself. The length of the lesion and degree of damage observed was greater in
the 15 µL group based on analysis of the histological images. It could not be determined
whether the injury was ventral or dorsal, due to the extent of tissue damage at the injury
epicentre. At the injury epicentre, conserved white matter remained in the penumbra
only, and the central region was filled with a cystic cavity, loose debris, and macrophage
infiltration. Parenchyma disruption, white matter vacuoles, and lesion extension have
been observed widely in other TSCI balloon models (Martin et al., 1992; Vanicky et al.,
2001; Lonjon et al., 2010; Chung et al., 2013).
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Upon evaluation with immunohistochemistry, across all animals, a significantly
greater proportion of tissue was stained with GFAP and CS56 at the injury epicentre
compared to the nearest intact rostral and caudal regions (p <0.05). This was indicative
of reactive astrogliosis, and, again, similar findings have been established in dorsal TSCI
balloon catheter model (Martin et al., 1992; Chung et al., 2013). Reactive gliosis is
a hallmark of TSCI pathology and increased GFAP and CSPG expression have been
observed widely in animal models and clinically (Norenberg et al., 2004; Sofroniew and
Vinters, 2010; Wanner et al., 2013; Hol and Pekny, 2015; Tachi et al., 2015; Sofroniew,
2018). This gives confidence that the balloon catheter model can induce a TSCI similar
to that of the wider literature using a modified insertion approach. In future studies, the
diameter of the 15 µL balloon will be matched for cohesion with previous TSCI studies.
Vertebral column anatomy and geometry
The subsequent unknown was how to control the extent of stenosis in NTSCI. This
involved two critical elements: the dimensions of the vertebral canal, and dimensions
of the balloon catheter system. This would facilitate understanding of the degree of
vertebral canal stenosis which could be applied with varying balloon volumes. Therefore,
the second aim of this chapter was to characterise the dimensions of the rat spinal
canal/vertebral foramen in the thoraco-lumbar region. The geometry of the spinal canal
has not been widely established in the literature but was important to understand for
NTSCI. A CT scan was undertaken of one rat post-mortem. The maximum cross-sectional
area was observed at vertebral level T7/8 (spinal cord level T8/9), with a value of 8.9 mm2.
At the lumbar levels, the differences between cross-sectional area at various vertebrae
were in keeping with a previous study (Jaumard et al., 2015). Due to the lack of wider
data, and the use of only one animal (to comply with the 3Rs), the exact dimensions of the
spinal canal could not be fully elucidated taking into account variation between animals.
However, this experiment was useful to provide an approximation, and could be validated
in the NTSCI studies themselves.
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Characterising 2F balloon catheter inflation
The other factor in determining spinal canal stenosis in the in-vivo model of NTSCI was
the balloon catheter dimensions. Various studies used a 2F balloon catheter with a volume
of 15 µL, but no previous studies had quantified the dimensions of the balloon with this
volume, or how the balloon dimensions changed with inflation. The third aim of this study
was to characterise how balloon volume affected diameter. The results of this section
were that the maximum diameter of the balloon was 4 mm. At 15 µL, the diameter of the
balloon was 2.8 mm. This equated to a cross-sectional area at the widest point of 6.165
mm2. One previous study using the same system stated with a volume of 15 µL a diameter
of 2.5 mm, but did not determine how it was measured (Lonjon et al., 2010). A different
study included a photograph of the balloon inflated with 15 µL, and the balloon appeared
to have a diameter of 3 mm (Figure 2 in Vanicky et al. (2001)). Therefore the finding of
this study was in keeping with other research.
The final aim of this chapter was to modify the balloon catheter system to facilitate
induction of NTSCI, i.e. inflation over the course of a period of days. The first method
attempted was to use an osmotic pump to inflate the balloon, however this did not
provide sufficient pressure to inflate the balloon. So, an injection port was subsequently
developed. Injection ports have been used in previous studies for venous injection studies
over an extended timeframe (Fiebig et al., 2013; Figueiredo et al., 2015). Using this port
affixed to the balloon catheter, a series of volumes were tested using multiple injections.
The overall aim was to achieve a diameter of 2.8 mm (matched to a volume of 15 µL in the
previous experiment) over 3 volume injections (i.e. 3 days in-vivo for future experiments).
Due to loss of volume and pressure upon needle insertion for each injection, this was
achieved using 3 x 7.5 µL injections (a total volume of 22.5 µL rather than 15 µL to
compensate). The estimated proportion of canal stenosis with each inflation was 8%
stenosis with no inflation; 28% stenosis with 1 inflation; 53% stenosis with 2 inflations;
73% stenosis with 3 inflations (matching a diameter of 2.8 mm).
Previous TSCI studies which have used a balloon volume of 15 µL resulted in a
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significant functional deficit (Lonjon et al., 2010; Vanicky et al., 2001). As such, the
maximum inflation used herein should also have resulted in a significant functional deficit,
since the balloon dimensions were matched. The degree of canal stenosis which would
initiate symptoms is not well understood. Clinical studies have identified that most
patients with symptoms have between 25% and 50% canal stenosis (Penning et al., 1986;
Steurer et al., 2011; Iwahashi et al., 2016; Weber et al., 2016; Kadanka et al., 2017; Martin
et al., 2018; Witiw et al., 2018). Conversely, a rat study undertaken by Kim et al. (2004)
found that 48% occlusion of the spinal canal did not induce functional deficits, but this
used implantation of an expanding material at the cervical level and therefore results may
be different using a balloon at T7/8. At 25% spinal canal stenosis, this may begin to
impinge on the spinal cord, however, the diameter of the spinal cord relative to the spinal
canal at T7/8 in a rat has not been established. It was of interest in subsequent in-vivo
studies to identify at which point functional deficits were observed.
Overall, this chapter developed a system for inducing NTSCI. Each component of
the system was evaluated separately: ventral balloon lesion; vertebral column geometry;
evaluation of the balloon catheter; and development of the injection port system for
NTSCI. The findings of this chapter were all limited by the fact they were carried out
on the bench, as opposed to in-vivo. The following chapter built upon this, and evaluated
the effects and success of the entire system in-vivo.
7.1.3.2 Outcomes of the NTSCI in-vivo model
In chapter 6, the model developed in chapter 5 was tested in-vivo, on a total of 10 animals.
This study was important to validate the model. Functional and histological changes
were evaluated in order to understand the injury induced, and determine whether it was
distinct from a traumatic lesion characterised earlier in the research. Of the 10 animals,
3 were shams, where the balloon system was implanted but not inflated. Theoretically,
the remaining 7 animals should have had the same functional and histological outcomes.
The primary aims of the chapter were to evaluate the histology/morphology of the lesion
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compared to TSCI lesions characterised in the model development phase of the study; and
to assess basic functional outcomes using the open field locomotor scale.
Animal weights and functional outcomes
All of the animals survived the surgery with minimal complications. However, the same
outcomes were not observed in all of the injury animals. For example, some of the injured
animals required manual bladder expression for up to 10 days after maximal balloon
inflation, whereas others did not. Based on this, and functional deficits, the animals were
split into severe and mild injury groups to evaluate histological outcomes relating to motor
deficit.
The open field locomotor score in all animals (sham and both injury groups) reduced
immediately after surgery, from a score of 21 to 19, and did not change after one inflation
in the injury groups. This may have been due to damage caused during the laminectomy,
or due to catheter insertion. A limitation of the study was that it did not contain a
’laminectomy only’ group, so this cannot be further elucidated. Since functional deficit
remained the same immediately after surgery and after one inflation in the injury groups
(from 0.38 to 2.38 mm2, approximate canal stenosis from 8% to 28%), the impingement
of the spinal cord at these timepoints was minimal.
With subsequent balloon inflations, the deficit in the severe injury group increased,
with a reduction in BBB score to 14 after 2 inflations; and to complete paralysis (score of
0) after 3 inflations. In the sham group, this was not reproduced and instead the open field
score improved to 21 by day 11. In the severe injury group, motor function subsequently
recovered up to a score of 11 to 12 (indicating weight supported plantar stepping with
minimal co-ordination). Using this information and the results of the model development
research, it could be concluded that after 2 inflations (approximately 50% spinal canal
stenosis), spinal cord impingement was achieved. This impingement increased after the
3rd inflation, when function further deteriorated.
The marked locomotor recovery observed in the severe injury group, was in keeping
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with wider studies of spinal cord injury in rats (Ballermann and Fouad, 2006; Kjell et al.,
2013; Hilton et al., 2016; May et al., 2017). In various TSCI dorsal balloon catheter
studies at the same spinal level, with a matched maximum balloon diameter to that used
in the present study, a finding of complete paralysis was observed immediately after
surgery (Vanicky et al., 2001; Urdzikova et al., 2006; Sedy et al., 2007). However, in
these studies, the recovery was more limited. At two weeks post injury, no sweeping or
stepping was observed in the TSCI studies, but this was observed in the study herein. This
difference in NTSCI and TSCI functional outcomes is noteworthy, and is discussed below
in combination with differences in histological outcomes.
In the mild injury group, the functional deficits observed in the severe group were not
reproduced, in spite of having subsequent inflations and intact catheter systems. Instead,
a moderate decline to a BBB score of 16 was observed after 3 inflations. This recovered
to a score of 20 or 21 by day 16. It was observed in-vitro that there was a loss of volume
in the balloon-port system each time the injection port was punctured. Although this
was overcome by using a greater total volume to achieve the same final diameter (22.5
µL rather than 15 µL), the control of the volume of water injected in the animal study
was achieved by eye using a low volume Hamilton syringe, which offered less precise
control of volume. A difference in inflation volume between mild and severe groups
would also explain the difference in spinal cord compression (transverse cross-sectional
area) between groups. This lack of precise control of the balloon volume was a limitation
of this study.
NTSCI lesion histology
In terms of lesion histology, there was a reduction in transverse cross-sectional area of
the spinal cord in all three groups, with the greatest effect being observed in the severe
injury group. The shape of the spinal cord at the epicentre and damage to the parenchyma
differed between groups. In all groups, the predominant region of damage was the right
lateral funiculus. In the sham group, this funiculus was no longer observable. In the
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mild group the epicentre had a C shape lesion around the lateral funiculus (where the
catheter was present), but the white and grey matter of the cord were still present and
distinguishable. Conversely, in the severe group the lesion site was semicircular, and the
right hand side of the spinal cord was no longer apparent, instead it had been flattened.
Further, there was observable local disruption of the grey matter. Similar observations
of compression of the cord as opposed to parenchyma disruption have been identified in
other models of NTSCI (Kubota et al., 2011; Long et al., 2013; Sun et al., 2016). These
findings are in contrast to those of the traumatic study in the model development chapter
(see section 7.1.3.1), wherein the round shape of the spinal cord was retained, but the only
the tissue penumbra remained intact and the centre became a cystic cavity.
A previous study evaluated a traumatic balloon catheter lesion at one week post-
injury (Martin et al., 1992). The epicentre was inhabited by lipid laden ’foamy’ astrocytes,
and subsequently a fibrogliotic (GFAP positive) scar tissue formed. This is in keeping
with reviews of spinal cord injury pathology and further animal models which identify
that the primary damage causes haemorrhage and gross tissue loss, then between two
days and two weeks post-injury macrophage infiltration, initiation of glial scar formation,
and oligodendrocyte apoptosis are observed (Kim et al., 2004; Rowland et al., 2008;
Almad et al., 2011; Kubota et al., 2011; Lee et al., 2012; Long et al., 2013; Wanner
et al., 2013; Anwar et al., 2016; Kjell and Olson, 2016; Alizadeh et al., 2019). In the
NTSCI balloon catheter study described herein, these findings were not replicated. A
greater proportion of spinal cord parenchyma was retained in this model of NTSCI than
comparative TSCI lesions in the model developmement chapter. Overall, this indicates
that the lesion induced by the injection port/balloon catheter system is distinct from TSCI,
and instead represented an NTSCI phenotype.
The shape of the spinal cord allowed elucidation of the direction of the injury. In
spite of attempting to induce a ventral lesion, the injury epicentre itself appeared to have a
lateral lesion. This was a limitation of the method, since ventral lesions are more clinically
relevant in NTSCI (Watson et al., 2009; Ferrara, 2012; Tetreault et al., 2015; Martin et al.,
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2018). However, there is a balance to be made between how invasive the method is,
relative to the directionality. This balloon catheter method, although it did not induce a
fully ventral lesion, was minimally invasive and required only a partial laminectomy at
T10, leaving the injury region closed (vertebral level T7/8).
Mechanical injury mechanics affect outcomes in TSCI and NTSCI
These differences between TSCI and NTSCI functional and pathological outcomes were
likely to be due to the differences in injury velocity and timeframes. The spinal cord is
viscoelastic; therefore the load exerted onto the cord and cells within are dependent on
strain rate (Dogliotti and Yelland, 1964; Hussein, 2018). For example, using a porcine
spinal cord in transverse compression, an increase in strain rate from 0.5 s-1 to 50 s-1
resulted in an increase in elastic modulus of 170%, reflecting the viscoelastic nature of
the spinal cord (Fradet et al., 2016). In adult rat samples ex-vivo, under uniaxial tension,
for any given strain, the stress was greater at higher strain rates (Clarke et al., 2009).
Therefore, at low strain rates in NTSCI, the spinal cord is more easily deformed, and less
load is imparted onto the system and cells within. Histologically this meant in NTSCI
the spinal cord appears deformed and compressed with a changed shape, as opposed to
gross tissue damage in TSCI (section 7.1.3.1). The resulting lower stress on the cells
meant neurones and tracts remained intact, allowing functional recovery. The paralysis
observed at 3 days post NTSCI therefore was likely to be due to other factors, such as
vascular ischaemia, as opposed to direct neuronal damage due to compression.
Immunohistochemistry after NTSCI
Immunohistochemical staining for RECA-1 allowed assessment of the vasculature after
NTSCI. At the severe injury epicentre, it was observed that the mean area of each
blood vessel was less than in intact regions and other injury groups. This indicated a
narrowing of vessels; which was hypothesised to be core to the pathology of NTSCI
(Karadimas et al., 2013; Long et al., 2014). For example, in a study using an expanding
polymer to model NTSCI, ischaemia was identified at the injury epicentre through a
247
Chapter 7. Discussion
reduction in fluorescence, via injection of fluorescent microspheres into the bloodstream
before perfusion (Kurokawa et al., 2011). The findings of this chapter, alongside the
wider research, therefore suggest ischaemia and vessel narrowing is important in the
pathogenesis of NTSCI.
There are few studies which have undertaken immunohistochemistry after NTSCI to
elucidate injury mechanisms. This study aimed to assess changes to GFAP (astrocytes)
and MBP (myelin) expression. There was a moderate increase in GFAP expression at the
epicentre of severe lesions, compared to intact rostral and caudal regions and mild and
sham injury groups. This finding was not statistically significant due to the low number
of repeats in the severe injury group, but warrants further investigation. Increased GFAP
expression, astrogliosis, and subsequent glial scar formation are the established pathology
of TSCI, but minimal studies have evaluated these outcomes in NTSCI (Cullen et al.,
2007; Klironomos et al., 2011; Kawano et al., 2012; Shunmugavel et al., 2013; Wanner
et al., 2013; Weightman et al., 2014). This finding was also observed where the balloon
catheter lesion was used in a TSCI context (Chapter 5, in-vivo model development).
For in-vitro studies, using a simplified reductionist approach to evaluate the effects of
mechanical impacts on astrocytes alone, an increase in GFAP staining was observed at
high velocity but not low velocity impacts. From these chapters, pathological mechanisms
in NTSCI can be elucidated. In TSCI, GFAP reactivity is stimulated, in part, by direct
compression of the astrocytes at high velocity. However, in NTSCI, this is not the case.
The moderate astrogliotic response observed in-vivo was therefore likely to be due to the
presence of other factors and systems. Together, the in-vitro and in-vivo results added
strength to the hypothesis that local changes to the vasculature, and concurrent ischaemia,
are important in the pathology of NTSCI.
There were no observable differences in myelin expression (MBP staining) in the
sham group at epicentre, rostral and caudal regions. In the mild group there was a slight
reduction in staining at the injury epicentre, and this effect was greater in the severe
group. It is worth noting that this difference was normalised to the overall tissue area
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and hence does not represent a loss of white matter tissue. Demyelination is frequently
reported in studies of NTSCI, whether the injury is caused by implanting an expanding
material, using a line to compress the spinal cord, or using a screw method (Baptiste
and Fehlings, 2006; Kubota et al., 2011; Shunmugavel et al., 2013; Dolan et al., 2016;
Sun et al., 2016). In clinical cases, apoptosis of oligodendrocytes has been observed
(Yamaura et al., 2002; Newcombe et al., 2015). A mouse model of chronic cervical
spondylosis, through ossification of the posterior longitudinal ligament, identified a
correlation between oligodendrocyte apoptosis and the magnitude of cord compression,
as seen in this research (Uchida et al., 2002). Oligodendrocytes are the myelinating
cells within the CNS, and their apoptosis results in demyelination. This demyelination
impacts neuronal electrical transmission and signalling, and therefore functional and
sensory disturbances. It is yet to be established whether this is due to direct mechanical
compression of the oligodendrocytes; or due to ischaemia in NTSCI.
7.1.4 Study limitations and future work
Overall, in-vitro and in-vivo models of NTSCI have been developed. The major limitation
of the in-vivo study was the low N numbers in each group, which meant statistical
significance was not obtained. In spite of this, the model of NTSCI was validated
in chapter 6: outcomes of NTSCI in-vivo. An observable functional and histological
deficit was achieved, with the lesion histopathology being distinct from that of TSCI in
the in-vivo NTSCI model development chapter (chapter 5). The findings of chapter 6,
together with chapter 4 (responses of neural cells to varying mechanical inputs) provide
an understanding of the cell types involved in the pathology of NTSCI. This is important
to direct future work in these experimental models, in order to better understand the whole
pathological cascade in NTSCI.
In both in-vitro and in-vivo studies, physiological changes observed in NTSCI were
distinct from those in TSCI. For NTSCI, the differences observed in-vitro were minimal,
whereas those in-vivo were more marked and diverse. The outcomes of the in-vivo model
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may provide direction for future work in-vitro.
As previously described, the main limitations of the in-vivo study described herein
were the low N number, and variation observed between groups. Therefore, the primary
focus of future work in-vivo should be to increase the number of animals, and develop
a system to better control or characterise inflation. This should be undertaken in injury
and sham groups, and also additional laminectomy only and healthy intact controls. This
would allow greater understanding of the damage induced by insertion of the catheter,
compared to the laminectomy itself, and therefore increased understanding of the injury
paradigm. It would also be of interest to incoporate further timepoints into future studies,
for example terminating animals immediately after each inflation to characterise the
effects of each inflation itself on spinal cord histopathology, as well as the overall injury
and recovery.
One potential reason for the difference between mild and severe injury groups, as
previously described, was a lack of precision in injecting injury volume. To better
control or characterise inflation, injection systems could be used including microprocessor
controlled injectors such as a Nanolitre device, or a sampling device such as used by
Vanicky et al. (2001). Further, use of devices such as these should prevent backflow into
the device, and therefore minimise the loss of volume and pressure observed for each
injection. This should be characterised in-vitro before use in-vivo. Evaluation of the
balloon in-situ within the vertebral column could be carried out by inflating the balloon
with a radio-opaque agent and undergoing imaging experiments at various timepoints.
This would allow assessment of balloon inflation during the experiment.
Once the findings of the model in-vivo are well established, these can be used to
direct the in-vitro model, and understand the contribution of specific cell populations
and input factors (e.g. mechanical compression or ischaemia). For example, if the
demyelination observed herein is reproduced on a larger scale and number of animals,
oligodendrocytes should be evaluated in the in-vitro model. The benefits of in-vitro
modelling are the direct control of cellular and environmental factors. This means
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individual cell populations can be evaluated in isolation, and the effects of ischaemia (low
oxygen, high carbon dioxide) and mechanical compression compared both in combination
and separately
Further, in-vitro models can elucidate the mechanisms of injury in terms of
the neurovascular unit. Tissue engineered neurovascular units are currently under
development, with 3D models created using a combination of biomaterials, bioprinting
and microfluidic channels (Kim et al., 2015; Uwamori et al., 2017; Potjewyd et al., 2018).
It remains to be determined if mechanical insults could be applied using the BOSE 5110
Electroforce or other devices.
There are, of course, a wide range of other markers which could be evaluated in the
in-vivo model: including electrophysiology to assess specific tracts, (Lee et al., 2012; Sun
et al., 2016), sensory methods such as the von Frey filament test (Kubota et al., 2011; Sun
et al., 2016), and other motor tests such as inclined plane (Martin et al., 1992; Lee et al.,
2012). In terms of histological markers, this could incorporate neuronal cell changes
using NeuN staining or Nissl (Kim et al., 2004; Lee et al., 2012), along with markers for
apoptosis to evaluate specific cell populations (Newcombe et al., 2015).
7.2 Conclusion
Experimental models of NTSCI in-vitro and in-vivo have been developed:
• In-vitro the model comprised a rat astrocyte-seeded collagen I hydrogel,
compressed at various velocities in the BOSE 5110 Electroforce apparatus
• In-vivo, the model consisted of a 2F Fogarty balloon catheter, which was adapted
to connect to an injection port. This was implanted into a rat, with the balloon
positioned within the vertebral canal at vertebral level T7/8 (spinal cord level T8/9).
Physiological changes were observed in these models, which differed in TSCI and
NTSCI:
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• In-vitro and in-vivo, high velocity TSCI resulted in reactive astrogliosis (increased
GFAP expression). In-vitro, this was accompanied with inflammation (IL-6
release), and in-vivo, this was accompanied with increased CSPG expression. These
results are indicative of secondary injury cascades described in the wider literature.
• In-vitro, low velocity insults to astrocytes in isolation did not result in any
significant changes to reactivity or cytokine release.
• In-vivo, the pathology of NTSCI comprised demyelination and narrowing of
vessels. Statistical significance was not established due to the low N Numbers
• Further work should be undertaken to evaluate these phenomena in greater detail,
as well as develop further complexities within the models to evaluate the pathology
of NTSCI.
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A Consumable materials
Materials used herein are described below (Table 1).
Table 1: Consumable materials including plasticware used in this research
Material Cat No. Supplier
Autoclave tape GS849 Appleton Woods, UK
Balloon catheter, 2F 120602F Edwards Lifesciences, UK
Bijou 5 mL SLS7522 Scientific Laboratory Supplies Ltd,
UK
Blue 25cm barrel roll, 2ply 12754296 Thermo-Fisher Scientific, UK
Bone wax 1130563 Henry Schein, UK
Cannula (Sentrawin 22G) LOCAA/
1103/
22/P/50
VWR International, UK
Cell scraper (18mm length,
260mm handle)
11597692 Thermo-Fisher Scientific, UK
Cotton buds - Boots, UK
Coverslips - 22x22 mm MIC3114 Scientific Laboratory Supplies Ltd,
UK
Coverslips - 22x64 mm MIC3228 Scientific Laboratory Supplies Ltd,
UK
Cryomolds (extra large) 11356810 Thermo-Fisher Scientific, UK
Cryomolds (large) 12542696 Thermo-Fisher Scientific, UK
Cryomolds (medium) 12559036 Thermo-Fisher Scientific, UK
Cryovials 2 mL 72.380.992 Sarstedt, UK
Disposable plastic syringe
10mL
S5-10ES Terumo, UK
Disposable plastic syringe
1mL
GS572 Appleton Woods, UK
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Consumable materials including plasticware used in this research continued.
Material Cat No. Supplier
Disposable plastic syringe
2mL
SYR2 Greiner Bio-one Ltd
Disposable plastic syringe
5mL
SYR6204 Scientific Laboratory Supplies Ltd,
UK
Disposable scalpel (21) INS4765 Scientific Laboratory Supplies Ltd,
UK
Eppendorfs 1.5 mL 72.690 Sarstedt, UK
Falcon tubes 15 mL 352095 Thermo-Fisher Scientific, UK
Falcon tubes 50 mL 14-959-49A Thermo-Fisher Scientific, UK
Gauze (7.5 x 7.5 cm) 9003308 Henry Schein, UK
Glass Duran Bottle (500mL,
1L, 2L)
Various Thermo-Fisher Scientific, UK
Incontinence pads - Amazon, UK
Isathal Vm
24883/4003
Henry Schein, UK
Lubrithal LELUB01 Henry Schein, UK
Masking tape - Wilko, UK
Microtome blades S35 3808310E Leica Biosystems, Germany
Needles, 21G SYR6108 Scientific Laboratory Supplies Ltd,
UK
Needles, 23G SYR6112 Scientific Laboratory Supplies Ltd,
UK
Needles, 26G SYR6250 Scientific Laboratory Supplies Ltd,
UK
Needles, 30G SYR6124 Scientific Laboratory Supplies Ltd,
UK
Nitrile gloves 62 5122 Shield Scientific, UK
Optiplate TM 6005290 PerkinElmer, UK
Osmotic pump filling tubes 0007988 Charles River, UK
Osmotic pumps (Alzet) 1002 Charles River, UK
Parafilm SEL-400-
030P
Scientific Laboratory Supplies Ltd,
UK
Pasteur pipette 612-1681 VWR International, UK
Petri dishes, 60mm diameter CLS430166 Sigma-Aldrich, UK
Prolene suture ETW8710 Henry Schein, UK
Silicone 3140 (Dow Corning) 2399677 RS Components Ltd, UK
Silicone tubing 007750 Charles River, UK
Slides - Themofrost Plus 10149870 Thermo-Fisher Scientific, UK
Spongostan JJ-005 Henry Schein, UK
Standard pipette tips (20, 200,
1000 microlitres)
Various Starlab, UK
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Consumable materials including plasticware used in this research continued.
Material Cat No. Supplier
Sterile pot (60mL, 150mL,
250mL)
Various Scientific Laboratory Supplies Ltd,
UK
Surgical drapes (60 x 90 cm) WDDRA60 Henry Schein, UK
Surgical masks 9882161 Henry Schein, UK
Sylgard 170 2785010 Onecall Farnell, UK
Syringe filter (0.22
micrometre pore size)
10268401 Merck Millipore, UK
Syringes (various sizes) Various Greiner Bio-one, UK
Tissue culture dish (60 x 10
mm)
CLS430166 Sigma-Aldrich, UK
Tissue culture flask 75 mL
(T75)
TKT-130-
210-T
Thermo-Fisher Scientific, UK
Universal tubes 30 mL CON9000 Scientific Laboratory Supplies Ltd,
UK
Universal tubes 30 mL ARVET69 Henry Schein, UK
Vetcal MPCAL01 Henry Schein, UK
Vicryl suture (resorbable) ETW9105 Henry Schein, UK
Weighing boat Various Scientific Laboratory Supplies Ltd,
UK
Well plate, 24 well, Nunclon
delta coated
150628 Thermo-Fisher Scientific, UK
Well plate, 48 well, Nunclon
delta coated
150687 Thermo-Fisher Scientific, UK
Well plate, 96 well, Nunclon
delta coated
161093 Thermo-Fisher Scientific, UK
Wide-bore pipette tips (1000
microlitres)
Z709999-
960EA
Scientific Laboratory Supplies Ltd,
UK
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B Equipment
Equipment used in this research are listed below (Table 2).
Table 2: Equipment used in this research
Equipment Model/Product No. Supplier
Animal transport boxes - University of Leeds, UK
Autoclave - Priorclave, UK
Automatic pipettes Various (2, 20, 200,
1000 µL
Scientific Laboratory Supplies
Ltd, UK
Automatic plate washer Wellwash Thermo-Fisher Scientific, UK
Balances GR200 GX2000 A&D, Jensons PLC, UK
BOSE Biodynamic Electroforce 5110 TA Instruments, USA
Centrifuge Harrier 15/80 Sanyo Biomedical, Japan
Chameleon plate reader - Hidex, Finland
Class II Laminar Flow
Cabinet
HERA safe Thermo-Fisher Scientific, UK
Confocal microscope LSM880 Axio
Imager Z2
Carl Zeiss AG, UK
Cryostat CM1850 Leica Biosystems, UK
Dissection microscope 47 50 52 Carl Zeiss AG, UK
Eppendorf Centrifuge 5415R Hyland Scientific, USA
Excel software 2013 Microsoft, UK
Fiji Is Just Image J (FIJI)
software
- Open source (online)
Forceps, Addisons 11028-15 Interfocus, UK, UK
Forceps, locking 12010 Interfocus, UK, UK
Forceps, Rat tooth 12710926 Thermo-Fisher Scientific, UK
Freezer (-20 oC) - Jencons Plc, UK
Freezer (-80 oC) - Sanyo Biomedical, Japan
Fridge (+4 oC) - Jencons Plc, UK
Fume cupboard - Whiteley fume extraction
solutions, UK
Glass beaker Various Thermo-Fisher Scientific, UK
Graticule 01B21202 Pyser Optics, UK
Haemocytometer Neubauer 717805 Sigma-Aldrich, UK
Haemostat 14109 VWR International, UK
Hamilton Syringe (10 µL) 20976 VWR International, UK
Hamilton Syringe (50 µL) 80920 VWR International, UK
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Equipment used in this research
Material Model/Product No. Manufacturer
Hollow punch set TL17196 Onecall Farnell, UK
Image J software - ImageJ (online)
Incubator inCu safe Sanyo Biomedical, Japan
Light microscope CK40-SLP Olympus, UK
Light microscope Axio Imager M2 Carl Zeiss AG, UK
Light source CLD-01 Optika, Italy
Liquid Nitrogen Dewar BIO65 Jencons Plc, UK
Magnetic Stirrer GyroStir 280H SciQuip, UK
Magnetic Stirrer Bar Various Scientific Laboratory Supplies
Ltd, UK
Nail brush - Wilko, UK
Orbital Shaker PSU 10i Grant-bio, UK
Peristaltic pump (Masterflex) WZ-77921-75 Cole-Parmer Instrument Co
Ltd, UK
Permanent marker - Wilko, UK
pH meter Jenway 3510 VWR International, UK
Pipette boy Integra acu Integra Bioscience, UK
Plate reader Multiskan Go Thermo-Fisher Scientific, UK
Razor blades; single edge 233-0156 VWR International, UK
Retractor 17003-03 Interfocus, UK
Rongeur clippers 16121-14 Interfocus, UK
Scissors, Curved Dissecting,
10 cm
14394 World Precision Instruments,
UK
Scissors, Curved Iris 4.5
inches
501759 World Precision Instruments,
UK
Scissors, Curved Spring, 10.5
cm
14127 World Precision Instruments,
UK
Scissors, straight, blunt 14 cm 501219 World Precision Instruments,
UK
Scissors, straight, blunt 16 cm 501224 World Precision Instruments,
UK
Scissors, straight, sharp 7.5
cm
503669 World Precision Instruments,
UK
Scissors, straight, sharp 9 cm 14070-09 Interfocus, UK
Spatula 231-1059 VWR International, UK
Stainless steel bowls Various Wilko, UK
Tea towel - Wilko, UK
Test tube rack - Scientific Laboratory Supplies
Ltd, UK
Tweezers, extra fine point T147 TAAB, UK
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Equipment used in this research
Material Model/Product No. Manufacturer
Watchmaker forceps, 4 232-0202 VWR International, UK
Watchmaker forceps, 55 14099 World Precision Instruments,
UK
Water Bath JBA5 Grant Instruments Ltd, UK
Xtreme CT - ScanCo Medical, Switzerland
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C Reagents
Chemical reagents used are listed below (Table 3).
Table 3: Chemical Reagents, Storage Conditions and Suppliers
Chemical/Reagent Storage (oC) Cat No. Supplier
10X Minimum Essential
Media
4 60-91-810 First Link, UK
Acetone Room
temperature
LS8/1970/G Genta Medical, UK
ATPlite 1000 assay kit 4 6016941 Perkin-Elmer, UK
Baytril Room
temperature
BABAY49 Henry Schein, UK
Bovine serum albumin
(BSA)
4 A7030 Sigma-Aldrich, UK
Chondroitin sulfate
proteoglycan Antibody
(CS-56)
-20 C8035 Sigma-Aldrich, UK
Deoxyribonuclease
(Dnase)
-20 D5025 Sigma-Aldrich, UK
Dimethyl sulfoxide Room
temperature
D26650 Sigma-Aldrich, UK
DPX mountant Room
temperature
RRSP29 Atom Scientific, UK
Dulbecco’s modified
Eagle’s medium (DMEM)
4 11594416 Lonza Biological, UK
Endothelial Cells
Antibody (RECA-1)
4 MA140240 Thermo-Fisher Scientific,
UK
Eosin Room
temperature
1.09844.1000 Merck Millipore, UK
Ethanol (100% v/v) Room
temperature
E/055DF/25 Thermo-Fisher Scientific,
UK
Foetal bovine serum
(FBS)
-20 E/0650DF/25 Thermo-Fisher Scientific,
UK
GFAP primary antibody 4 Z0334 DAKO, UK
Goat anti-mouse IgG
Alexa Fluor 647
4 A21236 Thermo-Fisher Scientific,
UK
Goat anti-mouse IgM
Alexa Fluor 568
-20 A21043 Thermo-Fisher Scientific,
UK
Goat anti-rabbit IgG
Dylight 488
4 DI-1488 Vector Laboratories, UK
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Chemical Reagents, Storage Conditions and Suppliers continued.
Chemical/Reagent Storage (oC) Cat No. Supplier
Haematoxylin (Mayer’s) Room
temperature
RRSP60 Atom Scientific, UK
Ham’s F-12 4 N4888 Sigma-Aldrich, UK
Hanks Balanced Salt
Solution (HBSS)
Room
temperature
H9269 Sigma-Aldrich, UK
Hanks Balanced Salt
Solution (without
Calcium or Magnesium;
HBSS modified)
Room
temperature
H9394 Sigma-Aldrich, UK
HEPES buffer Room
temperature
LZBE17-
737E
Scientific Laboratory
Supplies Ltd, UK
Hoechst 33258 -20 16756 Cambridge Bioscience,
UK
Horse serum -20 H1270 Sigma-Aldrich, UK
Hydrochloric acid (6M) Room
temperature
2611.5 VWR International, UK
Isoflurane Room
temperature
1182097 Henry Schein, UK
L-glutamine -20 G7513 Sigma-Aldrich, UK
LIVE/DEAD
Viability/Cytotoxicity
Kit, for mammalian cells
-20 L3224 Thermo-Fisher Scientific,
UK
Marvel milk powder Room
temperature
- Premier Foods, UK
Methanol Room
temperature
428 Genta Medical, UK
Myelin Basic Protein
Antibody (MBP)
4 ab40390 Abcam, UK
Neutralising solution 4 A-0054 Tap Biosystems (now
Sartorium Stedim
Biotech), UK
Normal goat serum 4 OASB01365 Generon, UK
Optimum cutting
temperature (OCT)
Room
temperature
361063E VWR International, UK
Paraformaldehyde (PFA)
powder
Room
temperature
P6148 Sigma-Aldrich, UK
Paraformaldehyde (PFA)
solution
-20 AR1068 Insight biotechnology,
UK
Penicillin/streptomycin -20 P4458 Sigma-Aldrich, UK
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Chemical Reagents, Storage Conditions and Suppliers continued.
Chemical/Reagent Storage (oC) Cat No. Supplier
Pentoject (pentobarbitone
200 mg.mL-1)
Room
temperature
Henry Schein, UK
Phosphate buffered saline
(PBS) tablets
Room
temperature
10209252 Thermo-Fisher Scientific,
UK
Phosphate buffered saline
(PBS) without calcium
and magnesium
Room
temperature
D8537 Sigma-Aldrich, UK
Poly-D-Lysine -20 P7886 Sigma-Aldrich, UK
Rat IL-10 ELISA Kit 4 CRE0007-
096
Generon, UK
Rat IL-6 ELISA Kit 4 CRE0005-
096
Generon, UK
Rat tail collagen 4 60-30-810 First Link, UK
Saline Room
temperature
VDAQU02 Aqupharm, UK
Scott’s tap water
substitute 10X
Room
temperature
RRSP190 Atom Scientific, UK
Sodium azide Room
temperature
786-299 VWR International, UK
Sodium chloride Room
temperature
42429-5000 Thermo-Fisher Scientific,
UK
Sodium phosphate
monobasic
Room
temperature
10667823 Thermo-Fisher Scientific,
UK
Soybean trypsin inhibitor
(SBTI)
4 T6522 Sigma-Aldrich, UK
Sucrose Room
temperature
S9378 Sigma-Aldrich, UK
TGF-beta 1 -20 GFH39-5 Cell Guidance Systems,
UK
Trigene Room
temperature
TRI1322 Scientific Laboratory
Supplies Ltd, UK
Tris Room
temperature
B2005 Sigma-Aldrich, UK
Triton X-100 Room
temperature
X100 Sigma-Aldrich, UK
Trizma base Room
temperature
T-1503 Sigma-Aldrich, UK
Trypan blue Room
temperature
T8154 Sigma-Aldrich, UK
Trypsin 4 T0303 Sigma-Aldrich, UK
Trypsin/EDTA -20 T3924 Sigma-Aldrich, UK
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Chemical Reagents, Storage Conditions and Suppliers continued.
Chemical/Reagent Storage (oC) Cat No. Supplier
Tween 20 Room
temperature
P1379 Sigma-Aldrich, UK
Vetergesic Room
temperature
VDVET02 Henry Schein, UK
Veterinary iodine solution Room
temperature
IodineV Hyperdrug.co.uk
Virkon Room
temperature
148-0202 VWR International, UK
Water (sterile) Room
temperature
31-58-589 Leeds Teaching
Hospitals, UK
Xylene Room
temperature
GPS1001-G Atom Scientific, UK
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D FIJI Image Analysis Macros
The general outline of all the FIJI Macros used is import, followed by set
scale/threshold/analyse, followed by export. The set scale/threshold/analyse macros used
were bespoke for each image type and can be found in the subsections below. The import
and export macros were as follows:
IMPORT:
d i r 1 = g e t D i r e c t o r y ( ” Choose Source D i r e c t o r y ” ) ;
f o r m a t = g e t F o r m a t ( ) ;
d i r 2 = g e t D i r e c t o r y ( ” Choose D e s t i n a t i o n D i r e c t o r y ” ) ;
l i s t = g e t F i l e L i s t ( d i r 1 ) ;
se tBatchMode ( t r u e ) ;
f o r ( i =0 ; i< l i s t . l e n g t h ; i ++) {
s h o w P r o g r e s s ( i +1 , l i s t . l e n g t h ) ;
open ( d i r 1 + l i s t [ i ] ) ;
EXPORT:
i f ( f o r m a t ==”8− b i t TIFF ” | | f o r m a t ==”GIF ” )
c o n v e r t T o 8 B i t ( ) ; saveAs ( fo rmat , d i r 2 + l i s t [ i ] ) ;
c l o s e ( ) ; }
f u n c t i o n g e t F o r m a t ( ) {
f o r m a t s = newArray ( ” TIFF ” , ”8− b i t TIFF ” , ”JPEG ” ,
”GIF ” , ”PNG” ,
”PGM” , ”BMP” , ” FITS ” , ” Text Image ” , ” ZIP ” , ”Raw ” ) ;
D i a l og . c r e a t e ( ” Batch Conve r t ” ) ;
D i a l og . addChoice ( ” Conve r t t o : ” , f o r m a t s , ” TIFF ” ) ;
D i a l og . show ( ) ;
r e t u r n D ia log . g e t C h o i c e ( ) ; }
f u n c t i o n c o n v e r t T o 8 B i t ( ) {
i f ( b i t D e p t h ==24) run (”8− b i t Co lo r ” , ” number = 2 5 6 ” ) ;
e l s e run (”8− b i t ” ) ; } }
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D.1 Macro for GFAP image analysis
The macro below was modified from Smith (2016) and the methods herein. It was used to
analyse the total area, count and average size of GFAP-labelled astrocytes in hydrogels.
/ /MACRO w r i t t e n by K Timms 16 t h December 2016 ,
a u t o m a t i c GFAP a n a l y s i s
run (”8− b i t ” ) ; t i t l e = g e t T i t l e ( ) ; run ( ” S e t S c a l e . . . ” ,
” d i s t a n c e =1 .48 known=1 p i x e l =1 u n i t =um g l o b a l ” ) ;
run ( ” S e t Measurements . . . ” , ” a r e a mean min
shape r e d i r e c t =None d e c i m a l = 3 ” ) ;
i f ( matches ( t i t l e , ” . ∗Ch1 . ∗ ” ) ) {
run ( ” Auto Loca l T h r e s h o l d ” , ” method= P h a n s a l k a r
r a d i u s =10 p a r a m e t e r 1 =0 p a r a m e t e r 2 =0 w h i t e ” ) ;
run ( ” Watershed I r r e g u l a r F e a t u r e s ” , ” e r o s i o n =1
c o n v e x i t y t h r e s h o l d =0 s e p a r a t o r s i z e =7− I n f i n i t y ” ) ;
run ( ” Despeck l e ” ) ; run ( ” F i l l Holes ” ) ;
run ( ” S e l e c t A l l ” ) ; run ( ” Measure ” ) ;
run ( ” Analyze P a r t i c l e s . . . ” , ” s i z e =10− i n f i n i t y
c i r c u l a r i t y =0.00−1.00 show=Masks d i s p l a y
e x c l u d e c l e a r i n c l u d e summarize i n s i t u ” ) ;
D.2 Transverse Spinal Cord Sections Area
Spinal cords were sectioned in the transverse plane at 40 µm thickness. These were stained
with H&E and imaged using brightfield microscopy. The area of tissue on each image was
determined using the macro below (adapted from Fedorova and Pavel (2019)):
/ /MACRO w r i t t e n by K Timms A p r i l 2019 , a n a l y s e
c r o s s−s e c t i o n a l a r e a s p i n a l co rd t i s s u e a f t e r H&E .
run ( ” S e t S c a l e . . . ” , ” d i s t a n c e =736 known=1 p i x e l =1
u n i t =mm g l o b a l ” ) ; run ( ” Despeck l e ” ) ; run (”8− b i t ” ) ;
t i t l e = g e t T i t l e ( ) ; run ( ” Auto T h r e s h o l d ” , ” method=Huang ” ) ;
run ( ” S e t Measurements . . . ” , ” a r e a mean min
shape a r e a f r a c t i o n l i m i t d i s p l a y
r e d i r e c t =None d e c i m a l = 3 ” ) ; run ( ” Measure ” ) ;
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D.3 Image Analysis of Immunofluorescent-labelled Spinal Cord
Sections
Spinal cords were sectioned in the transverse plane at 40 µm thickness. These were stained
with various immuno-fluorescent markers, including GFAP (488) + CS-56 (568), and
MBP (488) + RECA-1. The images were evaluated using the macro below:
/ /MACRO w r i t t e n by K Timms 10 t h Sep t 2019 , IHC a n a l y s i s
s o u r c e t i t l e = g e t T i t l e ( ) ; run ( ” D u p l i c a t e . . . ” , ” ” ) ;
copy = get ImageID ( ) ; run (”8− b i t ” ) ;
run ( ” S e t S c a l e . . . ” , ” d i s t a n c e =603 known=1 p i x e l =1
u n i t =mm g l o b a l ” ) ;
run ( ” S e t Measurements . . . ” , ” a r e a mean min shape
r e d i r e c t =[”+ s o u r c e t i t l e +”] d e c i m a l = 3 ” ) ;
/ / s e l e c t 488 , 568 , 647 images
i f ( matches ( s o u r c e t i t l e , ” . ∗ 5 6 8 . ∗ ” )
| | matches ( s o u r c e t i t l e , ” . ∗ 4 8 8 . ∗ ” )
| | matches ( s o u r c e t i t l e , ” . ∗ 6 4 7 . ∗ ” ) ) {
run ( ” Auto Loca l T h r e s h o l d ” , ” method= P h a n s a l k a r
r a d i u s =10 p a r a m e t e r 1 =0 p a r a m e t e r 2 =0 w h i t e ” ) ;
/ / r e d u c e background
run ( ” Despeck l e ” ) ; run ( ” S e l e c t A l l ” ) ; run ( ” Measure ” ) ;
run ( ” Analyze P a r t i c l e s . . . ” , ” s i z e =0.000−0.001
c i r c u l a r i t y =0.00−1.00 e x c l u d e c l e a r i n c l u d e summarize ” ) ;
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E BBB Scale, Open Field Locomotor Score
The scores and associated attributes, and definitions used therein, for the open field
locomotor scale (BBB scale) from Basso et al. (1995) are listed below (Table 4).
Definitions:
• Slight partial joint movement through less than half the range of joint motion
• Extensive movement through more than half of the range of joint motion
• Sweeping rhythmic movement of HL in which all three joints are extended, then
fully flex and extend again; animal is usually sidelying, the plantar surface of paw
may or may not contact the ground; no weight support across the HL is evident
• No weight support no contraction of the extensor muscles of the HL during plantar
placement of the paw; or no elevation of the hindquarters
• Weight support contraction of the extensor muscles of the HL during plantar
placement of the paw, or elevation of the hindquarter
• Plantar stepping The paw is in plantar contact with weight support then the HL is
advanced forward and plantar contact with weight support is reestablished
• Dorsal stepping weight is supported through the dorsal surface of the paw at some
point in the step cycle
• FL-HL coordination for every FL step an HL step is taken and the HLs alternate
• Occasional less than or equal to half of the time; 0-50%
• Frequent more than half but not always; 51-94%
• Consistent nearly always or always; 95-100%
• Trunk Instability lateral weight shifts that cause waddling from side to side or a
partial collapse of the trunk
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Table 4: The 21-point Basso, Beattive, Bresnahan (BBB) locomotor rating scale and
operational definitions of categories and attributes. Details from Basso et al. (1995)
Score Attributes
H
in
dl
im
b
m
ov
em
en
t
ex
te
nt
an
d
fr
eq
ue
nc
y
0 No observable hindlimb (HL) movement
1 Slight movement of one or two joints, usually the hip and/or
knee
2 Extensive movement of one joint or extensive movement of
one joint and slight movement of one other joint
3 Extensive movement of two joints
4 Slight movement of all three joints of the HL
5 Slight movement of two joints and extensive movement of the
third
6 Extensive movement of two joints and slight movement of the
third
7 Extensive movement of all three joints of the HL
W
ei
gh
ts
up
po
rt
an
d
co
-o
rd
in
at
io
n
8 Sweeping with no weight support or plantar placement of the
paw with no weight support
9 Plantar placement of the paw with weight support in stance
only (i.e. when stationaru) or occasional, frequency, or
consistent weight supported dorsal stepping and no plantar
stepping
10 Occasional weight supported plantar steps, no forelimb
(FL)-HL coordination
11 Frequent to consistent weight supported plantar steps and no
FL-HL coordination
12 Frequent to consistent weight supported plantar steps and
occasional FL-HL coordination
13 Frequent to consistent weight supported plantar steps and
frequent FL-HL coordination
X
X
X
X
X
X
Pa
w
po
si
tio
n
an
d
to
e
cl
ea
ra
nc
e
14 Consistent weight supported plantar steps, consistent FL-HL
cordination; and predominant paw position during locomotion
is rotated (internally or externally) when it makes initial
contact with the surface as well as just before it is lifted off at
the end of stance or frequent plantar stepping, consistent
FL-HL coordination, and occasional dorsal stepping
15 Consistent plantar stepping and consistent FL-HL
coordination, and no toe clearance or occasional toe clearance
during forward limb advancement; predominant paw position
is parallel to the body at initial contact
16 Consistent plantar stepping and consistent FL-HL
coordination during gait and toe clearance occurs frequently
during forward limb advancement; predominant paw position
is parallel at initial contact and rotated at lift off
267
Appendices
The 21-point Basso, Beattive, Bresnahan (BBB) locomotor rating scale continued.
Score Attributes
Pa
w
po
si
tio
n
an
d
to
e
cl
ea
ra
nc
e
17 Consistent plantar stepping and consistent FL-HL
coordination during gait and toe clearance occurs frequently
during forward limb advancement; predominant paw position
is parallel at initial contact and lift off
18 Consistent plantar stepping and consistent FL-HL
coordination during gait and toe clearance occurs consistently
during forward limb advancement; predominant paw position
is parallel at initial contact and rotated at lift off
St
ab
ili
ty
19 Consistent plantar stepping and consistent FL-HL
coordination during gait and toe clearance occurs frequently
during forward limb advancement; predominant paw position
is parallel at initial contact and lift off; and tail is down part or
all of the time
20 Consistent plantar stepping and consistent FL-HL
coordination during gait and toe clearance occurs frequently
during forward limb advancement; predominant paw position
is parallel at initial contact and lift off; tail consistently up;
trunk instability
21 Consistent plantar stepping and consistent FL-HL
coordination during gait and toe clearance occurs frequently
during forward limb advancement; predominant paw position
is parallel at initial contact and lift off; tail consistently up;
consistent trunk stability
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F Mechanics of Collagen Hydrogel Compression
The table below describes further detail of compression mechanics.
Table 5: Mechanical compression data from astrocyte-seeded hydrogel experiments. Data shown are mean ± S.E.M., of at least 4
repeats per datapoint. Velocity data is the maximum velocity recorded.
Theoretical input velocity (mm.s-1)
Mechanic 0.1 1 10 100
Experimental velocity
(mm.s-1)
0.28 ± 0.02 1.31 ± 0.1 10.2 ± 0.01 112.11 ± 0.21
Theoretical velocity (mm.s-1) 0.1 ± 5.21 x10-4 1.02 ± 3.33 x10-4 10.01 ± 5.44 x10-3 100.15 ± 3.86 x10-3
% Difference -169.01 -28.54 -1.9 -11.94
Displacement (mm) 1.88 ± 0.08 1.98 ± 0.08 1.95 ± 0.02 1.95 ± 0.01
Axial command (mm) 1.88 ± 0.08 1.98 ± 0.08 1.94 ± 0.02 1.95 ± 0.01
% Difference -0.06 -0.11 -0.24 0.02
Load (N) 0.16 ± 0.02 0.65 ± 0.06 1.45 ± 0.03 1.51 ± 0.1
Work done (mJ) 0.05 ± 0.02 0.26 ± 0.03 0.78 ± 0.1 1.12 ± 0.13
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